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Lay summary 
 
Huntington’s disease is an inherited neurodegenerative disease that results in 
the child of an affected person having a 50% chance of developing the disease. The 
major characteristics of the disease are the preferential degeneration of a sub-type of 
brain cell (medium spiny neuron) that produce a peptide called enkephalin.  Loss of 
these particular neurons results in abnormal uncontrollable movements, impairment 
in comprehension, memory and psychiatric problems. Due to the fact that no 
effective treatment for the disease is available, development of a tool to explore the 
function of these neurons is essential. Use of embryonic stem cells is considered to 
be a potential approach for modelling neurodegenerative disorders including 
Huntington’s disease. This strategy, however, needs a robust method to produce the 
specific cells of interest. Previous studies have generated medium spiny neurons 
from embryonic stem cells but failed to show whether they produced enkephalin. We 
show here that, the standard method for deriving medium spiny neurons from 
embryonic stem cells generates low numbers of neurons that make enkephalin. 
Interestingly, higher numbers are produced from a simpler culture condition and that 
these cells exhibit normal electrical properties of functional medium spiny neurons. 
We, therefore, conclude that the simpler culture condition is preferable for deriving 
enkephalin-expressing medium spiny neurons from embryonic stem cells. 
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Abstract 
 
Medium spiny neurons (MSNs) play an important role in locomotion. 
Counterbalance between two MSN subtypes, enkephalin-positive and substance P-
positive MSNs, is crucial for maintaining normal movement. Preferential 
degeneration of enkephalinergic MSNs in early stage Huntington’s disease (HD) 
contributes to abnormal involuntary movement called chorea. The reasons for this 
selective vulnerability are unknown. In vitro differentiation of pluripotent stem cells 
(PSCs) to neuronal cells is considered a potential approach for modelling 
neurodegenerative disorders including HD. Generation of PSC-derived 
enkephalinergic MSNs would be an ideal tool for dissecting their preferential 
degeneration. However, an enkephalinergic phenotype has never been reported in 
PSC-derived MSNs. We, therefore, have generated a mouse embryonic stem cell 
(mESC) reporter line that expresses enhanced yellow fluorescent protein (EYFP) 
when the cells are committed to an enkephalinergic fate. Characterisation of this 
mESC line via chimaera generation showed that all EYFP-positive cells were also 
enkephalin-positive. We have then optimised an enkephalinergic neuronal 
differentiation protocol using this ESC line. Interestingly, we found that a 
combination of Wnt inhibitor Dickkopf-related protein 1 (DKK1), sonic hedgehog 
(Shh) and brain-derived neurotrophic factor (BDNF), commonly used in addition to 
basal medium for deriving MSNs from PSCs, had a detrimental effect on enkephalin 
expression. Absence of these three factors, surprisingly, did not reduce the potential 
of ESCs to become MSNs nor did it affect the electrophysiological properties of 
ESC-derived MSNs. Further investigation revealed that Pre-pro-enkephalin is down-
regulated in the presence of exogenous DKK1 and/or Shh but not in the presence of 
BDNF. We, therefore, propose that addition of exogenous DKK1 and Shh is 
unfavourable to derive enkephalinergic MSNs from mouse ESCs. These findings 
could be used to derive enkephalinergic MSNs in vitro allowing the disease in a dish 
approach for HD modelling. 
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Chapter 1: Introduction 
 
1.1 The basal ganglia 
 
1.1.1 Anatomy and physiology 
The basal ganglia consist of a number of nuclei within the brain. Their main 
function is to control voluntary movement. Developmentally most of the basal 
ganglia structures, including the striatum, the globus pallidus (GP) and the 
subthalamic nucleus (STN), originate from the forebrain whereas the substantia nigra 
(SN) derives from the midbrain. The basal ganglia receive signals from the cerebral 
cortex and relay them to the thalamus, which in turn is the input for the cortex. The 
basal ganglia are involved not only in the motor function, but also in non-motor 
functions such as mood and reward-related behaviour (O'Callaghan et al., 2014). 
Regarding motor function, the basal ganglia are believed to contribute to the 
selection and execution of, but not the initiation of, voluntary movement (Bear et al., 
2001, Wichmann and DeLong, 2013).  
The striatum is widely considered the main input of the basal ganglia (Albin 
et al., 1989, DeLong, 1990, Bolam et al., 2000, Schroll and Hamker, 2013, 
Wichmann and DeLong, 2013). This structure is also known as the neostriatum or 
the dorsal striatum. In some mammals including the primates, the striatum is divided 
into two structures, the caudate nucleus and the putamen. The striatum receives 
glutamatergic inputs from efferent fibres of cortical and thalamic neurons (Albin et 
al., 1989, Wichmann and DeLong, 2013). It is also innervated by dopaminergic 
fibres from the substantia nigra pars compacta (SNc) and the ventral tegmental area 
(VTA) (Albin et al., 1989, Kreitzer, 2009, Wichmann and DeLong, 2013). Striatal 
projection neurons (also known as medium spiny neurons or MSNs, for more details 
see chapter 1.1.2), which are normally quiescent in the resting stage (Bolam et al., 
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2000), then relay the signal via GABAergic efferent fibres to their targets after being 
activated by cortical efferent fibres. 
Microscopically, the striatum could be divided into two compartments, the 
striosome (also known as the patch) and the matrix (Graybiel, 1990, Gerfen, 1992, 
Mitchell et al., 1999, Kreitzer, 2009). The striosome, which represents approximately 
10-20% of striatal volume (Graybiel, 1990, Kreitzer, 2009), is identified by an 
enrichment of µ-opioid receptor (Herkenham and Pert, 1981) and a lack of 
acetylcholinesterase (Graybiel and Ragsdale, 1978). Inputs to patch neurons are 
mainly from the prelimbic and frontal cortices (Kreitzer, 2009, Shepherd, 2013). On 
the other hand, the matrix compartment is defined by area of dense calbindin (Gerfen 
et al., 1985), choline acetyltransferase (ChAT) (Graybiel et al., 1986) and 
acetylcholinesterase (Graybiel and Ragsdale, 1978) staining. Matrix neurons receive 
input projections from both the cortex and the thalamus (Kreitzer, 2009).  
The main outputs of the basal ganglia are neurons in the internal segment of 
globus pallidus (GPi, also known as medial globus pallidus or entopeduncular 
nucleus in rodents) and the substantia nigra pars reticulata (SNr) (Albin et al., 1989, 
DeLong, 1990, Bolam et al., 2000, Schroll and Hamker, 2013). Unlike MSNs, the 
GABAergic neurons of the GPi/SNr are constantly active unless they receive 
inhibitory signals. GABAergic inhibitory efferent fibres from both structures then 
project to the ventral-anterior/ventral-lateral (VA/VL) nuclei of the thalamus. These 
nuclei in turn send their glutamatergic excitatory axons back to the cortex. In the 
resting state, thalamic activity is usually suppressed by inhibition from the GPi/SNr 
and therefore, less signal is transmitted to the cortex. 
Connections between the input (striatum) and the output (GPi/SNr) of the 
basal ganglia are composed of two different pathways, the direct and the indirect 
(Figure 1.1). The striatal projection neurons in the direct pathway project their 
inhibitory fibres directly to the basal ganglia output, the GPi and the SNr (Albin et 
al., 1989, DeLong, 1990, Bolam et al., 2000, Schroll and Hamker, 2013). Upon 
activation of MSNs in the direct pathway, inhibition discharge from the MSNs 
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suppresses the activity of the output neurons in the GPi/SNr, which in turn leads to a 
disinhibition of the projection neurons within the thalamus, a GPi/SNr target. 
Consequently, thalamic neurons produce the excitation discharge to their targets, the 
cerebral cortex.  
Conversely, another group of MSNs send inhibitory fibres to the external 
segment of the globus pallidus (GPe, also known as lateral globus pallidus). 
GABAergic projection neurons within the GPe in turn negatively regulate the 
activity of subthalamic nucleus (STN) excitatory neurons, which project their axons 
to the GPi and the SNr (Albin et al., 1989, DeLong, 1990, Bolam et al., 2000, Schroll 
and Hamker, 2013). It has been found that, in addition to GPe-STN-GPi/SNr circuit, 
GABAergic neurons of the GPe have a direct connection to output neurons in the 
GPi/SNr (Bolam et al., 2000, Schroll and Hamker, 2013). Thus, the MSNs in this 
pathway are indirectly connected to the GPi/SNr via neurons of the GPe and STN. 
Activation of the striatal projection neurons in the so-called “indirect pathway” leads 
to a reduction in GABAergic inhibitory activity of the GPe neurons, which in turn 
causes disinhibition of excitatory discharge from neurons of the STN. Further 
excitatory input from the STN then stimulates GABAergic discharge from the 
GPi/SNr, which eventually results in the inhibition of the basal ganglia target, the 
VA/VL nuclei of the thalamus. Therefore, stimulation of the direct and indirect 
pathways produces opposite outcomes. Counterbalance of the two pathways provides 
feedback to the cerebral cortex and is necessary for appropriate voluntary movement 
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Figure 1.1 The motor circuits of basal ganglia. The cortico-basal ganglia-thalamocortical 
tracts consist of two parallel pathways within the basal ganglia. Excitatory signals from 
cerebral cortex and thalamus stimulate two MSN subtypes in the striatum. Activation of the 
direct pathway MSNs, which are substance P (SP)-positive, express the dopamine D1 
receptor and send their inhibitory axons to the GPi/SNr, leads to suppression of GABAergic 
neurons of the GPi/SNr. Consequently, disinhibition of glutamatergic neurons in the 
thalamus results in more signal being sent back to the cerebral cortex. In contrast, activation 
of another group of the MSNs, which are enkephalinergic (Enk, note that enkephalinergic 
neurons are also found in the granular layer of cerebellum and olfactory bulb and, to a lesser 
extent, in the cerebral cortex) and express the dopamine D2 receptor, causes an opposite 
outcome. The MSNs of the indirect pathway inhibits the activity of GABAergic neurons of the 
GPe by receiving excitatory signals from the cerebral cortex. This subsequently stimulates 
GPi/SNr inhibitory function. Thus, the cerebral cortex receives less feedback signal from the 
thalamus. The cerebral cortex then integrates the signals received from the basal ganglia 
and thalamus before sending the signals through the corticospinal tract to execute motor 
function. GPe, external segment of globus pallidus; GPi, internal segment of globus pallidus; 
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1.1.2 Neuronal cell types within the striatum 
1.1.2.1 Medium spiny neurons 
Neuronal cells in the striatum are categorised into two distinct groups 
according to their function, GABAergic projection neurons called “medium spiny 
neurons (MSNs)” and aspiny interneurons (Kreitzer, 2009). The majority of neurons 
(approximately of 95%) in the striatum are MSNs (Mitchell et al., 1999, Gil and 
Rego, 2008, Kreitzer, 2009). As mentioned in chapter 1.1.1, their main function is to 
relay a signal from the cerebral cortex to the thalamus via two different pathways, the 
direct and indirect pathways so regulating movement. Thus, the MSNs can be 
classified into two subtypes according to the contribution to the specific movement 
pathway. The MSNs of the direct pathway project their axon to the GPi and SNr. 
They are, thus, named the striatonigral MSNs, which indicates their location and 
targets (Kreitzer, 2009). On the other hand, the MSNs of the indirect pathway, which 
send their axonal terminals to the GPe, are known as the striatopallidal MSNs 
(Kreitzer, 2009).  
Electrophysiologically the two MSN subtypes exhibit unique properties. They 
possess a hyperpolarised resting membrane potential and low input resistance due to 
the function of inwardly rectifying potassium channels (Kirs). During depolarisation, 
the inhibition of Kirs is elicited whilst the fast-inactivating A-type potassium channel 
(Kv4.2), the slow-inactivating potassium channel (Kv1.2) and the Kv7 potassium 
channel are active (Kreitzer, 2009). The activation of Kv4.2, Kv1.2 and Kv7 
channels results in the hallmark of MSN electrical property, a depolarisation with a 
delayed onset in generating the initial spike (Kreitzer, 2009) indicated by the 
presence of a low-voltage-activated potassium current (IA) (Ericsson et al., 2011). 
The difference between striatonigral and striatopallidal MSNs in terms of electrical 
property is subtle. Striatopallidal MSNs were shown to be more excitable than the 
striatonigral MSNs due to the difference in properties of Kir inactivation (Kreitzer, 
2009). Additionally, the striatopallidal MSNs are more responsive to the inhibition of 
muscarinic M1 receptors compared to the striatonigral counterpart (Shen et al., 2007, 
Kreitzer, 2009).   
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Until recently, both MSN subtypes were initially thought to be 
morphologically identical. Gertler and colleagues have demonstrated that the 
striatonigral MSNs have higher number of primary dendrites than the striatopallidal 
subtype (Gertler et al., 2008). Indeed, this morphological distinction contributes, in 
part, to the electrophysiological differences between two MSN subtypes (Gertler et 
al., 2008). 
In addition to the electrophysiological and morphological dichotomy, both 
striatonigral and striatopallidal MSNs are distinct in terms of the molecular 
phenotype (Table 1.1). Although all MSNs are GABA-producing neurons and 
express a common marker, dopamine- and cAMP-regulated phosphoprotein of 
32,000 kDa or Darpp32 (also known as protein phosphatase 1 regulatory subunit 1B 
or Ppp1r1b), neuropeptides present in each subtype are different. Substance P and 
dynorphin are selectively produced by the striatonigral MSNs whilst the 
striatopallidal MSNs preferentially secrete enkephalin (Gerfen and Young, 1988, 
Gerfen et al., 1990). Differential expression of various receptors in MSN subtypes 
has also been well described in rodents. The striatonigral MSNs possess dopamine 
D1 receptor (D1R, encoded from Drd1a gene) (Gerfen et al., 1990) and muscarinic 
M4 receptor (Harrison et al., 1996). In contrast, dopamine D2 receptor (D2R, 
encoded from Drd2 gene) (Gerfen et al., 1990) and adenosine A2a receptor (Ferré et 
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Table 1.1: Basic characteristics of the striatonigral and striatopallidal MSNs. 
 Striatonigral MSN Striatopallidal MSN 
Neuropeptide produced Subtance P 
Dynorphin 
Enkephalin 
Type of dopamine receptor 
expressed 
D1 receptor D2 receptor 
Other receptors expressed Muscarinic M4 receptor Adenosine A2a receptor 
Axonal projection Substantia nigra pars 
reticulata and internal 
portion of globus pallidus 
External portion of globus 
pallidus 
 
Function  Initiation of voluntary 
movement (direct 
pathway) 
Suppression of unwanted 
movement (indirect 
pathway) 
Striatal compartment Patch and matrix Patch and matrix 
Degeneration in 
Huntington’s disease 
Degeneration occurs in 
the late stage of the 
disease 
Degeneration starts in the 
early stage of the disease 
(most vulnerable neuronal 
population) 
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1.1.2.2 Striatal interneurons 
Striatal interneurons represent only a small fraction (approximately 2.3% in 
rodents) of striatal neuronal cells (Rymar et al., 2004). They receive input from the 
cerebral cortex and the thalamus. Their major function is to modulate the activity of 
the MSNs. The striatal interneurons consist of two main groups, the medium-sized 
GABA-producing interneurons and the large-size cholinergic interneurons (Tepper 
and Bolam, 2004, Kreitzer, 2009). GABAergic interneurons comprise approximately 
2% of total striatal neurons (Rymar et al., 2004) and can be further classified into 
three subtypes: parvalbumin-positive, somatostatin-positive and calretinin-positive 
neurons (Rymar et al., 2004, Tepper and Bolam, 2004, Kreitzer, 2009). Parvalbumin-
positive interneurons account for about 0.7% of total neurons within the rodent 
striatum (Rymar et al., 2004) and are the best characterised striatal interneurons. In 
terms of electrophysiology, they are called fast-spiking (FS) interneurons because 
they exhibit rapid and sustained firing rates (Tepper and Bolam, 2004, Kreitzer, 
2009). They inhibit activity of both striatonigral and striatopallidal MSNs via 
numerous synaptic connections (Gittis and Kreitzer, 2012, Do et al., 2012) although 
they preferentially target the former rather than the latter (Gittis et al., 2010). 
Interestingly, it has been shown that depletion of dopamine leads to a shift of 
connections between parvalbumin-positive interneurons and MSNs by doubling the 
parvalbumin-positive interneuron-striatopallidal MSN innervation (Gittis et al., 
2011). This increase could result in the induction of aberrant activity of 
striatopallidal MSNs resulting in the observed motor symptoms in Parkinson’s 
disease (Gittis et al., 2011).  
Another GABAergic striatal interneuron subtype, the somatostatin-positive 
neurons, also expresses high level of neuropeptide Y, NADPH diaphorase and nitric 
oxide synthase. They make up about 0.8% of total rat striatal cells (Rymar et al., 
2004). Due to their typical electrical properties, low threshold spike and prolonged 
plateau potential mediated by calcium channels, they are called the persistent and 
low-threshold spike (PLTS) neurons (Tepper and Bolam, 2004). In terms of their 
function this group of GABAergic interneurons is less well characterised than 
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parvalbumin-positive interneurons. Potentiation of GABA-mediated inhibition of 
MSN activity by somatostatin-positive neurons has been described in dopamine 
depleted condition (Dehorter et al., 2009).  Moreover, it has been proposed that 
somatostatin-positive interneurons might regulate corticospinal synaptic plasticity via 
their ability to produce nitric oxide (Tepper and Bolam, 2004).   
The third group of GABA-producting striatal interneurons is calretinin-
positive neurons. They comprise about 0.5% of striatal neurons in rodents (Rymar et 
al., 2004). Unlike the other striatal interneurons, no electrophysiological properties of 
calretinin-positive interneurons have been described (Tepper and Bolam, 2004, 
Kreitzer, 2009, Gittis and Kreitzer, 2012). However, an interesting study on adult 
neurogenesis of the human brain has recently demonstrated that the striatal 
calretinin-positive interneurons are being generated throughout life (Ernst et al., 
2014). Thus, this group of interneuron might have an important role in co-ordinating 
and regulating the striatal function.  
Unlike GABAergic interneurons, the cholinergic striatal interneurons are 
large-size, aspiny and can be identified by the presence of ChAT (Tepper and Bolam, 
2004, Kreitzer, 2009). They also express dopamine receptors (D2 and D5), and 
muscarinic receptors (M2 and M4) (Levey et al., 1993, Hersch et al., 1994, Bergson 
et al., 1995, Guzman et al., 2011). About 0.3% of neostriatal neurons are believed to 
belong to this group of interneurons (Rymar et al., 2004). They receive GABAergic 
inputs from the MSNs in addition to glutamatergic inputs from the cerebral cortex 
and thalamus (Tepper and Bolam, 2004, Kreitzer, 2009). Their axons innervate 
matrix neurons within the striatum, mainly MSNs, and, to a lesser extent, other 
GABAergic interneurons (Tepper and Bolam, 2004). Electrical characteristics of the 
cholinergic interneurons are slow and regular firing with a long duration action 
potential and slow spike after-hyperpolarisation, which give rise to the name of 
tonically active neurons (TANs) (Tepper and Bolam, 2004, Kreitzer, 2009). 
Regarding the function of cholinergic interneurons, they, together with dopaminergic 
nigrostriatal neurons, are believed to modulate the MSN activity that regulates 
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reward-based learning and motivated behaviour (Morris et al., 2004, Tepper and 
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1.2 Huntington’s disease 
 
1.2.1 General information 
 Huntington’s disease, originally described as Huntington’s chorea, is an 
autosomal dominant neurodegenerative disorder caused by abnormal expansion of 
CAG repeats within the first exon of the human huntingtin gene, located on the short 
arm of chromosome 4. The number of CAG repeats in the general population is 
normally less than 27 repeats whilst the presence of more than 35 repeats results in 
Huntington’s disease (Roos, 2010). This mutation results in the production of 
abnormal huntingtin protein that contains excess glutamine residues at its N-
terminus. The mutant huntingtin contributes to the loss of neurons in the central 
nervous system particularly the striatal projection medium spiny neurons. The onset 
of the disease is mid-adult life, ranging between 35 and 50 years in most patients 
although the production of mutant huntingtin has been found throughout life. The 
disease has a prevalence of 4-10 per 100,000 in Western countries (Ross and Tabrizi, 
2011). 
Given that the disease is caused by an expansion of CAG repeat, it is expected 
that higher repeats would lead to more severe clinical manifestation. Indeed, it has 
been shown that the number of CAG repeats correlates directly with neuronal loss. 
Individuals who have longer CAG repeats have higher degree of cell death in the 
striatum (Vonsattel and DiFiglia, 1998). However, the number of CAG repeats 
accounts for only 30-60% of overall variance in age of onset. Other factors affecting 
the disease onset are other genetic and environmental factors (Wexler et al., 2004, 
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1.2.2 Clinical manifestation  
The major clinical triad of Huntington’s disease consists of cognitive function 
deterioration, abnormal involuntary movement, known as chorea, and psychiatric 
disturbances (Roos, 2010). Psychiatric problems are normally the earliest symptoms 
presented in the patients. Prevalence of these symptoms varies greatly due to 
different methodologies as well as stages of the disease. In the REGISTRY study, a 
prospective observation study of Huntington’s disease in European countries, apathy 
was the most prevalent psychiatric symptoms in every stage of the disease (van Duijn 
et al., 2014). Approximately 28% of patients were diagnosed moderate to severe 
apathy whilst moderate to severe depression was found in only 12.7% of participants. 
Other neuropsychiatric problems reported include irritability, aggression, obsessive 
compulsive behaviour and psychosis (Gil and Rego, 2008, Roos, 2010, van Duijn et 
al., 2014). Similar to the psychiatric disturbances, cognitive decline can generally be 
observed long before the emergence of motor symptoms resulting in patients losing 
their organising ability as well as their memory. In the end stage of the disease, most 
patients show profound dementia (Gil and Rego, 2008).  
The most striking of the triad, and usually the last to appear is motor 
disturbance. This generally begins with a slightly clumsy gait, the patients later 
develop slowly progressive involuntary choreatic movement spreading from distal to 
proximal muscles. The progression of involuntary movement results in an inability to 
move at their own will, as well as dysarthria (difficulty in articulating words) and 
dysphagia (difficulty in swallowing). In the late stage of the disease, bradykinesia 
(slowness of movement) and akinesia (difficulty in starting movement) are present in 
the majority of patients (Gil and Rego, 2008, Roos, 2010).  
In addition to the classical symptoms mentioned above, other symptoms have 
been described in the patients. One of the most common extraneuronal symptoms is 
non-choreatic-related weight loss. Pathogenesis of a reduction in body weight in 
Huntington’s disease is unknown but it is believed that the loss of hypothalamic 
neurons would play a role (Kremer and Roos, 1992, Djoussé et al., 2002). 
Abnormalities in the endocrine system are also observed. These include an increase 
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in the level of corticosteroids caused by hypothalamic-pituitary-adrenal axis 
dysfunction (Heuser et al., 1991, Leblhuber et al., 1995) and a decrease of plasma 
testosterone (Markianos et al., 2005).  
The leading causes of death in Huntington’s disease patients are pneumonia 
and heart disease (Lanska et al., 1988, Sørensen and Fenger, 1992). Pneumonia, 
which is generally aspiration-related, is responsible for approximately 40% of deaths 
in Huntington’s patients. Although psychiatric problems are commonly present in 
Huntington’s patients, suicide accounts for only 5% or less of total death in these 
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1.2.3 Pathology 
Pathologically the hallmark of Huntington’s disease is striatal atrophy. 
Interestingly, it has been found that only the GABAergic striatal projection MSNs 
mainly degenerate whilst striatal interneurons are relatively preserved (Ferrante 
1985, Ferrante 1987, Gil 2008). A neuropathological grading system commonly used 
for the disease was introduced by Vonsattel and colleagues (Vonsattel et al., 1985). 
The Vonsattel grading system classifies Huntington’s disease into five grades 
ranging from grade 0 to 4 according to post-mortem examination, both macroscopic 
and microscopic. Grade 0 is the least severe and macroscopically indistinguishable 
from control normal brains. In contrast, grade 5 brains showed severe neuronal loss 
and diffuse astrogliosis in both the caudate nucleus and putamen.   
What is interesting regarding the MSN vulnerability in the disease is that 
degeneration is not equally observed amongst the MSN population (Table 1.2). 
Preferential loss of enkephalinergic striatopallidal MSNs is found in presymptomatic 
as well as initial and middle stages of the disease whilst the substance P-positive 
MSNs are less affected (Reiner et al., 1988, Albin et al., 1990, Albin et al., 1992, 
Richfield et al., 1995, Deng et al., 2004). Reiner and colleagues have demonstrated 
using immunohistochemistry that the number of enkephalin-containing fibres, found 
mainly in the GPe, was drastically reduced in the brains from all stages of 
Huntington’s disease when compared to controls (Reiner et al., 1988). Conversely, 
the number of substance P-containing axons projecting to the GPi of Vonsattel stage 
2 and 3 Huntington brains was similar to that of controls. Both enkephalin- and 
substance P-positive fibres were, however, markedly depleted in the advanced stage 
of the disease (Vonsattel grade 4). Interestingly, the activity of glutamic acid 
decarboxylase (GAD), an enzyme involved in the GABA synthesis, was markedly 
decreased in the lateral pallidum, but not in the medial pallidum (Spokes, 1980). 
These findings indicate the preferential loss of enkephalinergic striatal neurons 
projecting to the GPe in Huntington’s disesase (Reiner et al., 1988, Mitchell et al., 
1999). Several publications have confirmed these observations. An in situ 
hybridisation study revealed a greater decline of enkephalin-producing neurons 
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compared to substance P-producing neurons in the caudate nucleus of Huntington’s 
disease patients (Richfield et al., 1995). Albin and colleagues have reported a 
reduction in the number of enkephalin-positive fibre terminals in the GPe, but not in 
the number of substance P-containing fibres in the GPi, in the brain of two pre-
symptomatic Huntington’s disease individuals (Albin et al., 1990, Albin et al., 1992). 
In addition, studies in Huntington’s disease rodent models have also shown similar 
findings. Two Huntington’s disease mouse models, the transgenic R6/2 mice 
(Mangiarini et al., 1996) and the knock-in (CAG91 and CAG74) mice (Levine et al., 
1999), have demonstrated a severe reduction of enkephalin mRNA levels in striatal 
neurons of mutants (Menalled et al., 2000). However, the expression of substance P, 
Gad65 and Gad67 in mutant animals was identical to that of controls. Similarly, a 
reduction in the level of enkephalin mRNA, the number of enkephalinergic neurons 
in the striatum, as well as a lower intensity of enkephalin-immunoreactive fibres in 
the GP of R6/2 mice was found (Sun et al., 2002). These findings are in contrast with 
the number of substance P-positive neurons in the striatum as well as substance P 
immunoreactive fibre intensities in the GP, which were relatively normal in R6/2 
animals. 
Preferential degeneration of enkephalinergic striatopallidal MSNs has also 
been supported by the fact that the levels of other striatopallidal markers were also 
diminished in all stages of Huntington’s disease (Glass et al., 2000). In grade 1 
striata, the density of dopamine D2 receptor was markedly decreased to 6-7% of 
controls whereas moderate reduction (54-56% of controls) was described for 
dopamine D1 receptor density. The decline of D2 receptor density was even more 
prominent in the caudate nucleus and putamen of grade 2 and 3 brains (6-10% of 
normal brain) whilst D1 receptor density was diminished to a lesser degree (26-34%) 
(Glass et al., 2000). Likewise, the level of adenosine A2a receptor was drastically 
reduced in the striata of grade 1 Huntington’s disease patients, 11-13% compared to 
controls. At later stages, no detectable level of A2a receptor was found within the 
caudate nucleus and putamen (Glass et al., 2000). Since the D2 receptor and A2a 
receptor are specifically expressed in the striatopallidal MSNs, the findings from 
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Glass and co-workers have further confirmed that the enkephalinergic striatopallidal 
MSNs are the most vulnerable striatal population in Huntington’s disease.     
Given that the enkephalinergic striatopallidal MSNs are part of the indirect 
pathway of the basal ganglia, the loss of this MSN subtype in the early stage of the 
disease would lead to an imbalance between the direct and indirect pathways. It has 
been shown that an inactivation of the indirect pathway by an injection of GABA 
receptor antagonist bicuculline into either the putamen or the GPe resulted in a 
choreatic movement (Crossman et al., 1988). Indeed, this is consistent with the motor 
symptoms of early stage Huntington’s disease, when the choreatic movement is 
predominant (Gil and Rego, 2008, Roos, 2010).  
Also, Hedreen and Folstein have described the differential degeneration of 
striatal neurons within patch-matrix compartments of Huntington’s disease patients 
(Hedreen and Folstein, 1995). The cause of the preferential degeneration of patch 
neurons in the early stage Huntington’s disease is unknown. This may be explained 
by the fact that neurons in this compartment are devoid of the calcium binding 
protein calbindin. Calcium homeostasis has been implicated in neurodegeneration, 
and therefore, the absence of calbindin in striosomal neurons might contribute to the 
selective degeneration (Mitchell et al., 1999).  
Atrophy of other regions of the brain also occurs although to a lesser degree. 
Affected areas include the cerebral cortex, cerebellum, thalamus, hypothalamus, 
amygdala and substantia nigra (Kassubek et al., 2005, Douaud et al., 2006). The 
degree of atrophy in non-striatal structures, interestingly, is well correlated with 
Vonsattel grading system. A good example is the cerebral cortex, which shows only 
a subtle loss in grade 1 and 2. However, a marked degeneration of the cerebral cortex 
especially layers III, V and VI is evident in grade 3 and 4 brains (Gil and Rego, 
2008). Atrophy of brain structures contributes to a reduction of brain weight, which 
could be up to 40% in patients with advanced stage of the disease (Gusella, 2001).    
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Table 1.2: Differential vulnerability of striatal neurons in Huntington’s disease 
(Adapted from Mitchell et al., 1999). 
 Least vulnerable Most vulnerable 
Neuronal cell type Striatal interneuron MSN 
MSN subtypes Substance P-positive 
striatonigral MSN  
Enkephalinergic 
striatopallidal MSN 
Striatal compartment Matrix Patch 
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1.2.4 Pathogenesis and pathophysiology 
 It is believed that the pathogenesis of Huntington’s disease is caused by two 
mechanisms, loss of function of normal huntingtin protein and toxic gain of function 
of the mutant protein (Gil and Rego, 2008). Huntingtin is a protein that has at least 
3,100 amino acid residues. The precise amount of amino acids within the protein 
depends on the number of glutamine residues. This protein is found intracellularly in 
various types of cells throughout the body. Huntingtin is normally located in the 
cytoplasm although it is also found, to a lesser extent, in the nucleus (Kegel et al., 
2002, Gil and Rego, 2008). Huntingtin is associated with the mitochondria, the Golgi 
body, the endoplasmic reticulum and the microtubules (Young, 2003, Landles and 
Bates, 2004, Gil and Rego, 2008). Normal huntingtin interacts with many proteins 
such as the huntingtin-associated protein 1 (Hap1), the huntingtin-interacting protein 
1 (Hip1), the huntingtin-interacting protein 2 (Hip2), glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh) and β-tubulin (Gil and Rego, 2008). Within the central 
nervous system, huntingtin has been demonstrated to associate with several processes 
including regulation of brain-derived neurotrophic factor (Bdnf) expression, 
vesicular transportation of Bdnf and interaction with postsynaptic density 95 (Psd95) 
(Gil and Rego, 2008). Thereby, it involves several processes, for instance, embryonic 
development, intracellular transport, transcriptional regulation and anti-apoptotic 
function. In Huntington’s disease, the production of mutant huntingtin causes a 
disruption of the processes above.  
 The mutant huntingtin produced in Huntington’s disease is found in two 
forms, soluble and insoluble. The formation of insoluble aggregates of the mutant 
protein is one of the histological features of the disease. It was previously believed 
that an accumulation of mutant huntingtin aggregates was a cause of 
neurodegeneration in the disease (Landles and Bates, 2004, Gil and Rego, 2008). 
However, recent findings have indicated that, instead of being harmful to the cell, 
aggregates of mutant huntingtin may be a result of protective process by the cell to 
sequester the mutant protein and thus may not be pathogenic in the disease (Young, 
2003, Gil and Rego, 2008).  
Derivation of enkephalinergic medium spiny neurons                                                  
from mouse embryonic stem cells 
 Chapter 1: Introduction  19 
 The loss of normal huntingtin together with the accumulation of mutant 
huntingtin contributes to deregulation of several pathways and consequently cell loss 
in the disease. Mutant huntingtin causes transcriptional deregulation by sequestration 
of transcription factors. Abnormal interaction between mutant huntingtin and several 
transcription factors, for example, CREB-binding protein (Cbp), specificity protein 1 
(Sp1), TATA-binding protein (Tbp) and p53 has been reported (Landles and Bates, 
2004, Gil and Rego, 2008). Depletion of Cbp results in an inhibition of CBP-
mediated transcription. Interestingly, genes implicated in Huntington’s disease such 
as pro-enkephalin (PENK) are CBP-regulated genes (Huggenvik et al., 1991). Cbp 
ablation causes an Huntington’s disease-like phenotype in mice and down-regulation 
of CBP-regulated genes has been found in Huntington’s disease patients (Landles 
and Bates, 2004). Abnormal transcriptional processes in Huntington’s disease are 
also related to a loss of normal huntingtin function, for example the transcriptional 
regulation of the Bdnf gene. The inability of mutant huntingtin to bind to the 
transcription factor complex of repressor element 1-silencing transcription factor and 
neuron-restrictive silencer factor (Rest-Nrsf) results in nuclear translocation of Rest-
Nrsf. The intranuclear Rest-Nrsf then binds to the neuron-restrictive silencer element 
(NRSE) within the Bdnf promoter and consequently suppresses its transcription 
(Zuccato et al., 2003, Landles and Bates, 2004, Gil and Rego, 2008).   
Abnormal protein folding and degradation processes are another key 
pathologies in Huntington’s disease. Sequestration of heat-shock proteins (Hsps), 
such as Hsp40 and Hsp70, into mutant huntingtin aggregates leads to an 
accumulation of intracellular misfolded proteins (Landles and Bates, 2004, Gil and 
Rego, 2008). Abnormally folded proteins inside the cells are normally ubiquitinated 
and degraded by the proteasome. However, ubiquitin and proteasome subunits are 
also sequestered in the mutant huntingtin aggregates (Wyttenbach et al., 2000, 
Landles and Bates, 2004, Gil and Rego, 2008). Thus, the ubiquitin-proteasome 
system is also impaired in Huntington’s disease. Accumulation of mutant huntingtin 
and misfolded proteins over the course of the disease, consequently, contributes to 
cell death via apoptosis or autophagy (Landles and Bates, 2004, Gil and Rego, 2008).        
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Other mutant huntingtin-mediated neuropathology includes axonal transport 
dysfunction and synaptic dysfunction. Wild-type huntingtin, via an association with 
Hap1, is involved in both anterograde and retrograde axonal transports. Mutant 
huntingtin, conversely, could inhibit this activity. This may account for the 
disruption of microtubule-mediated axonal transport, such as the anterograde 
transport of Bdnf (Gauthier et al., 2004, Gil and Rego, 2008). Axonal transport 
malfunction is one of the causes of impaired synaptic transmission via depletion of 
synaptic vesicles and related proteins at nerve terminals (Gil and Rego, 2008). 
Moreover, synaptic dysfunction is also a result of other molecular abnormalities 
observed in Huntington’s disease. For instance, a reduction in wild-type huntingtin, 
which normally interacts with numerous vesicle proteins, brings about the synaptic 
dysfunction (Li et al., 2003, Gil and Rego, 2008). The presence of mutant huntingtin 
has also been identified as a main contributor for an alteration in available synaptic 
proteins as well as causing a functional abnormality in synaptic transmission. Indeed, 
increased glutamate release from presynaptic terminals, as well as a reduced 
glutamate clearance capacity, have been proposed as a cause of striatal excitotoxicity 
(Li et al., 2003, Gil and Rego, 2008). Lastly, transcriptional deregulation mediated 
by mutant huntingtin would lead to abnormal transcription of genes related to 
synaptic transmission. All of the abnormalities described above eventually lead to 
neuronal death. However, the question of why certain types of neurons are more 
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1.3 In vivo striatal neurogenesis 
 
1.3.1 Development of the central nervous system 
In adult mammals, the central nervous system is composed of two main 
structures, the brain and the spinal cord. They are developmentally derived from the 
neural tube. Neurulation, the process of forming the neural tube, creates neural folds 
that eventually fuse together forming a tube. Formation of the neural tube does not 
happen simultaneously but rather first begins at the anterior portion and then spreads 
to the posterior part (Gilbert, 2010). It is widely accepted that the neural tissue has an 
anterior identity by default (Levine and Brivanlou, 2007, Wilson and Houart, 2004). 
The caudal part of neural tube then acquires the posterior character by exposure to 
caudalizing factors, for instance, Wnts, Fgfs (fibroblast growth factors), retinoic acid 
(RA), Bmps (bone morphogenetic proteins) and Nodal, generated from posterior part 
of embryo. This means posterior identity could be induced in pre-specified anterior 
neural tissue. Maintenance of anterior neural identity in the anterior portion of neural 
tube, therefore, requires anticaudalizing agents, which are Wnt and Bmp inhibitor 
Cerberus, Wnt inhibitor Dickkopf-1 (Dkk1) and Nodal inhibitor Lefty produced from 
anterior visceral endoderm (AVE) (Kimura et al., 2000). 
In parallel to what is happened at cellular and molecular levels, anterior 
neural tissue undergoes morphological change by bulging into three vesicles, which 
are prosencephalon (forebrain), mesencephalon (midbrain) and rhombencephalon 
(hindbrain). All structures in the brain are derived from either one of these vesicles. 
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Table 1.3: Structures in embryonic brain and their adult derivatives. Adapted from 
Gilbert, 2010.  
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1.3.2 Regional patterning of the telencephalon 
 The prosencephalon is divided into the telencephalon and more caudally the 
diencephalon. Specification of the telencephalon occurs around embryonic day (E) 
8.5 in mice, when the expression of Foxg1 (Bf1) is found in this region (Hébert and 
Fishell, 2008). This specification is mediated by a number of mechanisms related to 
the structure called anterior neural boundary (ANB) since the absence of ANB 
causes loss of expression of telencephalic markers Foxg1 in mouse (Shimamura and 
Rubenstein, 1997) and emx1 in fish models (Houart et al., 1998). Houart and 
colleagues subsequently identified Tlc, a Wnt signalling antagonist, as the 
responsible protein for telencephalon-inducing property of ANB in Zebrafish. 
Transplantation of Tlc-expressing cells into ANB region of ANB-ablated embryos 
led to a restoration of telencephalic marker emx1 and bf1 (Houart et al., 2002). 
Requirement of WNT antagonists is likely a result of a presence of WNT molecules 
produced by posterior neural tissue (Wilson and Houart, 2004). In addition to the 
inhibitory Wnt signalling, activation of the Fgf signalling pathway is necessary for 
telencephalic specification. Shimamura and Rubenstein have demonstrated that Fgf8 
from the ANB induces expression of Foxg1 in rodents. Exogenous Fgf8 
administration is able to restore Foxg1 expression in ANB-depleted explants 
(Shimamura and Rubenstein, 1997). Also, Fgf8 mutant animals exhibit reduced 
Foxg1 expression (Storm et al., 2006). Interestingly, Martynoga and colleagues have 
reported that Fgf8 expression is diminished in the telencephalon of Foxg1-/- mice 
(Martynoga et al., 2005) suggesting that Fgf8 and Foxg1 may positively regulate 
each other (Hébert and Fishell, 2008).  
Once the anterior neural tissue acquires telencephalic fate, it further expands 
and subdivided into dorsal (pallial) and ventral (subpallial) telencephalon. A number 
of transcription factors as well as cell signalling pathways are known to contribute to 
regional patterning within the telencephalon (Figure 1.2). Dorsal and ventral 
telencephalon can be defined by the expression of their specific markers.  In rodents, 
dorsal identity is determined by the expression of transcription factors Pax6 and Gli3 
whereas ventral identity is specified by the presence of Shh and Fgf8 as well as 
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transcription factors Nkx2.1 and Gsx2 (Hébert and Fishell, 2008). Pax6 is initially 
expressed throughout the prospective telencephalon at the late 4-somite stage of 
mouse embryo (Inoue et al., 2000). Its expression is then lost from the ventral 
telencephalon around E9.5 (Sousa and Fishell, 2010). Loss of Pax6 expression in 
ventral telencephalon is mediated by Shh produced from the axial mesendoderm 
(Macdonald et al., 1995, Shimamura and Rubenstein, 1997). Pax6 is essential for 
dorsal telencephalic identity especially in the pallium-subpallium border since the 
expression of pallial markers in this area is lost in Pax6-/- embryos (Manuel and 
Price, 2005). Like Pax6, the transcription factor Gli3, is widely expressed in the 
telencephalon, but later the expression is limited to the dorsal portion only (Hébert 
and Fishell, 2008). Null mutation of Gli3 contributes to the loss of expression of the 
dorsal telencephalic marker Emx2, reducing the size of the neocortex as well as the 
absence of both the hippocampus and choroid plexus (all are dorsal telencephalic 
structures) in Gli3 deleted XtJ/XtJ mice (Theil et al., 1999). This indicates the 
requirement of Gli3 in dorsal telencephalic development.  
In contrast to Gli3, Sonic hedgehog (Shh) signalling is the major factor in the 
ventral telencephalon and suppresses any dorsalisation. In rodents, Shh transcript is 
found initially in the midline mesoderm of the head process around E7.5 (Echelard et 
al., 1993) and later found in the hypothalamus and ventral telencephalon (Rallu et al., 
2002a). In Shh mutant mice the ventral telencephalon structures are absent and the 
expression of dorsal forebrain specific gene Emx1 is detected throughout the 
telencephalon (Chiang et al., 1996). Interestingly, structural abnormalities and altered 
gene expression, observed in either Gli3 or Shh mutant mice, are restored in Shh/Gli3 
double mutants (Rallu et al., 2002b) indicating that Shh suppresses the dorsalisation 
process by counteracting Gli3 rather than promoting ventral identity. Thus, Gli3 and 
Shh have an antagonising effect on each other and the interaction between Gli3 and 
Shh regulates the division of telencephalon into dorsal and ventral regions. 
 Another important regulator for the acquisition of ventral telencephalic fate in 
rodents is Fgf signalling. Expression of the ventral telencephalic marker Nkx2.1 is 
greatly reduced in Fgf8 mutant mice (Storm et al., 2006). Furthermore, double 
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mutation of Fgf receptors Fgfr1 and Fgfr2, leads to the loss of Nkx2.1, Mash1 and 
Dlx2 expression. However, the expression of Pax6 and Emx2 is unaffected, 
indicating the loss of ventral telencephalic precursor cells (Gutin et al., 2006). Since 
the phenotype observed in Fgfr1/Fgfr2 double mutants resembles that of Shh 
mutants, it is thought that Fgfs may act either downstream, or independently, of Shh. 
Indeed, it has been shown Shh expression is unaffected in Fgfr1/Fgfr2 double 
mutants and the loss of Gli3 does not rescue ventral telencephalic phenotypes in 
these mutants (Gutin et al., 2006), indicating that Fgf signalling acts downstream of 









Derivation of enkephalinergic medium spiny neurons                                                  
from mouse embryonic stem cells 
 Chapter 1: Introduction  26 
 
Figure 1.2: Regulation of regional patterning of the telencephalon. Transcription factors 
involved in the patterning and specification of the murine telencephalon. Foxg1 and Fgf 
signalling are essential for telencephalic identity. Dorsal telencephalic identity is driven by 
the activity of Gli3 and Foxg1. Structures derived from dorsal telencephalon then acquire 
their fate by an expression of Emx1/2, Lhx2 and Pax6. In parallel, Foxg1 and Fgf signalling 
collaborate with Shh to induce ventral telencephalic fate. The ventral telencephalon is then 
committed to MGE and LGE fates by the transcription factors Nkx2.1 and Gsx2, respectively. 
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1.3.3 Development of the ventral telencephalon 
The murine ventral telencephalon can be divided into three structures, the 
medial, lateral and caudal ganglionic eminences (MGE, LGE and CGE, 
respectively), and are born chronologically. The emergence of a transcription factor 
Nkx2.1 around E9.5 marks the appearance of the prospective MGE. This occurs just 
after Shh-mediated repression of Pax6 in the ventral area of the forebrain (Sousa and 
Fishell, 2010). Both Pax6 and Nkx2.1 play an important role in a formation of 
dorsal-ventral telencephalic boundary at this stage. In addition, expression of Nkx2.1 
is implicated in the development of MGE derivatives. Nkx2.1 mutants lack MGE 
derivatives such as the GP and cortical interneurons (Butt et al., 2008, Sussel et al., 
1999).  
At E10, the appearance of transcription factor Gsx2, marks the second 
eminence, the LGE, and the dorsal-ventral boundary is evident. The sharp boundary 
of pallial-subpallial telencephalon is now determined by expression of Pax6 and 
Gsx2 (Hebert and Fishell, 2008, Toresson et al., 2000). Similar to the role of Nkx2.1 
in MGE specification, Gsx2 is essential for the expression of genes that are involved 
in the development of LGE derivatives including striatal neurons. Gsx2-/- mice show 
loss of expression of striatal progenitor genes such as Dlx1 and Dlx2 as well as a 
reduction of Pre-pro-enkephalin (Penk) and Drd2 expression (Corbin et al., 2000). 
Ectopic expression of cortical-enriched genes in the LGE was also noted in Gsx2 
depleted mice (Corbin et al., 2000, Toresson et al., 2000).   
The most caudal structure, the CGE, emerges from the ventral telencephalon 
around E11. Unlike MGE and LGE, the CGE does not have any known region-
specific markers and its identity is defined anatomically, an area posterior to the 
fusion of the MGE and LGE (Nery et al., 2002). The ganglionic eminences generate 
progenitors contributing to various types of neurons, mainly projection neurons and 
interneurons, which will distribute throughout the forebrain. Table 1.4 shows the 
corresponding adult neuronal populations that derive from the ventral telencephalon. 
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It is widely accepted that Shh is the master regulator of the ventral 
telencephalon development. Shh was shown to induce Nkx2.1 expression in 
telencephalic explants of chick embryos (Ericson et al., 1995) and no Nkx2.1 
expression was found in Shh-/- mice (Rallu et al., 2002b). Likewise, Gsx2 was absent 
from the forebrain of Shh-/- mice (Corbin et al., 2000). This indicates that Nkx2.1 and 
Gsx2 are both downstream of Shh. Despite its role as a morphogen in governing 
neuronal cell identity in the ventral telencephalon, Shh also acts as a mitogen. Study 
from the Fishell lab indicates that conditional knockout of Shh after ventral 
telencephalic patterning was established led to a reduction of progenitors in postnatal 
subventricular zone (Machold et al., 2003). All of the evidence here indicates that 
Shh regulates both the specification of the MGE and LGE as well as the proliferation 
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Table 1.4: Ganglionic eminences and their adult derivatives (Nery et al., 2002, 
Takahashi and Liu, 2006). 
Embryonic ganglionic eminences Adult derivatives 
Medial ganglionic eminence Pallidal projection neurons 
Cortical interneurons  
Hippocampal interneurons 
Lateral ganglionic eminence Striatal projection neurons 
Projection neurons in the nucleus 
accumbens 
Olfactory bulb interneurons 
Caudal ganglionic eminence Interneurons in layer V of neocortex 
Hippocampal neurons 
Neurons in the nucleus accumbens 
Bed nucleus of the stria terminalis 
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1.3.4 Development of medium spiny neurons 
MSNs derive from progenitor cells in the LGE. In rodents, neurogenesis in 
this area consists of two distinct temporal waves; early neurogenesis, occurring 
between E12-13, and late neurogenesis at E14-15 (Martynoga et al., 2005). Neural 
progenitors in early neurogenesis reside in the ventricular zone (VZ) of the LGE. 
Another area in the LGE, the subventricular zone (SVZ) is formed later by migrating 
progenitors from the VZ. The SVZ contains a group of progenitors for late 
neurogenesis. Early neurogenesis generates striatal neurons in the striosomes (van 
der Kooy and Fishell, 1987). In contrast, late neurogenesis contributes to matrix 
neurons (van der Kooy and Fishell, 1987). In situ hybridisation and 
immunohistochemistry studies have demonstrated that enkephalin-positive and 
substance P-positive MSNs were found in both striosomes and matrix (Graybiel and 
Chesselet, 1984, Gerfen and Young, 1988, Besson et al., 1990, Song and Harlan, 
1994). In rodents, the percentage of pre-pro-enkephalin mRNA-expressing MSNs 
defined by in situ hybridisation in patch and matrix compartments was 65% and 
58%, respectively (Gerfen and Young, 1988). These findings indicate that 
enkephalinergic MSNs are generated by both early and late neurogenesis in the LGE. 
1.3.4.1 Roles of transcription factors in development of 
medium spiny neurons 
It has been shown that the two waves of LGE neurogenesis are controlled by 
different transcriptional regulation (Figure 1.3). Early neurogenesis in the LGE is 
regulated by the transcription factor Mash1, a downstream target of Gsx2, via Notch 
signalling (Casarosa et al., 1999, Yun et al., 2002, Mason et al., 2005). Mash1 
prevents premature differentiation of VZ cells into SVZ cells in the LGE. VZ cells 
within the LGE of Mash1-/- mice exhibited SVZ markers including Gad1 (also 
known as Gad67) (Casarosa et al., 1999, Yun et al., 2002), Dlx5 (Casarosa et al., 
1999, Yun et al., 2002), Dlx6 (Yun et al., 2002), Brn4 (Yun et al., 2002) and Six3 
(Yun et al., 2002). In addition, expression of Notch ligands Dll1 and Dll3, as well as 
Notch output gene Hes5, was completely lost in the LGE of Mash1 mutants 
(Casarosa et al., 1999, Yun et al., 2002). A reduction in the number of early-born 
patch neurons is also observed in mice with a forebrain-specific Notch1 deletion 
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(Mason et al., 2005). Interestingly, later-born matrix neurons were not affected in 
this mouse model, possibly due to compensation by Notch3 expression (Mason et al., 
2005). Notch1 however, is not required for the differentiation of neurons once they 
exit the VZ since both striosomal and matrix neurons develop properly in mice that 
lack Notch1 in Dlx5/6-postive post-mitotic neurons (Mason et al., 2005). Therefore, 
Mash1 controls the generation, but not the maturation, of patch neurons by regulating 
early neurogenesis within the LGE via Notch signalling. 
 The transcription factors Dlx1 and Dlx2 are the main regulators of late 
neurogenesis in the murine LGE. Dlx1 and Dlx2 are indistinguishably expressed in 
the VZ and SVZ of the LGE (Bulfone et al., 1993, Anderson et al., 1997). Anderson 
and colleagues have demonstrated that later-born neurons did not differentiate into 
mature MSNs in Dlx1/2 double mutant mice (Anderson et al., 1997). These 
undifferentiated cells accumulated within the mutant LGE. In contrast, early-born 
striosomal neurons develop normally. This finding is consistent with the results from 
several studies which have identified Dlx1 and Dlx2 as the upstream factors that 
control the expression of late neurogenesis-related transcription factors such as Dlx5 
(Anderson et al., 1997, Long et al., 2009), Dlx6 (Anderson et al., 1997, Long et al., 
2009), Ikaros-1 (Martin-Ibanez et al., 2010, Long et al., 2009), Foxp1 (Long et al., 
2009), Ebf1 (Long et al., 2009) and Arx (Long et al., 2009, Cobos et al., 2005). It 
should be noted, however, that LGE progenitors from Dlx1/2 mutants are able to 
differentiate into Darpp32-positive neurons in vitro. This finding suggests that the 
block of differentiation observed in vivo might be a result of an inability of the 
progenitors to migrate from the SVZ to the developing striatum (Anderson et al., 
1997). Interestingly, the transcription factor Arx, a downstream target of Dlx1/2, also 
plays an important role in the migration of late-born progenitor in the LGE.  The 
phenotype of Arx-/- mice resembles that of Dlx1/2 mutants; accumulation of 
progenitors within the SVZ of the LGE and MGE (Colombo et al., 2007). In vitro 
cultivation of these LGE progenitors, however, resulted in the proper differentiation 
towards mature neurons in which they express Darpp32 (Colombo et al., 2007). 
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Therefore, it is possible that Dlx1/2 mediates the migration of late-born progenitors 
to their final destination in the MZ via Arx. 
Interaction between Mash1 and Dlx1/2 via Notch signalling has been shown 
in a study from the Rubenstein lab (Yun et al., 2002). Mash1 acts via Notch 
signalling to maintain the VZ identity and prevent transformation from VZ cells to 
SVZ cells (Casarosa et al., 1999, Yun et al., 2002). In contrast, Dlx1/2 mutants 
showed ectopic expression of Mash1, Dll1, Hes5 and Notch1 in the SVZ of the LGE. 
This indicates that Dlx1 and Dlx2 suppress Notch signalling, perhaps through Mash1 
repression, driving the differentiation of VZ cells into SVZ progenitors and 
promoting late neurogenesis within the LGE (Yun et al., 2002). Therefore, Mash1 
and Dlx1/2 antagonistically control early and late neurogenesis in the LGE, 
respectively (Yun et al., 2002). 
The function of the Dlx1 and Dlx2-dependent transcription factors in late 
neurogenesis in the LGE has been well described. Dlx5 and Dlx6 are expressed 
throughout the MGE and LGE. Their expression was found in SVZ and post-mitotic 
neurons of the mantle zone (MZ), suggesting their role in neuronal differentiation 
(Wang et al., 2011). Within the MGE, both Dlx5 and Dlx6 regulate the development 
of parvalbumin-positive cortical interneurons (Wang et al., 2010). In addition, 
another study demonstrated that ectopic expression of Dlx5 induces the expression of 
Gad65 (also known as Gad2), the key gene in GABAergic neuronal differentiation 
(Stuhmer et al., 2002). Recently, it has been shown that in the striatum of Dlx6 
mutants, the expression of Dlx5, Darpp32 and substance P is decreased while Ikaros 
expression is increased (Wang et al., 2011). Expression of D1R and D2R in the 
striatum of Dlx6 mutants was, interestingly, identical to controls (Wang et al., 2011). 
 Foxp1 and Foxp2 are members of the forkhead/winged helix transcription 
factors. They are expressed in the striatum during development and, unlike most of 
striatal-specific transcription factors, their expression remains in the adult rodents 
(Tamura et al., 2004, Kelly et al., 2009). However, their expression pattern within the 
striatum is not identical. Foxp1 was first detected in the MZ of the LGE around E14-
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14.5 whilst expression of Foxp2 was found earlier around E12.5-13 (Takahashi et al., 
2003). In situ hybridisation revealed that Foxp2 was co-expressed with the µ-opioid 
receptor, a marker for striatal patch neurons, but did not overlap with the expression 
of calbindin, a striatal matrix marker (Takahashi et al., 2003). The expression pattern 
of Foxp1, on the other hand, is controversial. Takahashi and colleagues were the first 
to show that Foxp1 was expressed in both patch and matrix compartments 
(Takahashi et al., 2003). A contradictory finding was reported by Tamura and 
colleagues indicating that Foxp1 expression was restricted to matrix neurons only 
(Tamura et al., 2004). Given that Foxp1 expression was detected at E14, 
corresponding to the time of late neurogenesis in the LGE, Foxp1 might be expressed 
in the later-born matrix neurons (Tamura et al., 2004). Consistent with this, Foxp1 
expression was greatly diminished in Dlx1/2 mutants, which showed a defect in later-
born matrix neurons (Long et al., 2009). Foxp2, in contrast, showed a subtle 
reduction of expression in Dlx1/2-/- mice (Long et al., 2009). Thus, Foxp1 may have 
a role in late neurogenesis within the developing striatum whereas Foxp2 is probably 
involved in early neurogenesis.  
Amongst Dlx-dependent factors, Ikaros plays a critical role in the 
development of enkephalinergic striatopallidal MSNs. Ikaros expression is 
dependent on Dlx1/2, since Dlx1/2-/- mice exhibited a severe reduction of Ikaros 
expression (Long et al., 2009). Ikaros isoforms 1 and 2 have been shown to be 
regulators of enkephalinergic striatopallidal neurons differentiation (Agoston et al., 
2007). Ikaros expression is found both proliferating and post-mitotic cells in the 
developing striatum and controls enkephalinergic fate by binding to the Ik-like cis-
regulatory element on the Penk gene. Mutation in DNA-binding domain of Ikaros 
causes severe reduction in the amount of enkephalin-positive cells whereas the 
number of substance P-positive and dynorphin-positive neurons is unaffected 
(Agoston et al., 2007). The role of Ikaros in striatopallidal neurons development is 
also underscored by the study from Martin-Ibanez and colleagues.  In addition to its 
role in enkephalinergic fate decision, they demonstrated that Ikaros isoform 1 
(Ikaros-1) can induce cell cycle arrest via cyclin-dependent kinase inhibitors. This 
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then leads to transformation of proliferating progenitors into post-mitotic neurons 
(Martin-Ibanez et al., 2010). Ikaros-/- mice exhibit reduced striatal volume as a result 
of a decrease in the number of enkephalinergic MSNs within the matrix 
compartment.  Furthermore, overexpression of Ikaros-1 can increase the number of 
enkephalin-positive neurons in primary LGE cultures. These findings highlight the 
importance of Ikaros in enkephalinergic differentiation. 
In contrast to Ikaros, the transcription factor Ebf1 is known for its role in 
controlling substance P-positive striatonigral neurons differentiation. Like other 
Dlx1/2-dependent transcription factors, Ebf1 expression was reduced in Dlx1/2 
mutants (Long et al., 2009). Within the striatum, Ebf1 is specifically expressed in the 
striatonigral MSNs (Lobo et al., 2006). Analysis of postnatal Ebf1 mutant mice 
showed that the number of substance P-positive striatonigral MSNs is decreased 
when compared to wild type whereas no change is observed in the number of 
striatopallidal MSNs (Lobo et al., 2006).  
 Despite two different waves of neurogenesis, differentiation of both early- 
and late-born post-mitotic neurons into mature MSNs in rodents is commonly 
governed by the transcription factor Ctip2 (also known as Bcl11b). Ctip2 is first 
detected at E12.5 in the post-mitotic neurons of the murine LGE and is continuously 
expressed in the developing striatum until animals reach their adulthood (Arlotta et 
al., 2005, Arlotta et al., 2008). Within the adult striatum, Ctip2 is exclusively 
expressed in MSNs but not in striatal interneurons (Arlotta et al., 2008). Ctip2 
knockout mice do not show any abnormality in the neurogenesis within the LGE, but 
rather exhibit abnormalities in MSN differentiation in both patch and matrix 
compartments of the striatum. Development of the patch compartment was 
predominantly affected whilst the matrix compartment displayed less abnormal 
differentiation (Arlotta et al., 2008). The expression of the mature MSN markers, 
Darpp32 and FOXP1, as well as the striatonigral specific gene Chrm4, was 
diminished (Arlotta et al., 2008). However, the expression pattern of striatopallidal-
enriched genes such as Penk, Adora2a (encoding for the adenosine A2a receptor) and 
Drd2 was not described. Interestingly, a study from Desplats and colleagues has 
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revealed that many striatal-enriched genes including Ctip2 itself, Ppp1r1b, Foxp2, 
Adora2a and Drd2 have a Ctip2 binding element within their promoter region 
(Desplats et al., 2008). Therefore, Ctip2 may direct MSN maturation by regulating 
the expression of striatal specific genes. 
1.3.4.2 Roles of signalling molecules in development of 
medium spiny neurons  
 In addition to the striatal specific transcription factors, ligands of several cell-
signalling pathways are also involved in the maturation of striatal neurons. Amongst 
these, retinoic acid (RA) and Bdnf are well described. Within the murine 
telencephalon, high levels of retinoids, produced from radial glia in the LGE as 
determined by high expression of cellular retinol binding protein I (Crbp I) are found 
in this area (Toresson et al., 1999). Generation of RA in the LGE is mediated by 
retinaldehyde dehydrogenase 3 (Raldh3), first detected around E12-12.5 (Li et al., 
2000, Molotkova et al., 2007). In fact, the expression of Raldh3 is regulated by Gsx2 
since Gsx2-/- mice have decreased expression of Raldh3 (Waclaw et al., 2004). This 
underscores the role of Gsx2 not only in the specification of LGE, but also in the 
regulation of retinoic acid signalling. Interestingly, a number of reports show that 
retinoic acid receptors (RARs) and retinoid X receptors (RXRs) are present in the 
striatum (Ruberte et al., 1993, Toresson et al., 1999). This implies that retinoic acid 
signalling might have a role in striatal neuronal development. Indeed, it has been 
shown that retinoic acid signalling regulates MSN maturation by enhancing Darpp32 
expression, since LGE cultures treated with RA contain more Darpp32 neurons 
compared to controls (Toresson et al., 1999). RA activates Darpp32 expression, 
possibly via Rarβ1, since ectopic expression of Rarβ1 was able to up-regulate 
Darpp32 in cortical explant cultures (Liao and Liu, 2005). Moreover, it has been 
shown that retinoic acid signalling is essential for Nolz1-mediated neurogenesis. 
Nolz1, a Gsx2 downstream target, promotes cell cycle exit and neuronal 
differentiation of progenitor cells in the LGE (Urban et al., 2010). Additionally, the 
presence of RA is needed for the expression of Meis2 (Oulad-Abdelghani et al., 
1997), a downstream transcription factor of Dlx1/2 (Long et al., 2009). Meis2 is 
initially expressed at E12.5 in the LGE, but not the MGE, and its expression remains 
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through adulthood in the striatum, albeit at lower levels (Toresson et al., 1999). 
Although no functional analysis of this gene has been reported, it is known that, in 
adult striatum, Meis2 has an expression pattern similar to that of the Darpp32 
(Toresson et al., 1999). Therefore, Meis2 may also have a role in the development of 
striatal projection neurons in the striatum. 
 Activation of tropomyosin-related receptor kinase B (TrkB) through its ligand 
Bdnf is believed to modulate the differentiation of striatal MSNs. Analysis of Bdnf 
null mice revealed that both mRNA and protein levels of Darpp32 in the striatum 
were decreased when compared to wild type animals (Ivkovic et al., 1997). Likewise, 
administration of Bdnf to in vitro LGE cultures resulted in an increased number of 
Darpp32-positive neurons compared to untreated controls (Ivkovic et al., 1997, 
Ivkovic and Ehrlich, 1999). Interestingly, addition of neurotrophin-3 (NT-3) and/or 
neurotrophin-4/5 (NT-4/5) in LGE cultures also induced Darpp32 expression at a 
level comparable to Bdnf (Ivkovic and Ehrlich, 1999). This finding is not surprising 
because NT-4/5 binds specifically to TrkB (Chao, 2003) and NT-3 specifically to 
tropomyosin-related receptor kinase C (TrkC) that are expressed in the striatum 
(Escandón et al., 1994). However, NT-3 does not compensate for the loss of Bdnf in 
vivo due to temporal and spatial expression differences (Ivkovic and Ehrlich, 1999). 
 In addition to its roles in striatal maturation, Bdnf is also essential in trophic 
support to MSNs. It was previously believed that Bdnf was necessary for MSNs 
survival in vivo. The striatum does not produce Bdnf by itself but rather receives 
Bdnf produced from cortical neurons via anterograde transport through the 
corticospinal tract (Altar et al., 1997). Also, reduction in numbers of calbindin-
positive MSN is found in Bdnf null mice (Altar et al., 1997). Interestingly, Baquet 
and colleagues reported similar finding. By using a mouse model in which Bdnf is 
deleted from cortical neurons, they showed that the number of striatal neurons was 
significantly reduced in aged mutant mice. They also observed, in the absence of 
Bdnf, a reduction in the size of MSNs and a decrease in dendritic spine density 
(Baquet et al., 2004). However, recent evidence suggests that this might not be the 
case. A publication from the Minichiello lab has suggested that Bdnf, through 
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activation of the TrkB receptor, is essential for the correct functioning of 
enkephalinergic striatopallidal MSNs, but is dispensable for long term survival of 
this neuronal population (Besusso et al., 2013). Indeed, conditional deletion of Bdnf 
from cortical neurons would lead to an alteration of cortical neuron morphology 
(Gorski et al., 2003), impairment of cortical input to the MSNs and, consequently, an 
increase in striatal vulnerability (Besusso et al., 2013). Recently, analysis of a 
Huntington’s mouse model, the BACHD (Gray et al., 2008), in early symptomatic 
stage revealed that Bdnf mRNA and protein levels are unaltered. However, the 
downstream signalling of Bdnf-TrkB is impaired (Plotkin et al., 2014). Thus, 
abnormal transmission of Bdnf-TrkB signalling, rather than impaired Bdnf transport, 
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Figure 1.3 Transcriptional regulation of neurogenesis within the LGE. Two peaks of 
neurogenesis take place in the LGE. Early neurogenesis occurs between E12 and E13 and 
is mainly regulated by MASH1. In contrast, late neurogenesis starts around E14-15 and 
involves several transcription factors including DLX1/2 and their targets. E, embryonic day; 
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1.4 In vitro derivation of medium spiny neurons 
There have already been several attempts to derive MSNs from various types 
of stem/progenitor cells. The generation of stem cell-derived MSNs would allow the 
modelling of basal ganglia disorders such as Huntington’s disease in vitro (Carter 
and Chan, 2012, Perrier and Peschanski, 2012), but also to provide a novel source of 
striatal cells for transplantation (Kelly et al., 2009, Benraiss and Goldman, 2011, 
Perrier and Peschanski, 2012, Maucksch et al., 2013). The source of stem/progenitor 
cells commonly used for deriving striatal neurons in both rodents and human is 
pluripotent stem cells (PSCs), which may either be embryonic stem cells (ESCs) or 
induced pluripotent stem cells (iPSCs). The use of striatal neural stem cell lines (El-
Akabawy et al., 2011) or primary striatal progenitors established from the LGE 
(Ivkovic and Ehrlich, 1999) have also been reported, although are less frequently 
used.  
Several differentiation protocols for deriving MSNs from PSCs have been 
reported. These protocols basically mimic the normal development of ventral 
telencephalon by adding various ligands and/or inhibitors exogenously. Aubry and 
colleagues have shown that human embryonic stem cells (hESCs) could be converted 
to DARPP32-positive neurons (Figure 1.5 A) (Aubry et al., 2008). Initially, hESCs 
were co-cultured with a mitotically inactivated stromal cell line, MS5, for three 
weeks to generate neural rosettes. These were then transferred to 
polyornithine/laminin-coated culture dishes containing N2 medium supplemented 
with DKK1, SHH and BDNF (cells were re-plated 3-4 times). In the last re-plating 
step, cells were plated onto coated culture dishes containing N2 medium 
supplemented with BDNF, dbcAMP and valproic acid. The percentage of 
DARPP32-positive neurons and GABAergic neurons derived from this protocol after 
culturing for at least 62 days was approximately 53% and 36% of total neurons, 
respectively (Aubry et al., 2008). When the striatal progenitors derived from this 
protocol were transplanted into quinolinic acid-lesioned rat striata, however, the 
grafts expanded beyond the limit of the striatum. Further analysis of the grafts 
revealed the major cell types in the overgrowth were NESTIN-positive neural 
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progenitors and DARPP32-positive neurons. This protocol is, therefore, unlikely to 
be suitable for deriving clinical grade MSNs. This differentiation scheme may, 
however, be used for disease modelling providing that more detailed 
characterisation, such as electrophysiological studies, are performed. 
Likewise, Zhang and colleagues used a similar approach to genearate 
DARPP32-positive neurons (Figure 1.5 B) (Zhang et al., 2010). They first converted 
human induced pluripotent stem cells (hiPSCs) derived from fibroblasts from a 
Huntington’s disease patient (Park et al., 2008) into NESTIN-positive/SOX1-
positive/PAX6-positive neural stem cells by embryoid body formation. Neural 
rosettes were picked and plated onto polyornithine/laminin-coated dishes containing 
neural proliferation medium supplemented with bFGF. These neural stem cells were 
then re-plated and cultured in the medium supplemented with DKK1, SHH, BDNF 
and Rho-associated kinase (ROCK) inhibitor (Y-26732) for 8-10 days. After that, 
cells were cultured in medium contained BDNF, cAMP, valproic acid and Y27632 
for a further three days. DARPP32-positive/calbindin-positive MSNs comprised 10% 
of cells obtained with this protocol (Zhang et al., 2010), which is less than that 
described by Aubry and co-worker. Moreover, neither the molecular phenotype, nor 
the electrophysiological properties of the DARPP32-positive neurons obtained with 
this protocol, were fully characterised.  
The Sasai group has developed a culture system known as quick-aggregation 
serum-free culture of embryoid body-like aggregates (SFEBq) to differentiate both 
mouse embryonic stem cells (mESCs) and hESCs into different types of 
telencephalic neurons (Watanabe et al., 2005, Eiraku et al., 2008, Danjo et al., 2011). 
Under these culture conditions a substantial number of neuronal cells generated had 
forebrain identity as determined by the induction of Foxg1 expression. The 
telencephalic fate in SFEBq culture is mediated by a blockage of endogenous Wnt 
signalling by addition of the Wnt inhibitor Dkk1 into the culture medium (Watanabe 
et al., 2005). Addition of recombinant Shh at the concentration of 10 nM from day 3 
to day 9 of differentiation into SFEBq resulted in an increase of Gsx2-positive cells 
within the Foxg1-positive forebrain progenitor population (Danjo et al., 2011). 
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Dosage of Shh, both endogenous and exogenous plays an important role in forebrain 
patterning, since treatment with the Shh inhibitor cyclopamine led to an increase of 
Pax6-positive dorsal forebrain progenitor whereas the number of Gsx2-positive LGE 
progenitors was diminished. Excess Shh signalling stimulation, either by higher Shh 
concentration or a more potent Shh agonist (Smoothened agonist or SAG), however, 
drives cells into the MGE lineage as determined by the higher proportion of Nkx2.1-
positive cells but a reduced number of Gsx2-positive cells in the culture. Use of 
SFEBq culture with addition of 10 nM SHH between day 3 and day 9, combined 
with FACS-sorting of telencephalic cells at day 9, demonstrated that at day 35 of 
differentiation approximately 50% of the FACS-sorted Foxg1::venus-positive 
neurons were DARPP32-positive (Figure 1.5 C) (Danjo et al., 2011). These 
Darpp32-positive neuronal cells also expressed Ctip2 and Gad67, consistent with 
their in vivo counterpart. 
Shin and colleagues have described the use of a feeder-free, serum-free 
adherent culture technique to derive Darpp32-positive MSNs (Figure 1.4 A) (Shin et 
al., 2011). They initially compared whether three different neural differentiation 
methods, the embryoid body formation (Bain et al., 1995), the five stage method 
(Okabe et al., 1996, Lee et al., 2000) and the monolayer culturing (Ying et al., 2003) 
were equally efficient in terms of GABAergic neuron generation. Analyses showed 
that all methods yielded similar amount of GABAergic cells ranging between 27-
33% of the total cells (Shin et al., 2011). This was the first study to show that the 
number of GABAergic cells in the serum-free monolayer culture is comparable to 
that of the other two methods. Due to the fact that the monolayer culture is relatively 
simpler than others and contains no serum, it has been considered as a potential 
method for MSN derivation. Indeed, after twenty-one days of differentiation, one 
third of GABAergic neurons derived from this method were Darpp32-positive (Shin 
et al., 2011). Interestingly, the electrical properties of the mESC-derived neurons 
generated with this method showed the presence of active sodium and potassium 
channels, an ability to fire repetitive action potentials, and membrane properties, 
some of which were similar to those of rat E15 LGE neurons in primary cultures. 
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Hence, for the first time and by using the monolayer culture, this study showed that 
mESC-derived neurons were functionally active. However, it is not clear whether the 
patched neurons were actually MSNs since post-patching staining for MSN marker 
was not performed. 
A study from Ma and colleagues has demonstrated that DARPP32-positive 
MSNs could be generated from hESC by using adherent cultures supplemented with 
SHH (Figure 1.4 B) (Ma et al., 2012). Consistent to what has been reported in Danjo 
et al., different concentrations of exogenous SHH regulates dorsal-ventral patterning 
of the telencephalic cells (Danjo et al., 2011, Ma et al., 2012). Addition of 200 
ng/mL recombinant SHH to the cultures between day 12 and 18 of differentiation led 
to a robust induction of DARPP32 expression in hESC-derived GABAergic neurons 
(89% of GABAergic neurons expressed DARPP32). In contrast, high doses of SHH 
(e.g. 500 ng/mL) reduced the expression of the LGE-specific marker GSX2 whilst the 
expression of MGE progenitor marker NKX2.1 was dramatically increased. 
GABAergic neurons derived from this protocol shown to be capable of producing 
action potentials. Transplantation of LGE-like progenitors derived from this protocol 
into quinolinic acid-lesioned striata of severe combined immunodeficiency (SCID) 
mice resulted in the repopulation of DARPP32-positive GABAergic neurons from 
the graft within the lesioned striatum. Interestingly, motor deficits resulting from 
destruction of the striatum by quinolinic acid were restored four months after the 
transplantation of LGE-like progenitors (Ma et al., 2012). Although the quinolinic 
acid-lesioned model does not completely recapitulate the pathology of Huntington’s 
disease, this study is the first to show a recovery of motor function upon 
transplantation of ESC-derived striatal-committed progenitors into the striatum. 
Another study about MSN derivation from human pluripotent stem cells 
(hPSCs) has recently been reported by Delli Carri and colleagues (Figure 1.5 D) 
(Delli Carri et al., 2013a, Delli Carri et al., 2013b). Neural induction in this study 
was performed by the dual inhibition of SMAD signalling by Noggin and SB431542 
(Chambers et al., 2009). Then at day 5 of differentiation, the ventral telencephalic 
fate was modulated by addition of recombinant DKK1 and SHH for 3 weeks. 
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Neuronal cells were maintained for at least 80 days in the N2 medium supplemented 
with B27 and BDNF. The presence of DKK1 and SHH induced the ventral 
telencephalic fate as determined by a reduction of EMX2/NKX2.1 expression ratio. 
Under these conditions they found that approximately 20% of MAP2ab-positive 
neurons were also DARPP32-positive at day 80 of differentiation. Although the 
number of DARPP32-positive neurons is considerably lower than that has been 
reported in previous studies (e.g. Aubry et al. and Ma et al.), this study is the first to 
show a detailed characterisation of striatal markers such as CTIP2, FOXP1, FOXP2, 
DRD1, D2R and A2a receptor in PSC-derived MSNs (Delli Carri et al., 2013b). 
Electrophysiological studies demonstrated that the DARPP32-positive MSNs derived 
with this protocol could fire repetitive action potentials and exhibit the onset delay in 
the generation of the first spike, a characteristic electrical property of mature MSNs 
(Delli Carri et al., 2013b). Transplantation of cells cultured for 38 days into the 
striatum of quinolinic acid-lesioned rats showed integration of nerve fibres from the 
graft into the host striatum. DARPP32 as well as FOXP1 and FOXP2 expression 
patterns were also detected within the graft. More importantly, transplanted animals 
exhibited an enhanced performance in apomorphine-induced rotation tests compared 
to controls (Delli Carri et al., 2013b). Therefore, this study demonstrated not only the 
generation of PSC-derived MSNs, but also showed the most comprehensive 
characterisation of PSC-derived MSNs, replicating molecular, electrophysiological 
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Figure 1.4 Schematic diagram of the published differentiation protocol used for 
deriving the MSNs. (A) From Shin et al., 2011. (B) From Ma et al., 2012. mESC, mouse 
embryonic stem cell; hESC, human embryonic stem cell; BDNF, brain-derived neurotrophic 
factor; cAMP, cyclic adenosine monophosphate; GABA, gamma-aminobutyric acid; GDNF, 
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Figure 1.5 Schematic diagram of the published differentiation protocols used DKK1, 
SHH and BDNF to derive the MSNs. (A) From Aubry et al., 2008. (B) From Zhang et al., 
2010. (C) From Danjo et al., 2011. (D) From Delli Carri et al., 2013a and 2013 b. BDNF, 
brain-derived neurotrophic factor; dbcAMP, dibutyryl-cyclic adenosine monophosphate; EB, 
embryoid body; hESC, human embryonic stem cell; hPSC, human pluripotent stem cell; 
KSR, KnockOut™ serum replacement; mESC, mouse embryonic stem cell; NT3, neuro-
trophin-3; SFEBq, quick-aggregation serum-free culture of embryoid body-like aggregates. 
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1.5 Aim of the project 
Despite the presence of MSN markers including DARPP32 in neuronal cells 
derived from published in vitro differentiation protocols (Aubry et al., 2008, Zhang 
et al., 2010, Danjo et al., 2011, Shin et al., 2011, Ma et al., 2012, Delli Carri et al., 
2013b), the phenotype of MSN subtypes has not been fully characterised. No study 
so far has demonstrated whether the DARPP32-positive neurons expressed 
enkephalin or substance P, the two major markers for striatopallidal and striatonigral 
MSNs, respectively. Although the MSN derived from Delli Carri’s protocol 
exhibited expression of dopamine receptor D1 and D2 as well as adenosine receptor 
A2a, it was not clear whether they expressed either substance P or enkephalin. The 
presence of substance P and/or enkephalin in these neurons is essential for the 
classification of MSN subtypes since the most vulnerable neuronal population in 
Huntington’s disease is identified by enkephalin expression (Reiner et al., 1988), not 
dopamine receptor D2 or adenosine receptor A2a.  
The aim of this thesis, therefore, was to generate one of the MSN subtypes, 
the enkephalinergic striatopallidal MSNs, from mESCs. We first have generated an 
enkephalinergic reporter ESC line that allows the expression of enhanced yellow 
fluorescent protein (EYFP) when the Cre-recombinase is specifically expressed in 
enkephalin-producing neurons. This reporter line would be useful not only for 
monitoring enkephalinergic expression during the differentiation, but also to provide 
a precise marker, which could be used for further analyses/characterisations of the 
enkephalinergic population within the culture. Using this reporter ESC line, we have 
optimised a differentiation protocol to derive enkephalinergic MSNs. Further 
characterisation has revealed the unexpected role of WNT and SHH signalling in the 
regulation of enkephalin expression. The enkephalinergic MSNs derived from our 
protocol are electrophysiologically active and exhibit the electrical hallmark of 
MSNs. Our findings could be used for deriving enkephalinergic MSNs for in vitro 
modelling of Huntington’s disease. 
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Table 2.1: Chemicals used in this study. 
Chemical Formula Catalogue 
number 
Manufacturer 
Agarose  A9539-500G Sigma-Aldrich 
Ammonium chloride NH4Cl A0171 Sigma-Aldrich 
Buffer solution pH4.0 (20°C)  33665-500ML Fluka 
Buffer solution pH7.0 (20°C)  33666-500ML Fluka 
Buffer solution pH10.0 (20°C) 33668-500ML Fluka 
Citric acid monohydrate C6H8O7.H2O C1909-25G Sigma-Aldrich 
4′,6-diamidino-2-phenylindole 
(DAPI) 
C22H27N5O6 D3571 Molecular 
Probes 
Dimethyl sulfoxide (DMSO) C2H6OS 34869-100ML Sigma-Aldrich 
Ethanol (EtOH) C2H6O 20821.330 vWR 
Ethidium bromide C21H20BrN3 E1510-10ML Sigma-Aldrich 
Ethylenedinitrilotetraacetic 




1084211000 Merck Millipore 
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Gelatin, from cold water fish 
skin 
 G7765-250ML Sigma-Aldrich 
Glycerol C3H8O3 G/0650/08 Fisher Scientific 
Glycine C2H5NO2 G/0800/60 Fisher Scientific 
Hydrogen peroxide solution 
(≥30%) 
H2O2 95321 Fluka 
Isopentane (2-methylbutane) C5H12 M32631-
500ML 
Sigma-Aldrich 
Isopropanol C3H8O 20842.330 vWR 
2-mercaptoethanol (2-ME) C2H6OS M6250-100ML Sigma-Aldrich 
Paraformaldehyde (PFA) OH(CH2O)nH  
(n=8-100) 
P6148-1KG Sigma-Aldrich 
Phosphate buffered saline 
(PBS) tablet 
 P4417-50TAB Sigma-Aldrich 
Sodium azide NaN3 S8032-25G Sigma-Aldrich 
Sodium citrate tribasic 
dihydrate 
C6H5Na3O7.2H2O C8532-1KG Sigma-Aldrich 
Sodium hydroxide NaOH S5881-500G Sigma-Aldrich 
Sodium pentobarbital C11H17N2NaO3 P3761-5G Sigma-Aldrich 
Sodium phosphate dibasic 
dihydrate 
Na2HPO4.2H2O 71643-1KG Sigma-Aldrich 
Sodium phosphate 
monobasic monohydrate 
NaH2PO4.H2O A429146347 Merck 
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Tris base (CH2OH)3CNH2 BP152-1 Fisher Scientific 
Triton X-100 C14H22O(C2H4O)n 
(n=9-10) 
T8787-250ML Sigma-Aldrich 
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2.1.2 Solutions 
Cell blocking buffer 10% normal goat serum, 0.3% TritonX-100, 0.2% sodium 
azide in PBS 
Phosphate buffer (PB) 100 mM PB, pH 7.4 (7.74% of 1 M Na2HPO4, 2.26% of 1 
M NaH2PO4) 
4% paraformaldehyde    40 g paraformaldehyde in PB, pH 7.4  
Quenching solution 0.1 M glycine, 0.1 M NH4Cl in PBS 
TB 50 mM Tris, pH 8.3 
10x TBE 890 mM Tris, 890 mM boric acid, 20 mM EDTA, pH 8.3 
TBS 50 mM Tris, 150 mM NaCl, pH 7.5 
Tissue blocking buffer 1 10% normal goat serum, 0.3% carrageen, 0.5% TritonX-
100, 0.2% sodium azide in TBS 
Tissue blocking buffer 2 10% normal goat serum, 0.3% TritonX-100, 0.2% sodium 
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2.1.3 Reagents 
Table 2.2: Reagents used in this study. 
Reagent Catalogue number Manufacturer 
DirectPCR lysis reagent (mouse tail) 102-T Viagen Biotech 
KAPA™ universal ladder KK6303 Kapa 
Biosystems  
LightCycler® 480 Probes Master 04887301001 Roche 
MgCl2 solution (25 mM) for PCR  M8787 Sigma-Aldrich 
Normal goat serum S-1000 Vector labs 
OCT mounting media 361603E VWR 
Orange G O3756-100G Sigma-Aldrich 






Taq DNA polymerase (from 
Thermus aquaticus) with 10x PCR 
reaction buffer containing MgCl2 
D1806-20X250UN Sigma-Aldrich 
Trizol® reagent 15596-018 Ambion 
Universal ProbeLibrary Probe 1 04684974001 Roche 
Universal ProbeLibrary Probe 5 04685024001 Roche 
Universal ProbeLibrary Probe 11 04685105001 Roche 
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Universal ProbeLibrary Probe 13 04685121001 Roche 
Universal ProbeLibrary Probe 17 04686900001 Roche 
Universal ProbeLibrary Probe 26 04687574001 Roche 
Universal ProbeLibrary Probe 27 04687582001 Roche 
Universal ProbeLibrary Probe 32 04687655001 Roche 
Universal ProbeLibrary Probe 34 04687671001 Roche 
Universal ProbeLibrary Probe 38 04687965001 Roche 
Universal ProbeLibrary Probe 40 04687990001 Roche 
Universal ProbeLibrary Probe 41 04688007001 Roche 
Universal ProbeLibrary Probe 47 04688074001 Roche 
Universal ProbeLibrary Probe 56 04688538001 Roche 
Universal ProbeLibrary Probe 60 04688589001 Roche 
Universal ProbeLibrary Probe 67 04688660001 Roche 
Universal ProbeLibrary Probe 75 04688988001 Roche 
Universal ProbeLibrary Probe 78 04689011001 Roche 
Universal ProbeLibrary Probe 89 04689143001 Roche 
Universal ProbeLibrary Probe 95 04692128001 Roche 
Universal ProbeLibrary Probe 97 04692144001 Roche 
Universal ProbeLibrary Probe 98 04692152001 Roche 
Universal ProbeLibrary Probe 100 04692187001 Roche 
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Universal ProbeLibrary Probe 102 04692209001 Roche 
Universal ProbeLibrary Probe 104 04692225001 Roche 
Universal ProbeLibrary Probe 110 04692306001 Roche 
VectamountTM mounting medium H-5000 Vector 
Laboratories 
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2.1.4 Kits 
Table 2.3: Kits used in this study. 
Kit Catalogue number Manufacturer 
MycoAlertTM mycoplasma detection kit LT07-118 Lonza 
MycoAlertTM assay control set LT07-518 Lonza 
Ready-To-Go T-primed first-strand kit 27-9263-01 Amersham 
RNeasy® mini kit 74106 Qiagen 
RNase-free DNase set 79254 Qiagen 
SuperScript® VILOTM cDNA synthesis kit 11754-250 Invitrogen 
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2.1.5 Primers 
Table 2.4: qRT-PCR primers used in this study. 




Actb             
(β-actin) 
AAG GCC AAC CGT 
GAA AAG AT 
GTG GTA CGA CCA 





GGT CCT CAC GCA 
GAG TTC C 
TCA CCA AGC CAT 




CTT CTG GCA CTG 
CTC CTA CC 
TGG TGG TAG CGT 
TAC TTG GA 
60 112 
Ctip2 TGG ATG CCA GTG 
TGA GTT GT 
GCT GCT GCA TGT 
TGT GC 
97 68 
Dkk1 TGG TTG GTG CTT 
TTG CCT A 
GAC CTG AGT TCA 
TGG GCA TC 
75 71 
Dlx1 CCG GAG GTT CCA 
ACA AAC T 
TCT GGA ACC ATA 
TCT TGA CCT G 
13 101 
Dlx2 GCC TCA CCC AAA 
CTC AGG T 
AGG CAC AAG GAG 





TGT TTG AAA TGT 
TTA CAA GGT GTT C 
CAG TCA GCC CTT 





TGA ACA GGC GGA 
GAA TGG 
CTG GTG CTT GAC 
AGC ATC TC 
17 70 
EYFP GAA GCG CGA TCA CCA TGC CGA GAG 67 62 
Derivation of enkephalinergic medium spiny neurons                                                  
from mouse embryonic stem cells 
 Chapter 2: Materials and methods  56 
CAT GGT TGA TCC 
Foxg1 GAA GGC CTC CAC 
AGA ACG 
CAA GGC ATG TAG 
CAA AAG AGC 
26 114 
Foxp1 CTG CAC ACC TCT 
CAA TGC AG 
GGA AGC GGT AGT 
GTA CAG AGG T 
102 73 
Foxp2 ACA TCG ACA GCA 
ATG GGA AC 
CTT CCT TGA CAT 
GGA TTG AATG 
5 75 
Gad1 ATA CAA CCT TTG 
GCT GCA TGT 
TTC CGG GAC ATG 
AGC AGT 
27 60 
Gata6 GGT CTC TAC AGC 
AAG ATG AAT GG 
TGG CAC AGG ACA 
GTC CAA G 
40 94 
Gfap TCG AGA TCG CCA 
CCT ACA G 
GTC TGT ACA GGA 
ATG GTG ATG C 
67 67 
Gsx2 GTC GGA CCC ACG 
GAG ATT  
TTT TGC CAT TGG 
GTA CCT G  
34 71 
Nanog TTC TTG CTT ACA 
AGG GTC TGC 
AGA GGA AGG GCG 
AGG AGA  
110 67 
Ncam1 AGT TCA AGA CAC 
AGC CAG TCC 
GAT GGA GTT CCC 
GTC CTC T 
11 77 
Nes TCC CTT AGT CTG 
GAA GTG GCT A  
GGT GTC TGC AAG 
CGA GAG TT  
67 68 
Nkx2.1 AAA ACT GCG GGG 
ATC TGA G 
TGC TTT GGA CTC 
ATC GAC AT 
95 144 
Ntrk2      
(TrkB) 
AAA GCA ATC GGG 
AGC ATC T  
CCA ACT TGA GCA 
GGA GCA AC 
40 96 
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Pax6 GTT CCC TGT CCT 
GTG GAC TC  
ACC GCC CTT GGT 
TAA AGT CT 
78 61 
Penk CCC AGG CGA CAT 
CAA TTT 
TCT CCC AGA TTT 




AAG AAG CCT GGG 
AAC CCA TA 
GGC CCA TAG ACT 
GTT CCT ACC 
11 68 
Plp1 TCA GAG TGC CAA 
AGA CAT GG 
CAG AAC AGT GCC 
ACT CCA AA 
49 114 
Oct4 ATT GGA GAA GGT 
GGA ACC AA 
CTC CTT CTG CAG 
GGC TTT C 
95 61 
Pax6 GTT CCC TGT CCT 
GTG GAC TC 
ACC GCC CTT GGT 




CCA CCC AAA GTC 
GAA GAG AC 
GCT AAT GGT CTG 
CAG GTG CT 
98 82 
Shh CCA ATT ACA ACC 
CCG ACA TC 
GCA TTT AAC TTG 
TCT TTG CAC CT 
32 91 
Sox1 GTG ACA TCT GCC 
CCC ATC 
GAG GCC AGT CTG 
GTG TCA G  
60 60 
T Brachyury CAG CCC ACC TAC 
TGG CTC TA 
GAG CCT GGG GTG 
ATG GTA 
100 72 
Tac1 AAG CCT CAG CAG 
TTC TTT GG 
TCT GGC CAT GTC 
CAT AAA GA 
89 100 
Tbp GGC GGT TTG GCT 
AGG TTT 
GGG TTA TCT TCA 
CAC ACC ATG A 
107 83 
Tubb3       GCG CAT CAG CGT TTC CAA GTC CAC 104 73 
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(βIII-tubulin) ATA CTA CAA CAG AAT GG 
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2.1.6 Primary antibodies 
Table 2.5: Primary antibodies used in this study. 
Antibody Isotype Dilution Catalogue 
number 
Manufacturer 
βIII-tubulin (clone TuJ-1) Mouse IgG2a 1:1,000 MAB1195 R&D Systems 
CD133 (clone13A4, 
biotin conjugated) 
Rat IgG1, κ 1:300 13-1331-82 eBioscience 
CD24 (clone M1/69,  
PE-Cy7 conjugated) 
Rat IgG2b, κ 1:600 101822 BioLegend 
Ctip2 Rat IgG 1:500 ab18465 Abcam 
DARPP32 Rabbit IgG 1:500 AB10518 Millipore 
GABA Rabbit IgG 1:1,000 A2052 Sigma-Aldrich 
GFAP Rabbit IgG 1:500 Z0334 Dako 
GFP Chicken IgY 1:1,000 ab13970 Abcam 
Nestin Mouse IgG1 1:50 Rat-401 DSHB 
Oct-3/4 Mouse IgG2b 1:200 sc-5279 Santa-Cruz 
Pax6 Mouse IgG1κ 1:500 PAX6 DSHB 
Pre-pro enkephalin Rabbit IgG 1:200 RA14124 Neuromics 
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2.1.7 Secondary antibodies 
Table 2.6: Secondary antibodies used in this study. 
Antibody Dilution Catalogue 
number 
Manufacturer 
Alexa Fluor® 350 goat anti-mouse IgG 
(H+L) 
1:500 A-11045 Molecular 
Probes 
Alexa Fluor® 488 goat anti-chicken IgG 
(H+L) 
1:1,000 A-11039 Molecular 
Probes 
Alexa Fluor® 488 goat anti-mouse IgG 
(H+L) 
1:1,000 A-11001 Molecular 
Probes 
Alexa Fluor® 488 goat anti-mouse IgG1 1:1,000 A-21121 Molecular 
Probes 
Alexa Fluor® 488 goat anti-mouse IgG2b 1:1,000 A-21141 Molecular 
Probes 
Alexa Fluor® 488 goat anti-rabbit IgG 
(H+L) 
1:1,000 A-11008 Molecular 
Probes 
Alexa Fluor® 555 goat anti-mouse IgG 
(H+L) 
1:1,000 A-21422 Molecular 
Probes 
Alexa Fluor® 555 goat anti-rabbit IgG 
(H+L) 
1:1,000 A-21428 Molecular 
Probes 
Alexa Fluor® 555 goat anti-rat IgG (H+L) 1:1,000 A-21434 Molecular 
Probes 
Alexa Fluor® 568 goat anti-mouse IgG2a 1:1,000 A-21134 Molecular 
Probes 
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2.1.8 Culture media, supplements and dissociation reagents 






B27® supplement 10 mL 17504-044 Gibco 
B27® supplement minus vitamin A 10 mL 12587-010 Gibco 
Bovine serum albumin fraction V 100 g K41-001P PAA 
Chicken serum 100 mL C5405-100ML Sigma-Aldrich 
DMEM/F12 without L-glutamine 500 mL 21331-020 Gibco 
DPBS without Calcium and 
Magnesium 
100 mL D8537-100ML Sigma-Aldrich 
Foetal bovine serum  
(batch number: 41G8502K) 
500 mL 10270-106 Gibco 
Gelatin (from porcine skin) 100 g G1890-100G Sigma-Aldrich 
Glasgow Minimum Essential Medium 
(GMEM) with sodium bicarbonate, 
without L-glutamine 
500 mL G5154-500ML Sigma-Aldrich 
Laminin (from Engelbreth-Holm-
Swarm murine sarcoma), 1 mg/mL 
1 mg L2020-1MG Sigma-Aldrich 
L-glutamine, 200 mM 100 mL 25030-024 Gibco 
Lif 550 µL NA ISCR tissue 
culture facility 
MEM non-essential amino acids 100 mL 11140-035 Gibco 
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2-mercaptoethanol 100 mL M6250-100ML Sigma-Aldrich 
NDiff® N2 neuronal supplement 5 mL SF-NS-01-005 StemCells Inc 
Neurobasal® medium 500 mL 21103-049 Gibco 
PBS, pH 7.4 500 mL 10010-015 Gibco 
Penicillin/Streptomycin (10,000 U/mL) 100 mL 15140-122 Gibco 
0.01% poly-L-ornithine solution 50 mL P4957-50ML Sigma-Aldrich 
Purmorphamine 5 mg 540220-5MG Calbiochem 
Recombinant human BDNF 100 µg 450-02 Peprotech 





Recombinant human DKK1 10 µg 5439-DK R&D systems 
Recombinant mouse Shh N-terminus, 
C25II substitution 
25 µg 464-SH-025 R&D systems 
Sodium pyruvate, 100 mM 100 mL 11260-039 Gibco 
StemPro® Accutase® cell dissociation 
reagent 
100 mL A11105-01 Gibco 
TrypLETM express with phenol red 100 mL 12605-010 Gibco 
2.5% trypsin 100 mL 15090-046 Gibco 
Y-27632 dihydrochloride 10 mg ab120129 Abcam 
Y-27632 dihydrochloride 1 mg 688000-1MG Calbiochem 
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Medium/reagent preparation 
mESC medium Glasgow minimum essential medium supplemented 
with  
-  Foetal bovine serum (10% v/v final concentration) 
-  1 mM sodium pyruvate 
-  2 mM L-glutamine 
-  1x MEM non-essential amino acid 
-  0.1 mM 2-mercaptoethanol 
-  1,000 U Lif 
 
Differentiation medium* Glasgow minimum essential medium supplemented 
with  
-  10% foetal bovine serum 
-  1 mM sodium pyruvate 
-  2 mM L-glutamine 
-  1x MEM non-essential amino acid 
-  0.1 mM 2-mercaptoethanol 
-  10 µM Y-27632 dihydrochloride 
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N2B27 medium  98 mL Neurobasal® medium and    
    100 mL DMEM/F12 medium supplemented with 
-  2 mL B27® supplement 
-  1 mL NDiff® N2 neuronal supplement 
-  1 mM L-glutamine 
-  0.1 mM 2-mercaptoethanol 
 
NB medium** N2B27 medium supplemented with 10 µM Y-27632 
dihydrochloride 
 
0.025% trypsin-EDTA 0.025% trypsin, 1 mM EDTA, 1% chick serum in PBS 
 
1% gelatin   1% porcine gelatin in sterile filtered H2O 
 
* Differentiation medium is used in the first day of NB and NB+3F differentiation 
protocols. 
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2.1.9 Consumables 




Falcon® 40 µm cell strainers 352340 Becton 
Dickinson 
Combitips advanced®, 0.1 mL, Eppendorf Biopur® 0030089618 Eppendorf 
Combitips advanced®, 0.2 mL, Eppendorf Biopur® 0030089626 Eppendorf 
13 mm cover glass 631-0149 vWR 
Cryogenic vials, internal thread, conical bottom,  
1 mL 
377224 Nunc 
Falcon® 35 mm polystyrene tissue culture dish 353001 Becton 
Dickinson 
Falcon® 60 mm polystyrene tissue culture dish 353004 Becton 
Dickinson 
EasYFlasksTM polystyrene tissue culture flasks, 
25 cm2 growth area 
156340 Nunc 
EasYFlasksTM polystyrene tissue culture flasks, 
75 cm2 growth area 
156472 Nunc 




Falcon® polystyrene tissue culture multiple well 
plates, 6-well, flat bottom 
353046 Becton 
Dickinson 
Falcon® polystyrene tissue culture multiple well 353043 Becton 
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plates, 12-well, flat bottom Dickinson 
Falcon® polystyrene tissue culture multiple well 
plates, 24-well, flat bottom 
353047 Becton 
Dickinson 
Axygen® 1,000 µL Maxymum Recovery® filter tips TF-1000-L-R-S Axygen 
Axygen® 200 µL Maxymum Recovery® filter tips TF-200-L-R-S Axygen 
Axygen® 20 µL Maxymum Recovery® filter tips TF-20-L-R-S Axygen 
Axygen® 10 µL Maxymum Recovery® Gilson-style 
filter tips 
TF-300-L-R-S Axygen 
Hard-Shell® thin-wall 384-well skirted PCR plates HSP-3805 Bio-Rad 
LightCycler® 480 white 384-well plates with 
sealing foils 
04729749001 Roche  
MicroAmp® adhesive film applicators 4333183 Applied 
Biosystems 
MicroAmp® fast optical 96-well reaction plates 4346906 Applied 
Biosystems 
MicroAmp® optical adhesive film 4311971 Applied 
Biosystems 
Microseal® ‘B’ adhesive seals MSB-1001 Bio-Rad 
1.5 mL microcentrifuge tubes S1615-5599 Starlab 
0.2 mL 8-strip PCR tubes I1402-2908 Starlab 
Costar® 5 mL Stripette® serological pipettes 4487 Corning 
Costar® 10 mL Stripette® serological pipettes 4488 Corning 
Costar® 25 mL Stripette® serological pipettes 4251 Corning 
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50 mL pipettes FB55486 Fisher 
Scientific 
Corning® 15 mL polypropylene centrifuge tubes, 
conical bottom 
430790 Corning  
Corning® 50 mL polypropylene centrifuge tubes, 
conical bottom 
430829 Corning 
Falcon® 5 mL polystyrene FACS tubes with 35 
µm cell strainer cap 
352235 Becton 
Dickinson 




Purple nitrile gloves, medium size 90627 Kimberly-Clark 
Professional 
RNase AWAY® 83931 Sigma-Aldrich 
RNaseZap® solution AM9780 Ambion 
RNaseZap® wipes AM9786 Ambion 
SigmaClean® water bath treatment S5525-4OZ Sigma-Aldrich 
1,000 µL tips F167104 Gilson 
200 µL tips F167103 Gilson 
10 µL tips F167101 Gilson 
30 mL universal tube 128A/P Sterilin 
150 mm unplugged glass Pasteur pipettes FB50251 Fisher 
Scientific 
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2.1.10 Cell lines 
Table 2.9: Cell lines used in this study. 
Cell line Description Reference 
E14tg2a A wild-type, hypoxanthine 
phosphoribosyltransferase (HPRT) 
deficient mESC line, 129/Ola background 
Hooper et al., 1987 
PNK6 A mESC line generated from the 
crossing between BAC-Penk-Cretg/+ line 
and Rosa26-EYFPtg/+ line with no Cre-
recombinase transgene inherited from 
parents, C57BL/6J:129 background 
This study 
PNK18 A reporter mESC line generated from the 
crossing between BAC-Penk-Cretg/+ line 
and Rosa26-EYFPtg/+ line and expresses 
EYFP upon Cre-mediated recombination 
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2.1.11 Animals 
Table 2.10: Animals used in this study. 
Mouse line Description Reference 
BAC-Penk-Cre A BAC (bacterial artificial chromosome) 
transgenic line expressing Cre-
recombinase under the control of pre-
pro-enkephalin promoter 
Besusso et al., 2013 
Rosa26-EYFP A reporter line expressing EYFP from the 
Rosa26 locus upon Cre-mediated 
removal of LoxP-flanked stop cassette  
Srinivas et al., 2001 
Trkb floxed A Trkb conditional knockout line, which 
has loxP sites flanking the second exon 
corresponding to the tyrosine kinase 
domain of the Ntrk2 gene  
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2.1.12 Analytical software 
Table 2.11: Analytical software used in this study. 
Software Application Developer 
FlowJo (version 8.8.7) Flow cytometry analysis Tree Star 
ImageJ (version 1.49b) Image analysis National Institutes of 
Health 
Prism 6 for Mac OS X 
(version 6.0d) 
Statistical analysis GraphPad 
Universal ProbeLibrary 
assay design center 
(version 2.45-2.50) 
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2.2 Methods 
 
2.2.1 Embryonic stem cell culture 
All prepared media and solutions were kept at 4°C. No media that had been 
prepared for more than one month were used. Culture media, trypsin-EDTA and PBS 
were heated to 37°C in a water bath before applying to cells. Unless otherwise stated, 
all tissue culture plasticware was coated with 0.1% porcine gelatin in PBS for at least 
30 minutes prior to use. 
2.2.1.1 Routine culture 
Cells were cultured in a humidified tissue culture incubator with 
5% CO2 at 37°C. Cells were passaged when they reached 80-90% 
confluence; media were removed, cells were washed once with 5 mL pre-
warmed PBS. After aspirating the PBS, 2 mL of 0.025% trypsin-EDTA was 
added to T25 flask (the amount of trypsin-EDTA added was adjusted 
according to the size of flasks/plates). The flask was incubated at 37°C for 5 
minutes and then tapped several times to dissociate the cells. 8 mL of mESC 
medium was added to the flask to inactivate the trypsin. The cell suspension 
was then transferred to a 15 mL tube and centrifuged in a bench top 
centrifuge at 300 g for 3 minutes. The medium was removed and the cell 
pellet resuspended in 1 mL pre-warmed mESC medium. Approximately 1/10 
to 1/5 of cell suspension, depending on the cell line, was added to a new 
gelatinised T25 flask with 9 mL pre-warmed mESC medium. The flask was 
then put in the incubator. Media were replaced every day and cells passaged 
when confluence (usually every 2-3 days).  
2.2.1.2 Freezing cells 
Embryonic stem cells were frozen as follows: cells grown in a 
T25 flask were passaged as usual but resuspended in 2 mL freezing medium 
(mESC medium, 10% (v/v final concentration) DMSO). The amounts were 
altered accordingly to the size of flasks used. 1 mL of cell suspension was 
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transferred to a cryovial labelled with cell line’s name, passage number and a 
date of freezing. The cryovial was put into Mr FrostyTM freezing container 
before storing in  -80°C freezer overnight. The vial was transferred to a liquid 
nitrogen cell bank the following day. 
2.2.1.3 Thawing cells 
Cryovials containing frozen cells were removed from liquid 
nitrogen cell storage and immediately thawed by placing them into a tissue 
culture water bath set at 37°C. To dilute DMSO, cell suspension was 
transferred to a 15 mL tube containing 9 mL pre-warmed mESC medium. 
After centrifugation at 300 g for 3 minutes, medium was aspirated and the 
cell pellet was gently resuspended in 1 mL mESC medium. The cell 
suspension was transferred to a gelatin-coated T25 flask containing 9 mL pre-
warmed mESC medium. The flask was placed in an incubator with 5% CO2 
at 37°C. The mESC medium was changed once after cells had attached to a 
floor of the flask (3-5 hours after thawing cells). 
2.2.1.4 Karyotyping 
Chromosome counting was performed by using exponentially 
growing cells. Cells were washed with PBS and fed with pre-warmed mESC 
medium supplemented with 0.1 µg/mL (final concentration) demecolcine and 
incubated at 37°C for 40 minutes prior to trypsinisation. After centrifugation 
at 300 g for 3 minutes, the media was aspirated and the cell pellet 
resuspended in 2.5 mL pre-warmed 0.56% KCl. After 6 minutes incubation at 
room temperature, the cells suspension was centrifuged, resuspended in 200 
µL fixative (methanol-acetic acid, 3:1 by volume) and left at 4°C for 30 
minutes. The cell suspension was then dropped onto a cleaned glass slide and 
air-dried. Cells were then stained with 10% Giemsa, pH 7.2 for 20 minutes. 
Chromosome counting was done using bright field microscopy. 
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2.2.1.5 Mycoplasma screening 
Newly derived cell lines were screened for mycoplasma 
contamination using the MycoAlertTM mycoplasma detection kit (Lonza) as 
per manufacturer’s instructions. Briefly, 100 µL of medium from attached 
cells was used as a blank control for luminometer. 100 µL MycoAlertTM 
reagent was added to medium and incubated for 5 miuntes, generating the 
reading A from the luminometer. 100 µL of the MycoAlertTM substrate was 
then added and incubated for 10 minutes providing reading B. The ratio 
between reading A and reading B was calculated and mycoplasma 
contamination was considered present if the ratio was greater than 1.2. The 
sensitivity of the luminometer was confirmed by the use of positive and 
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2.2.2 N2B27 monolayer neural differentiation 
2.2.2.1 Plate/cover slip preparation for neural 
differentiation 
Cover slips (13 mm diameter) were sterilised by treatment in 
70% ethanol for 5 minutes. They were dried by placing on the edge of 24-
well plate in a vertical position. The completely dry cover slip was placed 
into each well of a new sterile 24-well plate. Sterile cover slips were rinsed 
with PBS once before coating with poly-L-ornithine/laminin. 
For poly-L-ornithine/laminin coating, one well of 24-well plate 
or a single cover slip was coated with 400 µL poly-L-ornithine solution 
(0.01%) for either 2 hours at room temperature or overnight at 4°C. They 
were then washed once with PBS before coating with 400 µL laminin (10 
µg/mL) and incubated at room temperature for 2 hours or overnight at 4°C. 
The laminin was removed and the well/cover slip washed with PBS. The 
volume of poly-L-ornithine and laminin used was adjusted accordingly for 
other sized plastics. 
2.2.2.2 Neural differentiation 
Neural differentiation of mESCs was performed by N2B27 
monolayer culture as described in Ying et al. 2003, with some modifications. 
Cells used in neural differentiation were in passage 8-20 (PNK18) or 29-40 
(E14). One day prior to beginning the differentiation process, confluent 
mESCs were plated at high density (1/2 of total cell suspension or 
approximately 3,000,000-3,500,000 cells per T25 flask) in mESC medium. 
On the first day of differentiation or day 0, the confluent mESCs were 
trypsinised and plated onto gelatin-coated plasticware containing 
differentiation medium (Glasgow minimum essential medium supplemented 
with foetal bovine serum (FBS), sodium pyruvate, L-glutamine, MEM non-
essential amino acid, 2-mercaptoethanol and Y-27632 dihydrochloride) at a 
density of 20,000 cells/mL. Medium was changed to NB medium (N2B27 
supplemented with Y-27632 dihydrochloride) on day 1. Cells were fed every 
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day until they reached analytical time point at either day 15 or day 21. At day 
7 of differentiation, cells were washed with PBS and dissociated with 
accutase at 37°C for 10 minutes. After centrifugation, cell pellet was 
resuspended in 1 mL NB medium. Cells were replated onto poly-L-
ornithine/laminin-coated plastics/cover slip containing NB medium at a 
density of 5 x 104 cells/cm2. For NB+3F culture, 100 ng/mL recombinant 
human DKK1, 200 ng/mL recombinant mouse Shh and 20 ng/mL 
recombinant human BDNF were added from day 1 to day 6 of differentiation, 
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2.2.3 Animals 
2.2.3.1 Mouse line 
All animals were kept on a mixed genetic background 
(C57BL/6J:129). Colonies were maintained by Dr. Jacqui Horn. Three mouse 
lines were used in this project. The BAC-Penk-Cre transgenic line was 
generated by pronuclear injection of circular BAC carrying Cre-recombinase 
under the control of pre-pro-enkephalin promoter (Besusso et al., 2013). The 
Gt(ROSA)26Sortm1(EYFP)Cos/J (also known as Rosa26-EYFP) is a reporter line, 
which contains a LoxP-flanked stop cassette in front of a cDNA for the 
enhanced yellow fluorescent protein (EYFP) inserted into the 
Gt(ROSA)26Sor (also known as Rosa26 or R26) locus (Srinivas et al., 2001). 
This line expresses EYFP only when the stop cassette is removed in the 
presence of Cre-recombinase. The Trkb floxed line (Trkblx/lx) has LoxP sites 
flanking the second exon of the Ntrk2 gene; corresponding to the tyrosine 
kinase domain (Minichiello et al., 1999). Excision of the second exon by Cre 
recombination leads to a disruption of gp145TrkB receptor expression whilst 
expression of truncated Trkb isoforms is intact.  
2.2.3.2 Animal husbandry, maintenance and procedures 
Animals were housed in designated facility at the Institute for 
Stem Cell Research, University of Edinburgh and the Department of 
Pharmacology, University of Oxford. Animal husbandry was performed by 
staff from Biological Services (Edinburgh), and Biomedical Services 
(Oxford).  Mice were housed separately according to their sex. The maximum 
number of animals per cage was six. In a case of males, only littermates were 
housed together whereas female animals from different litters could be 
pooled. For breeding purposes, one male was housed with two females. The 
minimal age of breeding was 6 weeks for females, or 7 weeks for males. 
Litters were weaned after P19. An ear biopsy was collected from each mouse 
at P14-21 for identification purposes and for genotyping. The project had 
ethical approval. All animal welfares and procedures, including Schedule 1 of 
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the Animal (Scientific Procedures) Act 1986, were conducted under 
University of Edinburgh and University of Oxford ethical committee 
guidelines and in adherence with Home Office legislation, Animals 
(Scientific procedures) Act 1986, and EU legislation for the protection of 
animals used for scientific purposes, Directive 2010/63/EU. The project 
licence number and personal licence number are PPL60/4193 and 
PIL60/13118, respectively.   
2.2.3.3 Genotyping 
All genotyping was performed by Dr. Jacqui Horn.  
DNA isolation 
DNA used for genotyping was isolated from ear and tail 
biopsies, which had been kept at -20°C until processed. Ear punches were 
collected between P14-21 and used for genotyping. Tail biopsies were taken 
from experimental animals to confirm animals’ genotype at time of death. 
Samples were digested in 100 µL directPCR lysis reagent for mouse tail 
(Bioquote) with 1.5 µL PCR grade, recombinant proteinase K (16.4 mg/mL, 
Roche) at 56°C for a minimum of 4 hours. Heat inactivation at 85°C was then 
performed for 45 minutes. For each PCR reaction, 1 µL of DNA preparation 
was used.  
Polymerase chain reaction (PCR) 
Lyophilised primers were ordered from Sigma-Aldrich, 
dissolved in nuclease-free H2O (Ambion) to 100 µM and stored at -20°C. 
PCR reaction for each target was set accordingly. All PCR reactions were set 
up in 0.2 mL 8-strip PCR tubes (Starlab) and run on DNAEngine Peltier 
Thermal Cycler (Bio-Rad). 
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BAC-Penk-Cre PCR 
Primers: LM40  5’ - AGG CAC CCG GGG AGG TTG TT - 3’ 
   LM41  5’ - CCA CGA CCG GCA AAC GGA CA - 3’ 
   LM42  5’ - CTC CTG CCA CGC ACC TTC CG - 3’ 
Reaction contained:   1 µL gDNA 
     5 µL 5x buffer 
     2.5 µL MgCl2 (25 mM stock) 
     0.625 µL dNTPs  
(10 mM stock, 2.5 mM for each dNTP) 
     0.5 µL LM40 primer (10 µM stock) 
     0.5 µL LM41 primer (10 µM stock) 
     0.5 µL LM42 primer (10 µM stock) 
     0.05 µL Taq polymerase (Sigma-Aldrich) 
     14.325 µL neuclease-free H2O 
Total reaction volume: 25 µL 
Cycling conditions:  Denaturation for 2 minutes at 94°C 
     35 cycles of 15 seconds at 94°C 
       15 seconds at 64°C 
       1 minute at 72°C 
     Final extension for 5 minutes at 72°C 
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Product size:  Wild type 371 bp 
    Mutant 527 bp 
Rosa26-EYFP PCR  
Primers: LM17           5’ - AAA GTC GCT CTG AGT TGT TAT - 3’ 
   LM18           5’ - GCG AAG AGT TTG TCC TCA ACC - 3’ 
   LM19           5’ - GGA GCG GGA GAA ATG GAT ATG - 3’ 
Reaction contained:   1 µL gDNA 
     5 µL 5x buffer 
     2.5 µL MgCl2 (25 mM stock) 
     0.625 µL dNTPs  
(10 mM stock, 2.5 mM for each dNTP) 
     0.5 µL LM17 primer (10 µM stock) 
     0.5 µL LM18 primer (10 µM stock) 
     0.5 µL LM19 primer (10 µM stock) 
     0.1 µL Taq polymerase (Sigma-Aldrich) 
     14.275 µL neuclease-free H2O 
Total reaction volume: 25 µL 
Cycling conditions:  Denaturation for 2 minutes at 94°C 
     35 cycles of 15 seconds at 94°C 
       15 seconds at 58°C 
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       1 minute at 72°C 
     Final extension for 5 minutes at 72°C 
Product size:  Wild type 602 bp 
    Mutant 298 bp 
TrkB floxed PCR 
Primers:         LM11 5’ - TGA AGG ACG CCA GCG ACA ATG CAC G - 3’ 
            LM12 5’ - CCA AGG TGA TCA ACA GCC CAA GTC  - 3’ 
Reaction contained:   1 µL gDNA 
     2.5 µL 10x buffer 
     2.5 µL MgCl2 (25 mM stock) 
     0.625 µL dNTPs  
(10 mM stock, 2.5 mM for each dNTP) 
     0.5 µL LM11 primer (10 µM stock) 
     0.5 µL LM12 primer (10 µM stock) 
     0.1 µL Taq polymerase (Sigma-Aldrich) 
     17.275 µL nuclease-free H2O 
Total reaction volume: 25 µL 
Cycling conditions:   Denaturation for 2 minutes at 94°C 
     40 cycles of 15 seconds at 94°C 
       15 seconds at 68°C 
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       1 minute 30 seconds at 72°C 
     Final extension for 5 minutes at 72°C  
Product size:    Wild type 857 bp 
     Mutant 913 bp 
Agarose gel electrophoresis 
Gel electrophoresis of PCR reactions was done on 2% agarose 
gel in 0.5x TBE buffer. The gel was prepared by melting Agarose (Sigma-
Aldrich) in a microwave oven until completely dissolved. After the agarose 
had been allowed to cool to 55°C, ethidium bromide (10 mg/mL; Sigma-
Aldrich) was added to make a final concentration of 50 ng/mL. Agarose was 
poured onto a gel tray where both of its ends were sealed with tape and the 
appropriate comb inserted. Once solidified, the gel was placed into an 
electrophoretic chamber containing 0.5x TBE. 5 µL KAPA universal ladder 
(KAPA Biosystems) and 15 µL PCR reactions (with 3 µL of loading buffer 
added) were loaded into each well of the agarose. Gel was applied with 170 V 
electricity until the bands were clearly separated. Images of the bands were 
taken with either Gel DocTM XR+ system (Bio-Rad) or PhotoDoc-ItTM 
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2.2.4 Immunostaining for brain tissues 
2.2.4.1 Perfusion and fixation 
For eliminating blood from a brain as much as possible, mice 
were perfused with 0.1 M phosphate buffer (PB) pH 7.4. Initially, animals 
were intraperitoneally injected with 50 µL sodium pentobarbital (50 mg/mL, 
Sigma-Aldrich). To test whether mice were unconscious, their hind paws and 
tail were pinched and no further procedure would be carried unless the mice 
were totally unresponsive. After that, a tip of tail was collected for 
genotyping and the mouse pinned to a cork board. The abdominal wall of 
mouse was opened and the right atrium was cut to allow the blood to drain 
out. 20 mL PB was flushed through the animal via perfusion tubing attached 
to 30G needle and a perfusion pump at a rate of 3-4 mL/min (Masterflex L/S 
easyload II, Cole Parmer) to slowly perfuse the PB through the left ventricle 
of the animals. Perfusion with PB was performed until the liver cleared and 
only clear liquid was observed from the opening of right atrium. After that 
perfusion with 20 mL of 4% PFA in PB was performed. After decapitation, 
the skull was opened and the brain removed and placed in 4% PFA on ice for 
three hours or overnight (Brains were initially left in 4%PFA overnight but it 
has been found that some primary antibodies did not worked well on over 
fixed tissues). Tissues were then washed twice in PBS and transferred to 30% 
sucrose in Tris-Azide buffer. Brains were left in sucrose at 4°C until they 
sank to the bottom of a tube (usually 2-3 days). Brains were embedded in a 
plastic mold containing OCT and quickly frozen in dry ice-cold isopentane 
for 1 minute before long-term storage at -80°C. 
2.2.4.2 Immunohistochemistry 
OCT-embedded brains were transferred from -80°C freezer to 
the Cryostat chamber (-20°C) and left to equilibrate for at least 30 minutes. 
Sagittal sections of the brain were cut at 30 µm thickness using a Cryostat 
CM3030 S (Leica Biosystems). Sections were treated with 3% hydrogen 
peroxide (in TBS) at room temperature for 20 minutes. Three washes (10 
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minutes each) with TBS were done. Tissues were incubated in tissue blocking 
buffer 1 (10% normal goat serum, 0.3% carrageen, 0.5% TritonX-100, 0.2% 
sodium azide in TBS) at room temperature for 1 hour. Tissues were then 
incubated with the primary antibody (chicken anti-GFP, abcam, 1:1,000) 
diluted in 1% normal goat serum, 0.3% carrageen, 0.5% TritonX-100 in TBS 
at room temperature overnight. After three washes with TBS, sections were 
incubated with the secondary antibody, biotinylated goat anti-chicken (1:200, 
Novex) diluted in 1% normal goat serum, 0.3% carrageen, 0.5% TritonX-100 
in TBS at room temperature for 2 hours. After three washes, sections were 
incubated in Vectastain® ABC solution (Vector laboratories) at room 
temperature for 30 minutes. Tissues were washed three times (15 minutes 
each) with TBS followed by two washes (15 minutes each) with TB. Tissues 
were then incubated in DAB solution for 1-2 minutes. When colour 
developed, the reaction was stopped by adding cold TB. Sections were 
mounted on gelatin-coated slides and air-dried in a fume hood for 2 hours. 
Mounted sections were dehydrated in 90% and 100% ethanol, each for 1 
minute before incubating in xylene for 10 minutes. Vectamount permanent 
mounting medium (Vector laboratories) was then applied on the slide before 
cover slip was placed.  
2.2.4.3 Immunofluorescence 
OCT-embedded brains were transferred from -80°C freezer to 
the Cryostat chamber (-20°C) and left equilibrated for at least 30 minutes. 
Sagittal section of the brain was cut at 30 µm thickness using Cryostat 
CM3030 S (Leica Biosystems). Sections were washed with TBS for three 
times (15 minute each).  Heat-induced antigen retrieval was performed to 
reveal the masked epitope from protein cross-linking mediated by 
paraformaldehyde. Sections were immersed in 10 mM sodium citrate buffer 
pH 6.0 and incubated at 80°C for 1 hour. After antigen retrieval was done, 
sections were washed three times (15 minute each) with TBS. Sections were 
then incubated in tissue blocking buffer 2 (10% normal goat serum, 0.3% 
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TritonX-100, 0.2% sodium azide in TBS) at room temperature for 2 hours. 
Sections were incubated with primary antibodies diluted in tissue blocking 
buffer 2 (rabbit anti-pre-pro enkephalin, Lifespan Biosciences, 1:5,000 and 
chicken anti-GFP, abcam, 1:1,000) at room temperature overnight. After 
three washes with TBS, sections were incubated with secondary antibodies 
diluted in tissue blocking buffer 2 (goat anti-chicken Alexa Fluor 488 and 
goat anti-rabbit Alexa Fluor 555, Molecular Probes, 1:1,000) in the dark at 
room temperature for 3 hours. Sections were washed three times (15 minutes 
each) with TBS. Sections were then counterstained with 100 ng/mL DAPI at 
room temperature for 10 minutes, washed three times with TBS (15 minutes 
each), transferred to gelatin-coated slides, mounted using Vectashield 
Mounting Medium (Vector laboratories) and covered with a cover slip. 
Images were taken with a Leica AF6000 Modular System microscope (Leica 
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2.2.5 Immunofluorescence of cultured cells 
Cells grown on 13 mm cover slips were washed once with PBS. Fixation was 
done at room temperature in 4% PFA for either 5 minutes (for enkephalin 
immunostaining) or 20 minutes (for other stainings). Cells were washed three times 
with PBS. Fixed cells could be kept at 4°C for several days if desired. A quenching 
step was done by incubating fixed cells in quenching solution (0.1 M ammonium 
chloride, 0.1 M glycine in PBS) at room temperature for 10 minutes. After 
quenching, cover slips were washed with PBS for three times. Cells were incubated 
in cell blocking buffer (10% normal goat serum, 0.3% TritonX-100, 0.2% sodium 
azide in PBS) at room temperature for 30 minutes and incubated with primary 
antibodies diluted in cell blocking buffer at room temperature overnight. After three 
washes with PBS, cells were incubated with secondary antibodies diluted in cell 
blocking buffer in the dark at room temperature for 1 hour. After three washes with 
PBS, cells were stained with 100 ng/mL DAPI in the dark at room temperature for 10 
minutes. Cover slips were then washed with PBS for three times and transferred to a 
glass slide. Mounting was done using Vectashield Mounting Medium (Vector 
laboratories). Images were taken with a Leica AF6000 Modular System microscope 
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2.2.6 Flow cytometry and fluorescence-activated cell sorting 
(FACS) 
2.2.6.1 Cell dissociation 
Cells grown in a well of 12-well plate were washed once with 1 
mL PBS. Enzymatic dissociation was done by adding 400 µL Accutase and 
incubating at 37°C, 5% CO2 for 15 minutes. The plates were tapped five 
times to dissociate cells. 1.6 mL of N2B27 medium was then added. The cell 
suspension was pipetted up and down 15 times using 1 mL filter tip to create 
a single cell suspension. Samples were kept on ice until the staining step was 
performed. 
2.2.6.2 Antibody staining 
The cell suspension was centrifuged in a bench-top centrifuge at 
300 g, room temperature, for 4 minutes. Cells were then incubated with 
primary antibodies (PE-Cy7-conjugated rat anti-CD24, 1:600 per 1,000,000 
cells, Biolegend; biotinylated rat anti-CD133, 1:300 per 1,000,000 cells, 
eBioscience) at 4°C in the dark for 15 minutes. Cells were washed by adding 
1 mL PBS before centrifugation at 300 g, 4°C for 3 minutes. For CD133 
staining, cells were incubated in streptavidin conjugated APC at 4°C in the 
dark for 15 minutes. Cells were washed with 1 mL PBS then resuspended in 
200 µL FACS buffer. 0.2 µg/mL DAPI was added into samples to exclude 
dead cells. All samples were kept on ice until analysis/sorting was performed. 
2.2.6.3 Analysis 
Cells were analysed with a BD LSRFortessa cell analyser 
(Becton Dickinson). E14 (Hooper et al., 1987) -derived neural cells were 
used for setting forward and side scatter gate and calibrating DAPI, EYFP, 
PE-Cy7 and APC signals. Single-labelled samples (DAPI-positive, EYFP-
positive, PE-Cy7-positive and APC-positive controls) and fluorescence minus 
one (FMO) controls (FMO-DAPI, FMO-EYFP, FMO-PE-Cy7 and FMO-
APC) were used to compensate fluorescent overlap in different channels and 
to set gates. Data was acquired and saved in FCS formats with BD 
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FACSDivaTM software (Becton Dickinson).  Analysis was performed with 
FlowJo software version 8.8.7 (Tree Star).  
2.2.6.4 Cell sorting 
Cells were sorted with either a BD FACSAriaII or BD 
FACSAriaIII cell sorters (BD Biosciences). Gates were set with unstained 
E14 (Hooper et al., 1987) neural cells, single-labelled controls and FMO 
controls as described in chapter 2.2.6.3. An 100 µm nozzle was used for cell 
sorting. Pre-sort purity analysis was performed prior to the actual sort to 
determine the purity of the sorted cells. Most sorted samples were at least 
90% purity. Two thousand cells were sorted directly into a 1.5 mL tube 
contained 800 µL Trizol. After sorting, cells were mixed by inverting the 
collection tubes for several times. The tubes were briefly centrifuged and 
quickly frozen in dry ice. Frozen Trizol samples were kept at -80°C until 
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2.2.7 RNA isolation 
2.2.7.1 RNA isolation from cultured cells 
Total RNA was extracted from cultured cells using the RNeasy 
Mini kit (Qiagen). Briefly, cells were lysed in 350 µL buffer RLT, 10 µL/mL 
2-mercaptoethanol. Homogenisation was done by passing lysate five times 
through a 21-gauge needle connected to an 1 mL RNase-free syringe. The 
lysate was transferred to RNeasy spin column. After washing, on column 
genomic DNA digestion was done by adding 2.73 Kunitz units of DNase I. 
The final RNA was eluted with 40 µL RNase-free water (Qiagen). 
2.2.7.2 RNA isolation from sorted cells and brain tissues 
Total RNA was isolated from both sorted cells and brain tissues 
with Trizol (Ambion). For sorted cell samples, 2,000 cells were FACS-sorted 
into 1.5 mL tube contained 800 µL Trizol. For brain tissues, up to 100 mg of 
tissue was placed in 1 mL Trizol. Chloroform was added (200 µL per 1 mL 
Trizol) to all sample types. After centrifugation, the aqueous phase, which 
contains RNA, was transferred to a new tube. RNA was precipitated, first 
with isopropanol and then with 75% ethanol. The RNA pellet was air dried 
and resuspended in either 15 µL (sorted cells) or 40 µL (brain tissues) 
nuclease-free water (Ambion). 
2.2.7.3 RNA concentration measurement 
RNA quantification was done using an UV spectrophotometer 
Nanodrop ND-1000 (Thermo Scientific), NanoVue Plus (GE Healthcare Life 
Sciences) or NanoPhotometer P 300 (Implen). The UV absorbance was 
converted to an RNA concentration using the Beer-Lambert law with an 
extinction coefficient of 40. 
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2.2.8 cDNA synthesis 
2.2.8.1 T-primed kit (Amersham) 
One microgramme of total RNA was diluted with RNase-free 
water to a volume of 33 µL in 1.5 mL tube. RNA was heated at 65°C for 5 
minutes, then at 37°C for 5 minutes. While RNA was incubating at 37°C, the 
first-strand reaction mix tube was also warm to 37°C for 5 minutes. RNA was 
then transferred to the first-strand reaction mix tube and incubated at 37°C for 
5 minutes. The contents in the tube were mixed by gentle vortexing, then 
spun down briefly before incubating at 37°C for another 60 minutes. The 
resulting cDNA was either used immediately for quantitative RT PCR or kept 
at -20°C. 
2.2.8.2 Superscript VILO kit (Invitrogen) 
One to two microgrammes of total RNA was added to 200 µL 
tube containing 4 µL of 5x VILO reaction mix and RNase-free H2O (to 18 
µL) and 2 µL of 10x SuperScript enzyme mix was then added. The amount of 
5x VILO reaction mix, 10x SuperScript enzyme mix and total volume could 
sometimes be scaled up to 50 µL depending on the RNA concentration used. 
After gentle mixing, the tube was incubated at 25°C for 10 minutes, then at 
42°C for another 2 hours. The reaction was terminated by heating the tube at 






Derivation of enkephalinergic medium spiny neurons                                                  
from mouse embryonic stem cells 
 Chapter 2: Materials and methods  90 
2.2.9 Quantitative RT PCR (qRT-PCR) 
2.2.9.1 Primer design 
Primers were designed using the Roche Universal ProbeLibrary 
Assay Design Centre software. Chosen primers have a melting temperature 
between 59°C and 60°C. Primers with intron spanning assay were chosen to 
avoid genomic DNA amplification with an exception of EYFP primers, 
which does not contain any introns. 
2.2.9.2 qRT-PCR 
qRT PCR was done using an UPL assay on a LightCycler 480 
Instrument (Roche), ABI 7500 Fast Real-Time PCR System (Applied 
Biosystems) or CFX384 Touch Real-Time PCR Detection System (Bio-Rad). 
PCR settings are shown in Table 2.12. 
  



















Cooling 40 00:00:30 None 
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The Ct threshold value was either set automatically (in the 
LightCycler 480 Instrument and CFX384 Touch Real-time PCR Detection 
System) or manually (in the 7500 Fast Real Time PCR System) for each 
experiment. Data was analysed using the corresponding software. Ct values 
of each gene were normalised to that of a housekeeping gene, such as Actb, 
(ΔCt) of a same sample. Data was represented as either expression level 
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2.2.10 Electrophysiological studies 
All of the electrophysiological analyses were performed by Dr. Andrei-Sorin 
Illie, a postdoctoral research scientist in Dr. Colin Akerman’s group at the 
Department of Pharmacology, University of Oxford. 
All recordings were performed using the whole-cell patch-clamp technique in 
voltage- or current-clamp configurations. Patch pipettes were pulled from filamental 
borosilicate glass capillaries (1.2 mm outer diameter and 0.69 mm inner diameter; 
Harvard Apparatus) using a horizontal puller (Sutter P-97). The pipettes (5-8 MΩ tip 
resistance) were filled with an intracellular solution containing 130 mM potassium 
gluconate, 4 mM NaCl, 2 mM MgCl2, 2 mM Na2ATP, 0.3 mM Na3GTP, 5 mM 
phosphocreatine, 1 mM EGTA and 10 mM HEPES (Delli Carri et al., 2013a). 
Osmolarity was adjusted to 290 mOsm and the pH was adjusted to 7.25 with KOH. 
The PNK18 mESC line was cultured with either NB or NB+3F media to 
allow for neural differentiation. Cells were dissociated and re-plated at 50,000 
cells/cm2 density on poly-L-ornithine/laminin-coated 13 mm diameter cover slips. At 
day 22-24 of differentiation, cells were transferred from the incubator to the 
recording chamber. The cells were bathed in extracellular solution containing 140 
mM NaCl, 3 mM KCl, 10 mM glucose, 10 mM HEPES, 2 mM CaCl2, 1 mM MgCl2, 
pH 7.36 (adjusted with NaOH) (Delli Carri et al., 2013a). All recordings were 
performed at room temperature (22-24°C). Neurons were visualised under a 60x, 
water-immersion objective (Olympus BX51WI). Epifluorescence was used to 
visualise and identify EYFP-expressing neurons, which were then selected for patch-
clamp recordings. Following formation of a tight seal between the pipette and the 
underlying plasma membrane (>1 GΩ), whole-cell configuration was achieved by 
gently applying negative pressure via suction. Access resistance was calculated from 
-10 mV steps applied in voltage clamp from a holding voltage of -70 mV. Only 
recordings where access resistance was <50 MΩ were included. Recordings were 
made using an Axopatch 1D amplifier (Axon Instruments) and data was acquired 
using WinWCP Strathclyde whole cell analysis software (V.3.9.7; University of 
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Strathclyde) and stored on a PC for offline analysis. All voltages were corrected 
offline for a calculated junction potential of -15.8 mV. 
Voltage-clamp recordings were used to measure membrane resistance, 
membrane capacitance and voltage-activated currents. Membrane resistance and 
membrane capacitance were calculated from -10 mV voltage steps from a holding 
voltage of -70 mV. Voltage-activated fast inward sodium currents and delayed 
outward potassium currents were recorded by holding the cell at -90 mV and 
applying a series of depolarising voltage steps, progressively increasing by 10 mV 
and sequentially moving the membrane potential from -80 to +30 mV. Leak currents 
were removed by performing offline leak current subtraction. The current density of 
voltage-activated currents for each recording was calculated by dividing the peak 
amplitude of the current by membrane capacitance of the neuron. 
To check for the presence of a voltage-gated, fast inactivating, transient 
potassium current (IA) we used an IA-isolaing protocol in voltage-clamp mode in the 
presence of tetrodotxin (TTX, 1 µM) to block voltage-gated sodium currents (Delli 
Carri et al., 2013a). The membrane potential was held at -110 mV and the IA was 
activated with a series of depolarising test potentials in which the membrane 
potential was moved to a range between -40 and +70 mV in 10 mV increments. The 
IA current is completely abolished when the test potential is preceded by a 50 ms 
prepulse at -40 mV (Delli Carri et al., 2013a). Under these conditions, only delayed 
potassium currents are active. The IA was then isolated offline by subtracting traces 
containing the prepulse from those without the prepulse. 
Current-clamp recordings were used to measure resting membrane potential 
and action potential. The resting membrane potential was calculated from current-
clamp recordings with holding current (Ihold) at 0 A. To test for spiking activity, a 
series of depolarising current steps were injected from a membrane potential of -80 
mV in 5 pA increments. The rheobase was determined as the value of the injected 
current required for triggering the first action potential. Maximal firing rate was 
determined as the highest firing rate in response to suprathreshod current injection. 
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2.2.11 Statistical analysis 
Unless stated otherwise, results are reported as mean ± standard error of 
mean. Statistical analyses were performed using Prism 6 for Mac OS X (version 
6.0d, GraphPad). Statistical significance was assessed by student’s t-test, one- or 
two-way ANOVA with either Tukey’s multiple comparison test or uncorrected 
Fisher’s LSD test. Differences were considered statistically significant when p value 
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Chapter 3: Results 
 
3.1 Generation/characterisation of an enkephalinergic 
reporter embryonic stem cell line 
 
3.1.1 Generation of reporter cell lines 
Two mouse lines were utilised for generating enkephalinergic reporter 
embryonic stem cell lines, the Rosa26-EYFP and the BAC-Penk-Cre lines. The 
Rosa26-EYFP reporter line harbours LoxP flanked stop cassette followed by EYFP 
in the Rosa26 locus (Srinivas et al., 2001). Removal of the stop cassette by Cre-
recombinase allows expression of EYFP in these cells. The BAC-Penk-Cre line, 
where Cre-recombinase expression is under the control of the Pre-pro-enkephalin 
(Penk) promoter, was generated in the Minichiello laboratory and characterised by 
Drs. Dana Kramer and Dario Besusso. Some of those characterisations (Besusso et 
al., 2013) relevant to this work is reported in figure 3.1 A-E and described below. 
The recombination pattern of the BAC-Penk-Cre line was analysed by crossing the 
line with the Z/EG reporter line (Novak et al., 2000) as well as the Rosa26-EYFP 
reporter line (Srinivas et al., 2001). Cre-recombinase-mediated expression of GFP in 
adult animals was detected in the caudoputamen (Figure 3.1 A), nucleus accumbens, 
granular layer of olfactory bulb and cerebellum, layers II, V and VI of the cerebral 
cortex and in the hippocampal formation, similar to the in situ hybridisation data of 
Penk expression described in the Allen Brain Atlas Data Portal (http://mouse.brain-
map.org/). To evaluate recombination specificity within the striatum, double 
immunofluorescence using anti-GFP (which also binds to EYFP) and anti-pre-pro-
enkephalin antibodies was done on the brain of adult BAC-Penk-Cretg/+,Rosa26-
EYFPyfp/+ mice. Cre-mediated EYFP expression was found in the majority (98%) of 
enkephalinergic MSNs, and only 4% of EYFP-expressing cells had no 
enkephalinergic phenotype (Figure 3.1 B). Double immunostaining for EYFP and the 
generic MSN marker Ctip2 (Figure 3.1 C) showed 43.28%±3.77 Ctip2-positive 
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neuronal cells expressing EYFP (Figure 3.1 E, value is mean ± standard deviation). 
Markers for striatal interneurons including Calretinin, Choline acetyltransferase, 
Parvalbumin and Somatostatin were not detected in EYFP-positive neurons within 
the striatum (Figure 3.1 D). 
Enkephalinergic reporter embryonic stem cell lines were generated by 
collecting morula stage embryos from a Rosa26-EYFP female mouse that was 
crossed with a BAC-Penk-Cre male (Figure 3.1 F). The morulae were extracted by 
Jan Ure and Dr. Joe Mee, Transgenic Unit, Institute for Stem Cell Research, 
University of Edinburgh. The ESC lines were designated “PNK”. Four clones were 
successfully obtained, clone 6, 8, 13 and 18. Genotyping revealed that only clone 8 
and 18 carried the Cre-recombinase transgene. Clone 18 (PNK 18) was selected and 
used for this study. As mentioned above, EYFP would be detected upon expression 
of Cre-recombinase under the Penk promoter. Therefore, EYFP is only detectable 
once the cells have differentiated into enkephalinergic neurons but not in pluripotent 
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Figure 3.1: Generation of enkephalinergic reporter ESC line. (A) DAB staining against 
EYFP showed Cre-mediated EYFP expression in the caudoputamen (CP) and nucleus 
accumbens (NAc). (B) Immunofluorescence staining of adult BAC-Penk-Cretg/+,Rosa26-
EYFPyfp/+ brain revealed co-localisation between enkephalin and EYFP in the striatum. (C 
and E) Double immunostaining (C) of Ctip2 and enkephalin showed that approximately two 
fifths of Ctip2-positive MSNs are enkephalinergic (quantification shown in E). (D) Striatal 
interneuron markers did not co-localise with enkephalin-expressing cells. (F) Diagram 
depicting the generation of reporter ESC line. (G) Schematic representation of Cre-mediated 
EYFP expression in PNK18 ESC line undergoing enkephalinergic differentiation. Figure A-E 
are from Besusso et al., 2013. Scale bars are 500 µm (A) or 50 µm (B, C and D). Values are 
mean ± standard deviation (s.d). CX, cerebral cortex; ESC, embryonic stem cell; DAB, 3,3’-
diaminobenzidine; EYFP, enhanced yellow fluorescent protein.     
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3.1.2 Characterisation of the PNK18 reporter cell line 
 Characterisation of the PNK18 line was performed to confirm that during the 
ESC stage, the line did not express EYFP. Immunofluorescence for Oct4, the protein 
expressed in undifferentiated ESCs, demonstrated a presence of Oct4 in all cells. As 
expected, and in contrast to Oct4, EYFP immmunoreactivity was not detected at this 
stage (Figure 3.2 A). These findings confirmed that recombination specificity of the 
line was intact since no Cre-recombination was observed in undifferentiated ESCs.   
We next tested the ability of this ESC line to contribute to all germ layers by 
generating chimaeras. Chromosomes analysis determined that 75% of metaphase 
spreads (18/24) were euploid (Figure 3.2 B), indicating that chimaeras generated 
from the PNK18 line should have good contribution from the stem cells to all tissues 
including germ line. Chimaeras were generated by injecting PNK18 ESC clones into 
blastocysts. Seventeen pups were obtained from clone 18 injections. The percentage 
of chimaerism was assessed and five mice that showed high ESC contribution were 
chosen for further characterisation (Syto9 melt curve performed by Dr. Amit 
Grover). To examine the recombination pattern in these chimaeras, perfusion with 
4% paraformaldehyde was done. Immunohistochemistry using 3,3’-
diaminobenzidine (DAB) detected EYFP expression in the caudoputamen, 
hippocampal dentate gyrus and cerebellum of three out of five mice (Figure 3.2 C). 
Cell type specificity of recombination was checked in one brain of the three 
EYFP-positive adult chimaeras by double immunofluorescence staining of EYFP and 
pre-pro-enkephalin. EYFP-positive cells were found in the expected areas including 
the striatum, however, at the first attempt, enkephalin immunoreactiviy was not 
detected (data not shown). We hypothesised that prolonged fixation in 
paraformaldehyde could mask the epitope of pre-pro-enkephalin peptide. We, 
therefore, performed heat-induced epitope retrieval prior to immunostaining. Both 
EYFP and pre-proenkephalin were detected successfully in the sections. Co-
localisation between EYFP and pre-pro-ennkephalin was observed in all EYFP-
positive cells in the striatum (Figure 3.2 D). However, only half of the striatal 
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enkephalinergic neurons showed EYFP staining. This can be explained by the fact 
that these animals were chimaeras so not all cells may derive from the injected ESCs. 
In conclusion, the PNK18 ESC line was shown to possess pluripotency 
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Figure 3.2: Characterisation of the PNK18 enkephalinergic reporter line. (A) 
Immunofluorescence staining showed Oct4 expression but not EYFP in PNK18 ESCs. (B) 
Chromosome counting from metaphase spreads with Giemsa stain demonstrated that the 
majority of spreads analysed (75%) were euploid (n=24). (C) DAB staining depicted EYFP 
immunoreactivity within the striata (asterisks) of three chimaeras. (D, upper panel) Double 
immunohistofluorescence staining for EYFP and enkephalin of the brain one of the 
chimaeras (ID 354072) showed most of the EYFP-positive cells were found mainly in the 
striatum (asterisks). (D, lower panel) Higher magnification of the inlet in the upper panel 
revealed co-localisation of EYFP and enkephalin in the striatum. All scale bars are 25 µm 
with an exception for the top panel of (D), which are 1 mm. EYFP, enhanced yellow 
fluorescent protein; ESCs, embryonic stem cells. 
 Derivation of enkephalinergic medium spiny neurons                                                 
from mouse embryonic stem cells 
Chapter 3: Results  101 
3.2 Enkephalinergic differentiation from mouse 
embryonic stem cells 
 
3.2.1 Neural differentiation using N2B27 monolayer culture 
Monolayer neural differentiation (Ying and Smith, 2003) was selected as a 
platform for the differentiation. Initially, confluent ESCs were trypisinised and plated 
onto gelatin-coated tissue culture dish containing N2B27 medium at three densities, 
7,500, 15,000 and 30,000 cells/cm2. It was found that higher initial cell densities 
gave greater yield of cells that survived the differentiation process. However, a 
significant number of undifferentiated cells were evident in the highest suggested 
density, in particular at 30,000 cells/cm2. For this reason, we selected 15,000 
cells/cm2 as an optimal plating density. We noticed that neural differentiation was 
slightly different between the control PNK6 line (a line without Cre-recombinase 
transgene) and the PNK18 line. By qualitative analysis at the same time point, PNK6 
culture had more cells with mature morphology (Figure 3.3 A). This is not 
unexpected since variability amongst cell lines in neural differentiation efficiency 
has previously been reported (Ying and Smith, 2003). At day 12 of differentiation, 
immunocytofluorescence was performed to check whether the cultures contained any 
neural cell lineages. Nestin-positive progenitors and post-mitotic neurons, shown by 
βIII-tubulin (also known as TuJ1) staining, were found in the PNK6 cultures (Figure 
3.3 B). Interestingly, Pax6, a marker commonly used to define forebrain identity, was 
also expressed in the PNK6 cultures. Expression of Ctip2, a transcription factor 
shown to be specific to corticospinal motor neurons (Arlotta et al., 2005) and all 
MSNs (Arlotta et al., 2008), was also detected in some cells (Figure 3.3 C). To 
investigate whether this differentiation protocol could generate any enkephalinergic 
neural cells, PNK18 cells at day 10 of differentiation (ND day 10) were harvested 
and processed for flow cytometric analysis (Figure 3.4). A percentage of EYFP-
positive cells, reflecting enkephalinergic neurons, were increased nearly thirty fold 
when compared ESCs (Figure 3.4 B and C). Control PNK6 and E14 lines did not 
show any significant amount of EYFP-positive cells in both ESC stage and ND day 
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10 (Figure 3.4 D and E). This finding demonstrated that N2B27 cultures could be 
used as a basal medium for deriving enkephalinergic neurons from mESCs.  
Due to the fact that this protocol is not specific to enkephalinergic 
differentiation, we speculated that addition and/or withdrawal of factors (both 
stimulators and inhibitors), which have a major role in striatal neuronal development 
to the culture medium would, in theory, lead to higher number of striatal neurons 
including enkphalinergic MSNs. In addition, we also observed a huge amount of cell 
death during differentiation, which, in some experiments, resulted in loss of the 
entire culture. For these reasons we optimised N2B27 culture medium by adding or 
removing certain factors to improve both the differentiation efficiency and cell 
survival. We also tested whether re-plating cells on optimal substrata would improve 
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Figure 3.3: N2B27 monolayer neural differentiation in PNK18 and PNK6 ESC lines.    
(A) Images taken at day 8 of differentiation showed N2B27 neural differentiation of PNK6 
(left) and PNK18 (right) lines. (B) Immunofluorescence staining showing Nestin-positive 
neural progenitors and βIII-tubulin-positive neuronal cells in PNK6 line cultured in N2B27 at 
day 12 of differentiation. (C) Expression of the forebrain progenitor marker Pax6 and MSN-
specific marker Ctip shown by immunofluorescence of day 12 cultures of PNK6 line. All scale 
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Figure 3.4: Presence of enkephalinergic neural cells in N2B27 monolayer culture. Flow 
cytometric analysis of PNK18, PNK6 and E14 lines was performed at ESC stage and day 10 
of N2B27 neural differentiation. (A) Gate setting on forward and side scatter plot (left), and 
the viability gate (right), was set to exclude dead cells (as determined by a high propridium 
iodide (PI) signal). (B and C) Increased EYFP-positive cells in the PNK18 line at day 10 of 
differentiation compared to ESCs. (B) Flow cytometric plots of EYFP intensity in X axis vs 
forward scatter (FSC) in Y axis and (C) graph showing the percentage of EYFP-positive cells 
from total live cells. (D and E) In contrast, PNK6 (D) and E14 (E) lines, which were negative 
controls (no Cre-recombinase transgene), did not show any EYFP-positive cells in either 
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3.2.2 Role of retinoic acid signalling in monolayer neural 
differentiation 
Retinoic acid (RA) is one of the crucial factors involved in most steps of ESC 
differentiation towards MSN. It has been shown that RA promotes differentiation via 
FGF signalling pathway (Stavridis et al., 2010). After neural fate is acquired, RA 
plays an important role in neural patterning together with other caudalising factors by 
inhibiting anterior neural identity (Gaspard and Vanderhaeghen, 2010). For this 
reason, absence of these factors, including RA, is mandatory for forebrain structures 
to retain their identity. Interestingly, during maturation of striatal MSNs, RA 
treatment increases the number of Darpp32-positive cells in E13.5 LGE cultures 
(Toresson et al., 1999). Since the B27 supplement added to N2B27 medium contains 
retinyl acetate, which can be converted to RA, we, therefore, investigated whether a 
removal of retinyl acetate would affect neural differentiation by using B27 
supplement that did not contain retinyl acetate (B27-vitA supplement). The retinyl 
acetate deficient medium was called N2B27-vitA.  
The E14 ESC line was cultured in either N2B27 or N2B27-vitA media for 20 
days before cells were collected for analysis. In addition to N2B27 and N2B27-vitA 
cultures, we tested a third culture condition, which consisted of E14 ESC cultivated 
in N2B27 medium for two days before changing the medium to N2B27-vitA from 
day 2 of differentiation onwards (N2B27-vitA d2 onwards). The reason for adding 
the third culture condition was to lower the proportion of undifferentiated cells in the 
cultures since RA signalling is needed for neural differentiation (Stavridis et al., 
2010). Quantitative reverse transcription polymerase chain reaction (qRT-PCR) 
analysis at day 20 of differentiation (Figure 3.5) showed a surprising finding, the 
expression of Oct4 was highest in the N2B27-vitA d2 onwards condition, but not 
N2B27-vitA culture condition. The N2B27 culture, however, showed lower 
expression of Oct4 compared to the other two culture conditions. We observed a 
trend of lower expression of the MGE marker Nkx2.1, and higher expression of the 
LGE marker Gsx2, in the N2B27 culture medium compared to the other conditions. 
However, statistical analysis could not be obtained since only one biological 
replicate was performed. Neural differentiation appeared to be more efficient in the 
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N2B27 culture as determined by the highest level of expression of the pan-neuronal 
marker Tubb3 (gene encodes for βIII-tubulin). MSN-specific markers Ctip2 and 
Ppp1r1b (gene encodes for Darpp32) showed a tendency to be slightly up-regulated 
in the N2B27-vitA d2 onwards culture condition.  
No obvious difference in terms of the expression of striatal neuronal genes 
was observed in the two culture conditions (with and without the presence of vitamin 
A) at the time point analysed (day 20). Due to the potential problems of omitting 
vitamin A, such as an accumulation of undifferentiated cells in cultures, reduced 
striatal cell fate commitment but higher MGE-lineage priming, and lower neuronal 
differentiation efficiency, we continued to use the regular B27 supplement (with 
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Figure 3.5: Pluripotency and neural gene expression in cultures with and without 
vitamin A. The E14 ESC line was cultured in either N2B27, N2B27-vitA or in N2B27 on the 
first two days then in N2B27-vitA (N2B27-vitA d2 onwards). Cells were processed for qRT-
PCR analysis at day 20 of differentiation. Expression of the pluripotency gene Oct4 and the 
MGE marker Nkx2.1 in both vitamin A-deficient cultures showed an increased trend when 
compared to that of the standard N2B27 cultures. The striatal progenitor marker Gsx2 and 
pan-neuronal gene Tubb3 also showed a minimal trend of enrichment in N2B27 sample. 
MSN-specific genes Ctip2 and Ppp1r1b were expressed at higher levels in N2B27-vitA d2 
onwards culture compared to N2B27. No statistical analysis performed; n=1 for each group; 
Values are mean ±  s.d from technical replicates. ESC, embryonic stem cell; MGE, medial 
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3.2.3 Effects of DKK1, Shh and BDNF in enkephalinergic 
differentiation 
 Several published differentiation protocols used extrinsic factors to derive 
DARPP32-positive neurons from both mouse and human PSCs. Amongst these, a 
combination of WNT inhibitor DKK1, SHH and BDNF is the most common cocktail 
used (Aubry et al., 2008, Zhang et al., 2010, Danjo et al., 2011, Delli Carri et al., 
2013b). To test whether enkephalinergic neurons could be obtained when those 
factors were present in the culture medium, we added the three factors (recombinant 
murine Shh, recombinant human DKK1 and BDNF) into N2B27 neural culture at the 
specified time points (Figure 3.6 A). Flow cytometric analysis performed at day 30 
of differentiation showed that the percentage of EYFP-positive cells from N2B27 
culture supplemented with the three factors (N2B27+3F) was higher than that of 
N2B27 culture without any factor added (Figure 3.5 B and C). Thus, the addition of 
these factors resulted in a higher percentage of enkephalinergic neurons. 
Additionally, qRT-PCR analysis of key markers of E14 ESC undergoing neural 
differentiation in either of the two culture conditions (N2B27 or N2B27+3F) 
revealed higher expression of Oct4 and Gsx2 in N2B27 cultures compared to that of 
N2B27+3F (Figure 3.5 D). In contrast, expression of the pan-neuronal gene Tubb3, 
MSN markers Ctip2 and Ppp1r1b was more robust in cultures with the three factors.  
In conclusion, the N2B27+3F culture medium produced more mature 
neuronal cells and decreased the proportion of undifferentiated cells in the culture, as 
determined by lower expression of Oct4 compared to the factor-free N2B27 culture 
condition. Further analysis showed higher expression of MSN-specific markers such 
as Ctip2 and Ppp1r1b in N2B27+3F cultures. Moreover, N2B27+3F cultures 
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Figure 3.6: Enrichment of EYFP-positive cells and MSN-specific genes in the 
N2B27+3F culture. (A) Schematic representation of the differentiation protocol used. (B and 
C) Flow cytometric analysis of EYFP-positive cells obtained from PNK18 cell line cultured in 
either N2B27 or N2B27+3F. (B) Graph shows percentage of EYFP-positive cells from total 
live cells analysed. (C) Plots show an increase in the proportion of EYFP population during 
neural differentiation in the presence of the three factors. (D) qRT-PCR analysis of 
pluripotency marker (Oct4), LGE marker (Gsx2), MGE marker (Nkx2.1), pan-neuronal 
marker Tubb3 and MSN markers (Ctip2 and Ppp1r1b) of the E14 cell line in undifferentiated 
ESC, day 35 of N2B27 culture (N2B27) and day 32 of N2B27 with the three factors 
(N2B27+3F). No statistical analysis performed; n=1 for each group; Values are mean ±  s.d 
from technical replicates. EYFP, enhanced yellow fluorescent protein; MSN, medium spiny 
neuron; LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence; ESC, 
embryonic stem cell.   
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3.2.4 Improvement of cell survival during neural 
differentiation by using a modified culture medium  
It is known that up to 50% of cells may die when cells cultured in serum-
containing medium are transferred to serum-free medium (Ying and Smith, 2003). 
Cell viability can be increased by several strategies. We have taken three approaches 
to address this issue. Firstly, by either the addition of leukaemia inhibitory factor 
(Lif) into N2B27 medium or replacement of N2B27 with ESC medium on the first 
day of differentiation. Secondly, by adding a proliferation factor such as Fgf2, a 
potent mitogen for neural progenitors. Lastly, the use of an anti-apoptotic reagent, 
Rho-associated kinase (ROCK) inhibitor Y-27632. The four culture conditions tested 
are detailed in Table 3.1, and the number of live cells remaining at day 4 and day 11 
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Table 3.1: Details of media used in four culture conditions 
Culture 
condition 
Medium used on 





N2B27+          
ROCK inhibitor 
2 GMEM+FBS+    
ROCK inhibitor 
N2B27+            
ROCK inhibitor 






N2B27+          
ROCK inhibitor 
4 N2B27+Lif+       
ROCK inhibitor 
N2B27+            
ROCK inhibitor 
N2B27+          
ROCK inhibitor 
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 Cell survival was comparable in all culture conditions at day 4 of 
differentiation, however, massive cell death was observed in culture conditions 3 and 
4 at differentiation day 11. It is clear that the use of ESC medium without Lif on the 
first day of neural differentiation (culture conditions 1 and 2) has an enhanced effect 
on cell survival when compared to the use of N2B27 with Lif (culture conditions 3 
and 4) at day 11 of differentiation (Figure 3.7 A). Culture condition 2 showed 
significantly higher numbers of live cells than that of culture conditions 1, 3 and 4 
(Figure 3.7 A; two-way ANOVA, interaction between culture condition and time 
point: F(3,6)=13.63, p=0.0044; effect of culture condition: F(3,6)=15.09, p=0.0033; 
effect of time point: F(1,6)=0.04629, p=0.8368; Tukey’s multiple comparison test: 
p=0.0050 condition 1 vs condition 2 day 11; p=0.0016 condition 2 vs condition 3 day 
11; p=0.0017 condition 2 vs condition 4 day 11; n=2 per group except day 11 of 
culture condition 3 and 4, n=1). Likewise, the proportion of DAPI-negative (viable) 
cells from flow cytometric analysis at day 11 of differentiation showed higher cell 
viability in culture conditions 1 and 2 compared to culture condition 3 and 4 (Figure 
3.7 B; two-way ANOVA, interaction between culture condition and time point: 
F(3,6)=200.2, p<0.0001; effect of culture condition: F(3,6)=221.1, p<0.0001; effect of 
time point: F(1,6)=1173, p<0.0001; Tukey’s multiple comparison test: p=0.0237 
condition 1 vs condition 2 day 11; p<0.0001 condition 1 vs condition 3 day 11; 
p<0.0001 condition 1 vs condition 4 day 11; p<0.0001 condition 2 vs condition 3 day 
11; p<0.0001 condition 2 vs condition 4 day 11; n=2 per group except day 11 of 
culture conditions 3 and 4, n=1). Surprisingly, addition of Fgf2 in culture conditions 
1 and 3 did not show a beneficial effect on cell viability. Based on these findings we 
decided to use culture condition 2 as a basal medium for neural differentiation. We 
designated this culture “modified N2B27 (NB)” culture. 
We next tested whether Y-27632 effect on cell survival would be preserved if 
the treatment time was restricted to only the first day of differentiation. We 
compared the number and percentage of live cells between two cultures, NB and a 
new culture condition (NB+R), which is similar to NB culture except Y-27632 was 
added on day 0 only. Although there was a considerable amount of live cells in both 
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cultures at day 15 of differentiation, we found that both total number and percentage 
of live cells in NB+R cultures were significantly lower than that of NB culture 
(Figure 3.8; p=0.0004 for total cell number and p=0.0203 for percentage of viable 
cells, unpaired Student’s t-test, n=3 per group). This underscored the anti-apoptotic 
effect of Y-27632 and supported its addition in the medium throughout the entire 
differentiation period. 
To ensure that addition of Y-27632 would not interfere with the neural 
differentiation process or direct cells to other lineages, we performed gene 
expression analysis of different markers on cells from NB and NB+R cultures. The 
presence of Y-27632 in cultures, regardless of duration, led to an enrichment of the 
neural progenitor marker Sox1 compared to ordinary N2B27 culture (Figure 3.9). 
This correlated with a reduction of the pluripotency marker Nanog expression in NB 
and NB+R cultures. Consistent with what has been reported in literature that ROCK 
is involved in the maintenance of undifferentiated state of ESCs and its inhibition 
induces neural differentiation (Chang et al., 2010, Frisca et al., 2013). Interestingly, 
longer duration of Y-27632 treatment resulted in an increase in the expression of 
both forebrain progenitor genes Foxg1 and Pax6, and LGE marker Gsx2, which is 
more specific for the neuronal population of interest here. Expression of striatal 
markers Dlx1 and Dlx2, downstream targets of Gsx2, however, was identical 
between NB and NB+R cultures. To ensure that the persistent administration of Y-
27632 did not bias differentiation towards other lineages, we checked and found that 
both mesodermal marker Brachyury (T) and endodermal marker Gata6 were 
expressed in a comparable level in both NB and NB+R cultures. These results 
indicate that the prolonged exposure to ROCK inhibitor had a beneficial effect on 




 Derivation of enkephalinergic medium spiny neurons                                                 
from mouse embryonic stem cells 
Chapter 3: Results  114 
 
Figure 3.7: Cell survival is enhanced using ESC medium without Lif the first day of 
differentiation together with Y-27632 treatment. Culture conditions 1-4 are detailed in 
table 3.1. (A) Total number of live cells per one well of a 12-well plate assessed by trypan 
blue staining at days 4 and 11 of differentiation. Culture condition 2 had the highest number 
of live cells at day 11 of differentiation. (B) Flow cytometric analysis of individual cultures 
showing the percentage of live cells to the total number of cells analysed. Approximately 
49% and 56% of total cells analysed in culture conditions 1 and 2, respectively, were alive at 
day 11 of differentiation. The proportion of live cells in culture was significantly less in culture 
conditions 3 and 4. Two-way ANOVA with Tukey’s post-hoc analysis; * p<0.05; ** p<0.01; 
**** p<0.0001; p are adjusted p-value from Tukey’s test; n=2 for each group except day 11 of 
culture condition 3 and 4, n=1; Values are mean ± standard error of the mean (s.e.m.). ESC, 
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Figure 3.8: ROCK inhibitor enhances cell survival. The PNK18 line was cultured in either 
NB or NB+R media before analysis was performed on day 4 and day 15 of differentiation (A) 
Total number of live cells per one well of a 12-well plate assessed by trypan blue staining. 
Total number of live cells in NB culture was significantly higher than that of NB+R culture at 
day 15 of differentiation. (B) Percentage of live cells to the total number of cells analysed by 
flow cytometric analysis. At day 15 of differentiation, proportion of live cells in NB culture was 
significantly higher than NB+R culture. Unpaired Student’s t-test; * p<0.05; *** p<0.001; n=3 
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Figure 3.9: Gene expression analysis of cells from NB and NB+R cultures. The PNK18 
line was cultured in either NB or NB+R media. Cells were harvested at time points indicated 
in each graph for qRT-PCR analysis. Down-regulation of Nanog, Brachyury (T) and Gata6 
was observed in both NB and NB+R cultures at day 3 of differentiation. Sox1 was highly 
expressed in cultures treated with Y-27632. NB cultures showed higher expression of Foxg1, 
Pax6 and Gsx2 whilst Dlx1 and Dlx2 were expressed in a similar manner in both cultures. No 
statistical analysis performed; n=1 for each group; Values are mean ±  s.d from technical 
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3.2.5 Re-plating increases neural differentiation efficiency 
Another factor known to promote neural differentiation efficiency is the use 
of positively charged substrates, such as poly-L-ornithine, poly-lysine and laminin 
(Ying and Smith, 2003, Lorincz, 2006). It is also possible that re-plating cells onto a 
new culture dish may reduce the number of undifferentiated cells in culture and 
remove the paracrine effect of high cell densities that might impede neural 
differentiation. Moreover, PNK18 neural cells detached from the plates when 
maintained in gelatin-coated Petri dishes for long term, indicating that gelatin is not 
an ideal substrate for culturing neuronal cells. We, therefore, tested whether re-
plating differentiating cells on gelatin-coated plates to those coated with poly-L-
ornithine/laminin improved neural differentiation efficiency as well as cell survival. 
PNK18 neural cells at day 4 of N2B27 differentiation were dissociated and plated at 
a density of 50,000 cells/cm2 onto new culture plates coated with either 0.1% gelatin 
or 0.01% poly-L-ornithine/10 µg/mL laminin. Images of live cells taken at day 5 of 
differentiation showed that cells re-plated onto poly-L-ornithine/laminin-coated 
dishes were properly attached (Figure 3.10 A) whereas almost all the cells re-plated 
onto gelatin-coated dishes had detached and were floating and clustered in clumps 
(Figure 3.10 B). This finding demonstrates that poly-L-ornithine and laminin are 
better substrates for neuronal attachment after re-plating. 
To further investigate the status of the re-plated cells on the different 
substrata (gelatin and poly-L-ornithine/laminin), they were processed in parallel for 
immunofluorescence staining and qRT-PCR analysis. PNK18 and E14 neural cells 
were cultured on gelatin-coated dish for four days before re-plating onto new plates 
coated with either gelatin or poly-L-ornithine/laminin. For each condition, we did re-
plate cells with four different densities (25,000 cells/cm2, 50,000 cells/cm2, 75,000 
cells/cm2 and 100,000 cells/cm2) to determine an optimal re-plating density. At day 
12 of differentiation, cells were processed for immunofluorescence staining for the 
pluripotency marker Oct4 and post-mitotic neuronal marker βIII-tubulin. Regardless 
of the re-plating density, very few βIII-tubulin-positive cells were seen when cells 
were re-plated onto gelatin-coated dishes and no Oct4 staining was detected (Figure 
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3.11 A and B; cultures re-plated at 25,000 cells/cm2 and 75,000 cells/cm2 showed 
similar recovery to that of the 50,000 cells/cm2 and 100,000 cells/cm2, respectively, 
data not shown). This confirms gelatin is not a good substratum for neural 
differentiation cultures. Conversely, βIII-tubulin-positive neuronal cells were 
abundantly found when poly-L-ornithine/laminin was used as substrate (Figure 3.11 
C and D). Although a few Oct4 expressing cells were present, most of them were 
clustered in clumps, clearly distinguishable from differentiated βIII-tubulin-positive 
cells.  
Quantitative RT-PCR was performed using cDNA prepared from RNA of 
PNK18 line cultured in low and high re-plating densities (50,000 and 75,000 
cells/cm2, respectively). Expression of the neural progenitor marker Nestin (Nes), 
post-mitotic neuronal marker Tubb3, MSN-specific marker Ppp1r1b and 
enkephalineric MSN-specific marker Penk was enriched in cultures maintained on 
poly-L-ornithine/laminin compared to those on gelatin (Figure 3.12). In contrast, 
Oct4 expression level was higher in cultures on gelatin substratum. There was a 
subtle difference between low and high re-plating densities on both substrata used for 
the expression analysis of all the genes mentioned.    
From these results, it is clear that the use of poly-L-ornithine/laminin 
substratum for neural differentiation is better than gelatin. The advantages include 
higher number of neuronal cells present, higher expression of neuronal/striatal 
markers and lower expression of Oct4. There was not any obvious difference 
between the different plating densities tested in terms of the proportion of 
differentiated and undifferentiated cells based on immunoflourescence staining or the 
expression of genes by qRT-PCR. However, for long-term cultures, higher cell 
densities would complicate the analysis due to the difficulty in distinguishing single 
cells and the increase of multilayer cultures. Therefore, the low re-plating density, 
50,000 cells/ cm2, was chosen as the optimal one.     
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Figure 3.10: Re-plating on poly-L-ornithine/laminin-coated dish reduced cell 
detachment during neural differentiation. The PNK18 line was cultured on gelatin-coated 
plates at the start of the differentiation process. At day 4, cells were dissociated and re-
plated on poly-L-ornithine/laminin- or gelatin-coated dishes. Live images taken at day 5 of 
differentiation showing that most of cells plated on poly-ornithine/laminin substrates were 
properly attached (A) whilst the majority of cells re-plated on gelatin-coated wells were 
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Figure 3.11: Oct4 and βIII-tubulin were highly expressed in cultures re-plated on poly-
L-ornithine/laminin. The PNK18 line cultured on gelatin-coated dishes in N2B27 medium 
was dissociated and re-plated on gelatin- (A and B) or poly-L-ornithine/laminin- (C and D) 
coated dishes at day 4 of differentiation at different re-plating densities (A and C, 50,000 
cells/cm2, and B and D, 100,000 cells/cm2). (A and B) Immunofluorescence staining for 
Oct4 and βIII-tubulin at day 12 of differentiation demonstrated no Oct4-positive cells and few 
βIII-tubulin-positive cells on gelatin-coated dishes at either density. (C and D) Higher 
numbers of βIII-tubulin-positive cells were found in poly-L-ornithine/laminin-coated dishes 
regardless of re-plating densities. All scale bars are 75 µm. 
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Figure 3.12: Expression of key genes from neural cells cultured on either gelatin- or 
poly-L-ornithine/laminin-coated dishes. PNK18 line was cultivated on gelatin-coated 
dishes prior to re-plating at day 4 of differentiation at either low (50,000 cells/cm2) or high 
(75,000 cells/cm2) density on either gelatin- or poly-L-ornithine/laminin-coated dishes. qRT-
PCR analysis was performed at day 12 of differentiation. Enrichment of Oct4 expression was 
detected in cells cultured on gelatin substratum whereas Tubb3, Ppp1r1b and Penk 
expression was more prominent in cells grown on poly-L-ornithine/laminin-coated plates. No 
obvious dissimilarities in gene expression were detected between low and high re-plating 
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3.2.6 Addition of DKK1, Shh and BDNF in modified N2B27 
culture 
We have demonstrated that both NB culture and re-plating cells on poly-L-
ornithine/laminin-coated dishes contributed to increasing cell survival. We next 
investigated whether these two strategies, when combined with the exogenous 
addition of the three factors (DKK1, Shh and BDNF) would result in a higher 
enkephalinergic neuronal yield in cultures. PNK18 line was then cultivated in a 
newly generated protocol we called NB+3F (Figure 3.13 A). Cells were dissociated 
and re-plated onto poly-L-ornithine/laminin-coated dishes at day 7 of differentiation 
and flow cytometric analysis was performed at the indicated time points (Figure 3.13 
B and F). As expected, we found a significant increase in the percentage of EYFP-
positive cells in culture when compared to control NB cultures at day 15 and day 21 
of differentiation (EYFP percentage at day15: NB 0.217±0.109, NB+3F 
1.632±0.394; EYFP percentage at day 21: NB 0.158±0.048, NB+3F 1.661±0.477; 
values are mean ± s.e.m.; two-way ANOVA, interaction between culture condition 
and time point: F(3,14)=4.432, p=0.0217; effect of culture condition: F(1,14)=17.03, 
p=0.0010; effect of time point: F(3,14)=5.096, p=0.0136; Tukey’s multiple comparison 
test: p=0.0221 NB day 15 vs NB+3F day 15; p=0.0315 NB day 21 vs NB+3F day 21; 
n=3 per group). In addition, qRT-PCR analysis at day 21 showed that Ctip2 was 
slightly higher expressed in NB+3F culture (Figure 3.13 E), although this did not 
reach a level of significant difference (p=0.3134, unpaired Student’s t-test; n=4 per 
group). These findings suggested that the NB+3F cultures might have more EYFP-
positive (and consequently more enkephalinergic) MSNs compared to NB cultures. 
Expression level of post-mitotic neuronal marker Tubb3 was higher, but not 
significant, in NB+3F cultures (Figure 3.13 E; p=0.1788, unpaired Student’s t-test; 
n=4 per group). This indicates that neural cells cultured with NB+3F are slightly 
more mature than those cultured in NB medium. The finding was consistent with the 
morphology observed in live images (Figure 3.13 C and D), which clearly show that 
the NB+3F culture contained more morphologically mature neurons. All data have 
supported the superiority of NB+3F over NB cultures in terms of EYFP-positive 
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(enkephalinergic) MSN generation. We, therefore, have used the NB+3F culture as a 
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Figure 3.13: Enkephalinergic neuronal differentiation in NB+3F cultures. (A) Schematic 
representation of the differentiation protocol used. (B and F) Flow cytometric analysis at four 
time points during differentiation showed a gradual increase of EYFP percentage in NB+3F 
cultures with significant differences between NB and N3F were observed in day 15 and 21 of 
differentiation. (B) Flow cytometric plots of EYFP intensity in X axis vs FSC in Y axis and (F) 
graph showed percentage of EYFP-positive cells from total live cells analysed in the NB and 
NB+3F cultures (Two-way ANOVA with Tukey’s post-hoc analysis; * p<0.05; p is adjusted p-
value from Tukey’s test; n=3 for each group).  (C and D) Brightfield and fluorescent live 
images of NB (C) and NB+3F  (D) cultures at day 23 of differentiation. EYFP-positive neural 
cells in NB+3F culture exhibited a more mature neuronal morphology compared to those in 
NB cultures. (E) At day 21 of differentiation, expression MSN-specific gene Ctip2 in neural 
cells from NB+3F culture was slightly higher than that of NB culture. Expression of post-
mitotic neuronal marker Tubb3 expression was higher in NB+3F cultures, albeit not 
statistically significant (Unpaired Student’s t-test; n.s., no significance; n=4 per group). This 
confirmed the findings from live imaging (C and D) that neuronal cells in NB+3F were more 
mature. Scale bars in (C) and (D) are 50 µm. Values are mean ± s.e.m. EYFP, enhanced 
yellow fluorescent protein; FSC, forward scatter; MSN, medium spiny neuron. 
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3.3 Surface marker identification of neural cells in 
culture 
 
3.3.1 CD24 is highly expressed in differentiating neural cells 
but not in undifferentiated embryonic stem cells  
Monolayer neural differentiation cultures are not homogeneous but composed 
of undifferentiated cells, neural progenitors and post-mitotic neuronal cells (Ying et 
al., 2003, Lorincz, 2006). In the N2B27 culture medium without re-plating step, a 
moderate level of Oct4 expression is found even in day 35 of differentiation (Figure 
3.6 D), indicating that there are still pluripotent cells present in the culture. To 
distinguish between undifferentiated and differentiated cells by flow cytometry, we 
sought surface markers described in the literature, which could be used to distinguish 
between these two populations. Amongst many markers the heat stable antigen CD24 
has been described to define a neuronal population derived from hPSCs, when used 
together with CD15 and CD29 (Pruszak et al., 2009) or CD15, CD44 and CD184 
(Yuan et al., 2011). Interestingly, CD24 is expressed at a low level in mESCs and its 
expression level increases gradually along neural differentiation with strongest 
expression observed in post-mitotic neurons (Pruszak et al., 2009). These findings 
encouraged us to address whether CD24 alone was sufficient to isolate neuronal 
populations from undifferentiated ESCs in culture. ESCs and cells from three time 
points (day 5, 15 and 21) throughout NB differentiation were stained with CD24 
antibody prior to flow cytometric analysis. The majority of cells from all of the 
differentiation time points analysed were found to express higher levels of CD24 
compared to ESCs (Figure 3.14 A and B). When cells were classified into two 
groups, CD24-low and CD24-high, there was a significant difference in terms of 
percentage of the two populations in all time point analysed (Figure 3.14 A and C; 
two-way ANOVA, interaction between CD24 expression level and time point: 
F(3,16)=88.83, p<0.0001; effect of CD24 expression level: F(1,16)=70.25, p<0.0001; 
effect of time point: F(3,16)=0.2518, p=0.8589; Tukey’s multiple comparison test: 
p<0.0001 ESC, day 15 and day 21 CD24lo vs CD24hi; and p=0.0003 day 5 CD24lo vs 
CD24hi; n=3 per group). Approximately 78% of the live ESCs analysed could be 
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classified as CD24-low (Figure 3.14 A and C; CD24lo: 78.20±4.09, CD24hi: 
9.65±0.39; values are mean of percentage of live cells analysed ± s.e.m.) whilst the 
majority of differentiating neural cells at any stage were CD24-high with less than a 
quarter of live cells remaining as CD24-low (Figure 3.14 A and C; CD24lo: 
24.40±7.25 (day 5), 9.50±5.70 (day 15) and 11.61±1.24 (day 21), CD24hi: 
68.23±2.41 (day 5), 86.63±5.73 (day 15) and 78.40±3.34 (day 21); values are mean 
of percentage of live cells analysed ± s.e.m.). The data indicates that ESCs and 
differentiating neural cells express distinct levels of CD24. It also confirms the 
finding from Pruszak and colleagues that CD24 expression is increased during mESC 
differentiation towards neural lineages (Pruszak et al., 2009).  
Confirmation of the gating settings used for the CD24-low and CD24-high 
populations was achieved by measuring the level of Cd24a (the gene encoding 
CD24) expression by qRT-PCR of cells sorted from the two populations (Figure 3.14 
D). Cd24a expression in the CD24-low fraction was significantly lower than in the 
CD24 high population in all the differentiating samples but not in ESCs (two-way 
ANOVA, interaction between CD24 expression level and time point: F(3,10)=3.004, 
p=0.0815; effect of CD24 expression level: F(1,10)=73.71, p<0.0001; effect of time 
point: F(3,10)=6.239, p=0.0117; Uncorrected Fisher’s LSD test: p=0.1510 ESC CD24lo 
vs CD24hi; p=0.0004 day 5 CD24lo vs CD24hi; p=0.0006 day 15 CD24lo vs CD24hi; 
and p=0.0002 day 21 CD24lo vs CD24hi; n=2 per group for ESCs, day 5 and day 15, 
and n=3 for day 21). This confirms the gating we used reflects the exact expression 
of Cd24a. 
Since EYFP will be expressed when cells are committed to an 
enkephalinergic neural fate, we hypothesised that most of the EYFP-positive cells 
should be CD24-high. Flow cytometric analysis revealed that EYFP-positive cells 
were equally resided in both CD24 low and CD24 high fractions when cells were 
pluripotent (Figure 3.14 E and F). In contrast, there was an enrichment of EYFP-
positive cells in the CD24-high fraction in differentiating neural cells. The proportion 
of CD24-high/EYFP-positive cells was significantly higher than that of CD24-
low/EYFP-positive cells suggesting higher CD24 expression in more mature cells. 
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(two-way ANOVA, interaction between CD24 expression level and time point: 
F(3,16)=11.41, p=0.0003; effect of CD24 expression level: F(1,16)=93.47, p<0.0001; 
effect of time point: F(3,16)=8.004 x 10-14, p>0.999; Tukey’s multiple comparison test: 
p<0.001 for day 5 % EYFP+ cells in CD24lo vs % EYFP+ cells in CD24hi; p<0.001 
for day 15 % EYFP+ cells in CD24lo vs % EYFP+ cells in CD24hi; and p=0.007 for 
day 21 % EYFP+ cells in CD24lo vs % EYFP+ cells in CD24hi; n=3 per group).  
To investigate this further cells were sorted from both CD24-low and CD24-
high populations from ESCs and differentiating cells at day 5, 15 and 21, and qRT-
PCR performed (Figure 3.15). In addition to pluripotency gene (Oct4) and pan-
neuronal genes (Tubb3, Rbfox3 and Ncam1), neural progenitor genes (Sox1, Nes and 
Pax6), the oligodendrocyte marker (Plp1) and glial marker (Gfap) were included in 
the analysis. As expected, significant difference in Oct4 expression were observed in 
two populations (based on CD24 gating) and the four time points (Figure 3.15 and 
Table 3.2 for post-hoc analysis; two-way ANOVA, interaction between CD24 
expression level and time point: F(3,10)=6.394, p=0.0108; effect of CD24 expression 
level: F(1,10)=78.50, p<0.0001; effect of time point: F(3,10)=15.41, p=0.0004; n=2 per 
group for ESCs, day 5, day 15 and n=3 for day 21). Expression of Oct4, was very 
high in the ESC sample regardless of CD24 expression level (no statistical difference 
between two populations). Oct4 was also highly expressed in CD24-low population 
throughout neural differentiation. In contrast, Oct4 expression in the CD24-high 
fraction declined during the differentiation process.  
The expression of three neural progenitor markers Sox1, Nes and Pax6 was 
statistically different between CD24 low and CD24 high fractions (Figure 3.15 and 
Table 3.2 for post-hoc analysis; two-way ANOVA, interaction between CD24 
expression level and time point: F(3,10)=2.543, p=0.1151 for Sox1; F(3,10)=0.6658, 
p=0.5919 for Nes; and F(3,10)=13.27, p=0.0008 for Pax6; effect of CD24 expression 
level: F(1,10)=15.83, p=0.0026 for Sox1; F(1,10)=11.49, p=0.0069 for Nes; and 
F(1,10)=48.61, p<0.0001 for Pax6; effect of time point: F(3,10)=3.172, p=0.0723 for 
Sox1; F(3,10)=0.7846, p=0.5293 for Nes; and F(3,10)=21.63, p=0.0001 for Pax6; n=2 
per group for ESCs, day 5, day 15 and n=3 for day 21). These markers were 
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expressed in a constant and relatively low level in CD24-low fraction during 
differentiation. This suggests that the majority of cells in CD24-low population do 
not acquire a neural fate.  
Likewise, expression of neuronal genes such as Tubb3, Rbfox3 and Ncam1 
was also found to be significantly different between CD24-low and CD24-high 
populations (Figure 3.15 and Table 3.3 for post-hoc analysis; two-way ANOVA, 
interaction between CD24 expression level and time point: F(3,10)=2.688, p=0.1031 
for Tubb3; F(3,10)=6.180, p=0.0120 for Rbfox3; and F(3,10)=2.093, p=0.1649 for 
Ncam1; effect of CD24 expression level: F(1,10)=8.556, p=0.0152 for Tubb3; 
F(1,10)=25.88, p=0.0005 for Rbfox3; and F(1,10)=9.707, p=0.0110 for Ncam1; effect of 
time point: F(3,10)=3.101, p=0.0760 for Tubb3; F(3,10)=6.856, p=0.0086 for Rbfox3; 
and F(3,10)=2.378, p=0.1310 for Ncam1; n=2 per group for ESCs, day 5, day 15 and 
n=3 for day 21). Significant enrichment of Tubb3 (day 21), Rbfox3 (days 15 and day 
21) and Ncam1 (day 15 and day 21) expression in the CD24-high population was 
observed. These pan-neuronal genes were steadily expressed at a minimal level in 
CD24-low cells at all stages analysed but showed an upward trend of expression in 
the CD24-high subset as differentiation progressed.  
Unlike neural progenitor and neuronal genes, the oligodendrocyte-specific 
gene Plp1, and the astrocytic-specific gene Gfap, showed no difference in terms of 
their expression at any stage analysed (Figure 3.15; two-way ANOVA, interaction 
between CD24 expression level and time point: F(3,10)=1.306, p=0.3260 for Plp1; and 
F(3,10)=0.5638, p=0.6511 for Gfap; effect of CD24 expression level: F(1,10)=3.797, 
p=0.0800 for Plp1; F(1,10)=0.4654, p=0.5106 for Gfap; effect of time point: 
F(3,10)=1.570, p=0.2573 for Plp1; F(3,10)=0.8338, p=0.5054 for Gfap; n=2 per group 
for ESCs, day 5, day 15 and n =3 for day 21). This could be explained by the fact 
that oligodendroglial lineages are born later than neuronal cells in vivo (Qian et al., 
2000). Expression of these two markers, therefore, is expected to start at the later 
stages of differentiation. In agreement with this, expression of these genes in the 
CD24-high subset exhibited a sharp increase from day 15 onwards, whereas the 
increased expression of pan-neuronal genes began from day 5 onwards.  
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 Overall, these findings support the idea that CD24 is beneficial in 
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Figure 3.14: Distinct level of CD24 expression profiles differs between ESCs and 
differentiating neural cells. Flow cytometric analysis of CD24-positive cells from PNK18 
ESCs and cells underwent neural differentiation from three time points of neural 
differentiation (day 5, 15 and 21). (A) Plots show the gates for CD24-low and CD24-high 
populations on the left and right halves, respectively. (B) Summary of CD24 expression 
profiles from all samples is shown in a histogram. (C) CD24-low is the main population in 
ESCs whilst differentiating cells are mostly CD24-high. (D) qRT-PCR analysis of Cd24a 
expression in CD24 low and CD24 high populations. (E) Plots between CD24 (X axis) and 
EYFP (Y axis) and (F) a graph showing percentage of EYFP-positive cells in each population 
in differentiating neural cells and ESCs. An enrichment of EYFP-positive cells in CD24-high 
fraction is observed in differentiating neural cells but not in ESCs. (C, D and F) CD24lo (in 
red), CD24-low fraction; CD24hi (in blue), CD24-high fraction. (C and F) Two-way ANOVA 
with Tukey’s post-hoc analysis; *** p<0.001; **** p<0.0001; p are adjusted p-value from 
Tukey’s test; n=3 for each group. (D) Two-way ANOVA with uncorrected Fisher’s LSD test; 
*** p<0.001; n=2 except day 21, n=2; Values are mean ± s.e.m. ESCs, embryonic stem cells; 
EYFP, enhanced yellow fluorescent protein. 
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Figure 3.15: Expression of pluripotency gene and neural genes in CD24-low and 
CD24-high populations during neural differentiation. CD24-low and CD24-high fractions 
from ESCs and cells from three differentiation time points (day 5, 15 and 21) were sorted by 
FACS. qRT-PCR showed consistently high level of Oct4 in CD24-low population regardless 
of time points analysed. Additionally, expression of neural progenitors genes (Sox1, Nes and 
Pax6), pan-neuronal genes (Tubb3, Rbfox3 and Ncam1), and oligodendrocyte gene (Plp1) in 
CD24-low fraction of differentiating culture remained relatively low and comparable to their 
expression in ESCs. In CD24-high population, an opposite trend between Oct4 and neural 
gene expression was observed, Oct4 expression was declining along differentiation whereas 
the expression of most neural genes was increasing as differentiation progressed. CD24lo (in 
red), CD24-low population; CD24hi (in blue), CD24-high population. Two-way ANOVA with 
uncorrected Fisher’s LSD test; * p<0.05; ** p<0.01; *** p<0.001; **** p<0.0001; n=2 for each 
group except day 21, n=3; Values are mean ± s.e.m. ESCs, embryonic stem cells; FACS, 
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Table 3.2: Statistical analysis of expression of pluripotency and neural progenitor 
genes during neural differentiation (related to Figure 3.15) 





CD24lo vs CD24hi 
CD24lo vs CD24hi 
CD24lo vs CD24hi 









CD24lo vs CD24hi 
CD24lo vs CD24hi 
CD24lo vs CD24hi 









CD24lo vs CD24hi 
CD24lo vs CD24hi 
CD24lo vs CD24hi 









CD24lo vs CD24hi 
CD24lo vs CD24hi 
CD24lo vs CD24hi 





P-value from uncorrected Fisher’s LSD test; n=2 for each group except day 21, n=3. 
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Table 3.3: Statistical analysis of neuronal gene expression during neural 
differentiation (related to Figure 3.15) 





CD24lo vs CD24hi 
CD24lo vs CD24hi 
CD24lo vs CD24hi 









CD24lo vs CD24hi 
CD24lo vs CD24hi 
CD24lo vs CD24hi 









CD24lo vs CD24hi 
CD24lo vs CD24hi 
CD24lo vs CD24hi 





P-value from uncorrected Fisher’s LSD test; n=2 for each group except day 21, n=3. 
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3.3.2 CD133 does not distinguish between neural 
progenitors and post-mitotic neurons  
Although the use of CD24 excludes pluripotent cells in differentiating neural 
cultures, we further sought other surface antigens that could be used for labelling 
neural progenitors. This allows further characterisation of the enkephalinergic 
neurons and may be useful for future applications such as transplantation of purified 
neural progenitors. A literature search suggested CD133 (also known as Prominin-1), 
as a candidate marker. It is highly expressed in neural progenitor cells and has been 
used to purify mouse neural progenitor from postnatal forebrain (Corti et al., 2007) 
and cerebellum (Lee et al., 2005). Therefore, we tested the feasibility of using this 
marker to define a neural progenitor population in culture. The majority of ESCs did 
not express CD133 (Figure 3.16; CD133-: 71.53±21.81, CD133+: 12.81±10.66; n=3 
per group, values are mean of percentage of live cells analysed ± s.e.m.) and 
consistent with previous studies, a proportion of cells in CD133-negative fraction 
became less prominent and was comparable to that of CD133-positive fraction as 
differentiation progresses. (Figure 3.16; CD133-: 32.90±7.18, CD133+: 45.67±8.67 
for day 5; CD133-: 37.53±11.93, CD133+: 47.20±14.86 for day 15; CD133-: 
42.00±15.73, CD133+: 45.50±16.20 for day 21; two-way ANOVA, interaction 
between CD133 expression level and time point: F(3,16)=2.883, p=0.0683;  effect of 
CD133 expression level: F(1,16)=0.6891, p=0.4187; effect of time point: 
F(3,16)=0.03812, p=0.9897; n=3 per group, values are mean of percentage of live cells 
analysed ± s.e.m.).  
Since the CD133-negative population in differentiating cultures will consist 
of both undifferentiated ESCs and post-mitotic neuronal cells, we decided to use a 
combination of CD133 and CD24 to define three populations in culture. We 
hypothesised that CD24-high/CD133-positive and CD24-high/CD133-negative 
populations would define neural progenitors and post-mitotic neural cells, 
respectively, whilst CD24-low subset would label undifferentiated cells. 
As we have previously shown (Chapter 3.3.1) the CD24-low fraction defines 
undifferentiated cells in culture, we, therefore, excluded this population from further 
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analysis. (Figure 3.17 A). The percentage of CD24-high/CD133-negative and CD24-
high/CD133-positive populations is not significantly different at any time point 
analysed (Figure 3.17 B; two-way ANOVA, interaction between CD24/CD133 
expression level and time point: F(3,16)=0.3785, p=0.7698; effect of CD24/CD133 
expression level: F(1,16)=1.375, p=0.2581; effect of time point: F(3,16)=3.342, 
p=0.0458; n=3 per group). This was unexpected, however, it is possible that during 
differentiation, neural progenitors proliferate at the same rate as cells exiting the 
progenitor stage thus the percentage of cells in both fractions remains unchanged.     
To confirm that the two populations, CD24-high/CD133-negative and CD24-
high/CD133-positive are post-mitotic cells and neural progenitors, respectively, cells 
were sorted from both fractions at different stages and qRT-PCR analysis performed 
for key genes involved in ESC neural differentiation. Unexpectedly, no significant 
difference in expression levels was found in most of the genes examined in the two 
populations (Figure 3.18). The level of Oct4 expression exhibited a significant 
reduction coincident with differentiation progress but no statistical difference was 
observed between the CD24-high/CD133-negative and CD24-high/CD133-positive 
fractions. (Figure 3.18; two-way ANOVA, interaction between CD24/CD133 
expression level and time point: F(3,8)=0.3436, p=0.7948; effect of CD24/CD133 
expression level: F(1,8)=1.304, p=0.2865; effect of time point: F(3,8)=15.05, p=0.0012; 
n=2 per group). Expression of neural progenitor genes Sox1, Nes and Pax6 were also 
identical in both populations (Figure 3.18; two-way ANOVA, interaction between 
CD24/CD133 expression level and time point: F(3,8)=0.02115, p=0.9955 for Sox1; 
F(3,8)=0.1361, p=0.9357 for Nes; and F(3,8)=0.3716, p=0.7759 for Pax6; effect of 
CD24/CD133 expression level: F(1,8)=0.09059, p=0.7711 for Sox1; F(1,8)=0.2868, 
p=0.6069 for Nes; and F(1,8)=1.527, p=0.2517 for Pax6; effect of time point: 
F(3,8)=4.106, p=0.0489 for Sox1; F(3,8)=1.651, p=0.2535 for Nes; and F(3,8)=2.295, 
p=0.1546 for Pax6; n=2 per group) and reached peak expression at day15. 
Expression of the pan-neuronal marker Tubb3 showed a significant difference 
between populations at day 15 and 21 of differentiation (Figure 3.18; two-way 
ANOVA, interaction between CD24/CD133 expression level and time point: 
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F(3,8)=2.150, p=0.1721; effect of CD24/CD133 expression level: F(1,8)=7.148, 
p=0.0282; effect of time point: F(3,8)=4.523, p=0.0390; Uncorrected Fisher’s LSD 
test: p=0.9700 ESC CD24hi/CD133- vs CD24hi/CD133+; p=0.9244 day 5 
CD24hi/CD133- vs CD24hi/ CD133+; p=0.0278 day 15 CD24hi/CD133- vs 
CD24hi/CD133+; and p=0.0354 day 21 CD24hi/CD133- vs CD24hi/CD133+;  n=2 per 
group). The neuronal genes Rbfox3 and Ncam1 and oligodendroglial genes (Plp1 and 
Gfap) revealed no difference in their expression pattern (Figure 3.18; two-way 
ANOVA, interaction between CD24/CD133 expression level and time point: 
F(3,8)=0.9586, p=0.4577 for Rbfox3; F(3,8)=0.1456, p=0.9296 for Ncam1; F(3,8)=1.152, 
p=0.3858 for Plp1; and F(3,8)=0.8773, p=0.4923 for Gfap; effect of CD24/CD133 
expression level: F(1,8)=2.673, p=0.1407 for Rbfox3; F(1,8)=0.04795, p=0.8321 for 
Ncam1; F(1,8)=0.6277, p=0.4511 for Plp1; and F(1,8)=0.8714, p=0.3779 for Gfap; 
effect of time point: F(3,8)=3.823, p=0.0574 for Rbfox3; F(3,8)=2.905, p=0.1012 for 
Ncam1; F(3,8)=0.6890, p=0.5838 for Plp1; and F(3,8)=1.134, p=0.3919 for Gfap; n=2 
per group). These findings indicated that both the CD24-high/CD133-negative and 
CD24-high/CD133-positive populations have similar expression profiles of the genes 
examined. Therefore use of both CD24 and CD133 was not beneficial to further 
discriminate neural progenitors from post-mitotic neural cells in NB cultures. For 
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Figure 3.16: Expression of CD133 in ESCs and differentiating cells in NB cultures. 
Flow cytometric analysis of ESCs and cells at three differentiation time points (day 5, 15 and 
21) stained with a CD133 antibody. (A) Plots show gating for CD133-negative (left) and 
CD133-positive (right) subsets. (B) Summary of CD133 expression showing a nearly 
identical pattern of expression in all stages analysed. (C) CD133 expression profile 
throughout differentiation. ESC sample had high percentage of CD133-negative population 
in contrast to differentiating cells, which show a similar proportion of CD133-negative and 
CD133-positive populations. Two-way ANOVA; No significant difference was found; n=3 for 
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Figure 3.17: The use of CD24 and CD133 to define subpopulations of cells during 
neural differentiation. Flow cytometric analysis of CD24 and CD133 in ESCs and 
differentiating cells. (A) Plots gated for CD24-high/CD133-negative and CD24-high/CD133-
positive populations. (B) Quantification of the percentage of cells in both fractions at all time 
point analysed. CD24hi/CD133- (in red), CD24 high/CD133-negative fraction; CD24hi/CD133+ 
(in blue), CD24 high/CD133-positive fraction. Two-way ANOVA; No significant difference 
was found; n=3 for each group; Values are mean ±s.e.m. ESCs, embryonic stem cells. 
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Figure 3.18: Gene expression profiles of CD24-high/CD133-negative and CD24-
high/CD133-positive populations during neural differentiation. CD24-high/ CD133-
negative and CD24-high/CD133-positive fractions from ESCs and cells at three 
differentiation time points (day 5, 15 and 21) were sorted by FACS. qRT-PCR analysis 
shows the expression pattern of most genes (except Tubb3 at day 15 and day 21 of 
differentiation) in the two populations were similar. CD24hi/CD133- (in red), CD24 
high/CD133-negative fraction; CD24hi/CD133+ (in blue), CD24 high/CD133-positive fraction. 
Two-way ANOVA with uncorrected Fisher’s LSD test; * p<0.05; n=2 for each group; Values 
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3.4 In vitro characterisation of embryonic stem cell-
derived enkephalinergic neurons  
 
3.4.1 Characterisation of embryonic stem cell-derived EYFP-
positive neural cells in NB and NB+3F cultures 
We have shown that the NB+3F culture medium resulted in a higher 
percentage of EYFP-positive cells compared to NB medium (Chapter 3.2.6).  To 
confirm the identity of EYFP-positive cells, which were expected to be 
enkephalinergic MSNs, we next characterised the phenotype of the EYFP-positive 
neurons in both culture conditions by immunocytofluorescence staining. Consistent 
with the FACS analysis (Figure 3.13), we found that the number of EYFP-positive 
cells (by qualitative analysis) in NB culture was lower than that in the NB+3F 
culture. However, only a few EYFP neurons were enkephalin-positive (Figure 3.19 
A and 3.20 A). This finding was more obvious in the NB+3F culture. Staining of E14 
(wild-type) mESCs cultured similarly demonstrated that those grown in the NB 
medium had a higher proportion of βIII-tubulin-positive/enkephalin-positive neurons 
than NB+3F (Figure 3.21 A and B; qualitative analysis), confirming what was found 
in the PNK18 line. This discrepancy could be explained by the fact that enkephalin is 
a neurotransmitter, which is released by neurons in the central nervous system, 
therefore, hindering co-localisation. Another possibility is that the EYFP-positive/ 
enkephalin-negative neurons had previously been enkephalinergic. EYFP expression 
results from the expression of, and recombination by, Cre-recombinase, which is 
controlled by the Penk promoter. Activation of Penk promoter leads to Cre-mediated 
removal of the stop cassette in front of the EYFP reporter gene. Transient activation 
of the Penk promoter could potentially produce recombination and EYFP expression. 
However, the endogenous Penk promoter could have been inactive at the time of 
analysis and no enkephalin would be made from such cells. To understand which one 
of the two hypotheses was the cause of the absence of enkephalin in EYFP-positive 
neurons, we performed qRT-PCR analysis of Penk mRNA levels from bulk cultures 
at day 21 of differentiation (Figure 3.22) in the two culture conditions. If the first 
hypothesis was true; enkephalin was still produced from the EYFP neurons but is 
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undetectable because it was released from the cells, the Penk mRNA levels in 
NB+3F culture should be higher than that of the NB culture. However, if the EYFP 
neurons in the NB+3F culture were not expressing enkephalin at the time of analysis, 
the Penk mRNA levels in the NB+3F culture should be lower than that of the NB 
culture. We found that the expression of Penk was, indeed, significantly down-
regulated in the NB+3F culture (p=0.0018, unpaired Student’s t-test, n=4 per group), 
confirming the finding from the immunostaining data. Thus, the EYFP-positive cells 
in the NB+3F culture may have committed to an enkephalinergic fate during 
differentiation but they subsequently lost that identity. To investigate this possibility, 
we performed qRT-PCR analysis of PNK18 line cultured in NB or NB+3F 
conditions on earlier stages of differentiation, at the ESC stage, day 3, day 5, day 7 
and day 15 of differentiation. The first three time points are prior to the addition of 
BDNF in the NB+3F differentiation protocol, therefore, are called NB+D+S (Figure 
3.23 A). Expression of Penk in NB+D+S (NB+3F) culture was significantly up-
regulated at day 5 of differentiation compared to controls (Figure 3.23 B and C; one-
way ANOVA: F(2,3)=404.1, p=0.0002; Tukey’s multiple comparison test: p=0.0020 
ESC vs NB day 5; p=0.0001 ESC vs NB+D+S day 5; p=0.0013 NB day 5 vs 
NB+D+S day 5; n=2 for each group) Penk mRNA levels in NB+D+S (NB+3F) 
culture dropped sharply at day 7 of differentiation, reaching the lowest levels at day 
15 and 21 (Figure 3.23 B). In contrast, the expression of Penk in the NB culture 
showed only modest changes with no obvious fluctuation. This, therefore, provides 
an explanation of the higher proportion of EYFP-positive cells despite the lower 
expression of Penk in NB+3F cultures at the later time point of differentiation.  
The expression of other striatopallidal markers, such as Adora2a and Drd2 at 
day 21 of differentiation were slightly up-regulated in NB+3F culture compared to 
NB culture, although not at a significantly different level (Figure 3.22; p=0.4648 for 
Adora2a and p=0.2903 for Drd2, unpaired Student’s t-test, n=4 per group). All of the 
data provided here indicated that the addition of the three factors in the NB medium 
had a detrimental effect on enkephalin expression, but not on Adora2a and Drd2. 
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We then investigated whether EYFP-positive neurons demonstrated other 
features of a medium spiny neuron phenotype. Immunostaining analysis showed that 
some EYFP neurons in both culture conditions were Darpp32-positive (Figure 3.19 
B and 3.20 B) and GABAergic (Figure 3.19 C and 3.20 C), resembling the in vivo 
MSNs. A GABAergic phenotype was also found in the E14 line cultured in both 
media for 21 days (Figure 3.21 C and D). The expression profiles of both Ppp1r1b 
and Gad1 (Figure 3.22), the genes that encode for Darpp23 and the enzyme used for 
GABA synthesis, respectively, showed no difference between the NB and NB+3F 
cultures (p=0.4631 for Ppp1r1b and p=0.2003 for Gad1, unpaired Student’s t-test, 
n=4 per group), although there was a higher trend in the NB+3F sample. Likewise, 
other MSN markers such as Foxp1 and Foxp2 were similarly expressed in both 
culture conditions (Figure 3.22; NB vs NB+3F cultures; p=0.8694 for Foxp1 and 
p=0.6905 for Foxp2, unpaired Student’s t-test, n=4 per group). Lastly, we also 
checked the expression of substance P (also known as tachykinin or Tac1) and 
Drd1a, markers for striatonigral MSNs. Although no significant difference in 
expression levels was detected between the two cultures (Figure 3.22; p=0.1318 for 
Tac1 and p=0.1831 for Drd1a, unpaired Student’s t-test, n=4 per group), the NB+3F 
culture showed higher trend of expression compared to the NB culture.  
We next corroborated the gene expression finding from bulk cultures by 
analysing defined populations of cells within the cultures. We FACS sorted CD24-
high/EYFP-positive cells and CD24-high/EYFP-negative cells from day 21 of both 
NB and NB+3F cultures (Figure 3.24). Quantitative RT-PCR analysis demonstrated 
a significant difference in Penk expression between different culture conditions and 
populations (Figure 3.24; two-way ANOVA, interaction between population and 
culture condition: F(1,9)=5.141, p=0.0496; effect of population: F(1,9)=6.176, 
p=0.0347; effect of culture condition: F(1,9)=14.78, p=0.0039; n=3 per group except 
CD24-high/EYFP-negative in NB culture, n=4). Similar to data from bulk culture, 
Penk was significantly down-regulated in CD24-high/EYFP-positive cells from 
NB+3F culture compared to NB culture (Tukey’s multiple comparison test: 
p=0.0104). In the absence of the three factors, Penk is statistically enriched in EYFP-
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positive population compared to the negative population (Tukey’s multiple 
comparison test: p=0.0293). This supported the specificity of EYFP reporter 
expression. To confirm the purity of our FACS sorted populations, we checked 
EYFP expression and found a significant difference between population (CD24-
high/EYFP-positive cells vs CD24-high/EYFP-negative cells) but not culture 
condition (Figure 3.24; two-way ANOVA, interaction between population and 
culture condition: F(1,5)=2.349, p=0.1859; effect of population: F(1,5)=.115.2, 
p=0.0001; effect of culture condition: F(1,5)=1.171, p=0.3287; n=2 per group except 
CD24-high/EYFP-negative in NB culture, n=3). Indeed, EYFP expression was 
enriched in CD24-high/EYFP-positive cells when compared to CD24-high/EYFP-
negative cells in both NB and NB+3F cultures (Tukey’s multiple comparison test: 
p=0.0010 in NB culture and p=0.0059 in NB+3F culture). 
No significant difference between population nor culture condition in terms 
of expression profiles was found in any of the other striatal genes. Adora2a and 
Ppp1r1b were similarly expressed amongst both populations in both culture 
conditions (Figure 3.24; two-way ANOVA, interaction between population and 
culture condition: F(1,5)=0.1253, p=0.7378 for Adora2a; and F(1,7)=0.7254, p=0.4226 
for Ppp1r1b; effect of population: F(1,5)=1.278, p=0.3095 for Adora2a; F(1,7)=0.4770, 
p=0.5120 for Ppp1r1b; effect of culture condition: F(1,5)=0.5356, p=0.4971 for 
Adora2a; F(1,7)=0.1229, p=0.7362 for Ppp1r1b; n=2 per group for Adora2a except 
CD24-high/EYFP-negative in NB culture, n=3 and n=2 for Ppp1r1b except CD24-
high/EYFP-negative in NB culture, n=4 and CD24-high/EYFP-negative in NB+3F 
culture, n=3). Interestingly, expression of Drd2 in the EYFP-negative fraction from 
both cultures showed a higher trend when compared to the EYFP-positive 
population, although it did not reach any significant level (Figure 3.24; two-way 
ANOVA, interaction between population and culture condition: F(1,7)=0.01412, 
p=0.9087; effect of population: F(1,7)=3.635, p=0.0982; effect of culture condition: 
F(1,7)=1.054, p=0.3388; n=2 per group except CD24-high/EYFP-negative in NB 
culture, n=4 and CD24-high/EYFP-negative in NB+3F culture, n=3). This gene, 
however, is less specific to striatopallidal MSNs than Penk and Adora2a since it is 
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also highly expressed in striatal cholinergic interneurons (Guzman et al., 2011). 
Lastly, we found that Tubb3 expression showed a non-significant enrichment in the 
EYFP-negative population (Figure 3.24; two-way ANOVA, interaction between 
population and culture condition: F(1,9)=0.1831, p=0.6788; effect of population: 
F(1,9)=1.602, p=0.2374; effect of culture condition: F(1,9)=0.8593, p=0.3781; n=3 per 
group except CD24-high/EYFP-negative in NB culture, n=4). This may be due to the 
fact that the EYFP-negative population was composed of various types of neuronal 
cells including those that were more mature.  
From these findings, we concluded that both cultures were able to generate 
GABAergic striatal neurons with comparable efficiency. A striatonigral phenotype of 
ESC-derived MSNs could be obtained by both culture conditions. However, the 
striatopallidal phenotype, in particular enkephalin expression, is enriched in the NB 
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Figure 3.19: Enkephalinergic MSN phenotype of EYFP-positive neurons cultured in NB 
medium. Immunofluorescence staining for EYFP, βIII-tubulin and other key markers (A) 
enkephalin, (B) Darpp32 and (C) GABA at day 21 of differentiation. Co-localisation between 
(A) EYFP and enkephalin, (B) EYFP and Darpp32 and (C) EYFP and GABA was found in 
some but not all EYFP-positive cells. All scale bars are 25 µm. MSN, medium spiny neuron; 
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Figure 3.20: Enkephalinergic MSN phenotype of EYFP-positive neurons cultured in 
NB+3F medium. Immunofluorescence staining for EYFP, enkephalin, Darpp32, GABA and 
βIII-tubulin at day 21 of differentiation.  (A) Only a fraction of EYFP-positive cells expressed 
enkephalin whilst the majority of them did not. Darpp32 (B) and GABA (C) were expressed in 
some EYFP-positive cells. All scale bars are 25 µm. MSN, medium spiny neuron; EYFP, 
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Figure 3.21: Enkephalinergic and GABAergic phenotypes of E14 neuronal cells. 
Immunofluorescence staining of the E14 line grown in NB (A and C) and NB+3F (B and D) 
media. (A and B) Cells were fixed and stained for βIII-tubulin and enkephalin at day 21 of 
differentiation. The NB culture showed more enkephalin-positive cells than NB+3F. (C and 
D) βIII-tubulin and GABA staining at day 21 of differentiation showed both NB and NB+3F 
cultures exhibited GABAergic neurons. All scale bars are 25 µm. 
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Figure 3.22: Gene expression analysis of cells from NB and NB+3F cultures: qRT-PCR 
analysis of the PNK18 line cultured in NB or NB+3F media was performed at day 21 of 
differentiation. Only Penk showed a significant difference between the culture conditions. 
Other striatopallidal markers, Adora2a and Drd2, were similarly expressed. Expression of 
MSN markers such as Ppp1r1b, Foxp1 and Foxp2 and GABAergic neuronal marker Gad1 
was identical in both culture conditions. Increased expression of the striatonigral genes, 
Tac1 and Drd1a, was observed in NB+3F although it did not reach a significant level. 
Unpaired Student’s t-test; ** p<0.01; n.s., no significance; n=4 for both culture conditions; 
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Figure 3.23: Penk expression in NB and NB+3F cultures throughout differentiation. (A) 
Schematic representation of the NB+3F (or NB+D+S if samples were analysed at early time 
points prior to the addition of BDNF) differentiation protocol. (B) qRT-PCR analysis of the 
PNK18 ESC and differentiated PNK18 line in NB and NB+3F cultures at day 3, day 5, day 7, 
day 15 and day 21 of differentiation. (C) Differentiated cells from the two culture conditions at 
day 5 showed a significant enrichment of Penk compared to ESC. One-way ANOVA with 
Tukey’s post-hoc analysis; ** p<0.01; *** p<0.001; p are adjusted p-value from Tukey’s test; 
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Figure 3.24: Gene expression analysis of CD24hi/EYFP- and CD24hi/EYFP+ populations 
in NB and NB+3F cultures. The PNK18 line was cultured in NB or NB+3F medium. Sorting 
was performed at day 21 of differentiation to collect CD24hi/EYFP- and CD24hi/EYFP+ 
fractions. (A) Plots showed the gating used for sorting two populations. (B) qRT-PCR 
analysis of sorted samples revealed a significant enrichment of Penk expression in the 
CD24hi/EYFP+ fraction compared to the CD24hi/EYFP- fraction in NB cultures. Expression of 
Penk in the NB+3F culture, in contrast, did not show a difference between the two 
populations. When compared CD24hi/EYFP+ subset between two culture conditions, Penk 
expression was significantly higher in NB cultures. EYFP was highly expressed in the 
CD24hi/EYFP+ population of both cultures. Other genes including striatopallidal markers 
Adora2a and Drd2, MSN marker Ppp1r1b and post-mitotic neuronal marker Tubb3 were 
similar in terms of their expression, regardless of the culture conditions and populations. 
Two-way ANOVA with Tukey’s post-hoc analysis; * p<0.05; ** p<0.01; p are adjusted p-value 
from Tukey’s test; n=3 for each group except CD24hi/EYFP- in NB culture, n=4; Values are 
mean ± s.e.m. EYFP, enhanced yellow fluorescent; MSN, medium spiny neuron. 
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3.4.2 Penk expression is suppressed by addition of either 
DKK1 or Shh 
We have shown that the NB+3F culture condition resulted in the down-
regulation of Penk. It is likely that this is due to the addition of one or more of the 
factors in the NB+3F culture. We, however, believed that Bdnf via an activation of 
its high affinity receptor TrkB is essential, at least in vivo, for the Penk expression. 
This has been demonstrated in the work of Dr. Dario Besusso in the Minichiello lab 
(Besusso et al., 2013). In situ hybridisation analysis of the BAC-Penk-Cretg/+, 
Trkblx/lx line, in which the TrkB receptor was deleted specifically in enkephalinergic 
neurons, showed that the Penk transcript was significantly reduced in the striata of 
these animals compared to their control littermates (Figure 3.25 A; p=0.036, 
unpaired Student’s t-test, n= 3 per group). We have also confirmed this finding by 
qRT-PCR analysis of striata from the BAC-Penk-Cretg/+, Trkblx/lx mice (Figure 3.25 
B). Indeed, expression of Penk was significantly diminished in the absence of Bdnf-
TrkB signalling in enkephalinergic striatal neurons (p=0.0016, unpaired Student’s t-
test, n= 3 per group). From the data above, we hypothesised that the presence of 
exogenous human DKK1 and/or murine Shh in NB+3F culture led to Penk down-
regulation. 
To address which factor(s) in NB+3F contributed to the reduction of Penk 
transcript, we cultured the PNK18 line in three novel culture conditions, which 
contained only one or two factors used in NB+3F culture in addition to NB and 
NB+3F cultures (no Shh, NB+D+B; no DKK1, NB+S+B; and no DKK1 or Shh, 
NB+B; Table 3.4). Gene expression analysis was then performed at day 15 of 
differentiation. We found a significant reduction in Penk expression in the NB+3F, 
NB+D+B and NB+S+B cultures when compared to the NB culture (Figure 3.26; 
one-way ANOVA: F(4,13)=12.74, p=0.0002; Tukey’s multiple comparison test: 
p=0.0054 for NB vs NB+3F; p=0.0218 for NB vs NB+D+B; p=0.0300 for NB vs 
NB+S+B; n=4 for NB and NB+3F and n=3 for NB+D+B and NB+S+B). This 
indicated that addition of either DKK1 or Shh led to suppression of Penk expression. 
Consistent with in vivo findings, we can exclude the detrimental effect of BDNF on 
Penk expression since we did not find a difference in Penk mRNA level between NB 
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and NB+B cultures (Tukey’s multiple comparison test: p=0.6985; n=4 for NB+B). In 
reality, Penk expression was slightly higher in NB+B than NB cultures. When 
compared to other cultures, the expression of Penk in NB+B cultures was 
significantly higher than that of NB+3F, NB+D+B and NB+S+B cultures (Tukey’s 
multiple comparison test: p=0.0006 for NB+B vs NB+3F; p=0.0026 for NB+B vs 
NB+D+B; p=0.0035 for NB+B vs NB+S+B). We conclude that the presence of 
exogenous DKK1 and/or Shh but not BDNF down-regulates Penk expression at day 
15 of differentiation. Addition of exogenous BDNF, interestingly, did not enhance 
the Penk expression in cultures.   
To corroborate the findings above, we repeated the same analysis at day 21 of 
differentiation (Figure 3.26). Consistent with day 15 data, Penk was highly expressed 
in NB culture but not in NB+3F, NB+D+B or NB+S+B cultures (one-way ANOVA: 
F(4,13)=13.82, p=0.0001; Tukey’s multiple comparison test: p=0.0007 for NB vs 
NB+3F; p=0.0011 for NB vs NB+D+B; p=0.0004 for NB vs NB+S+B; n=4 for NB 
and NB+3F and n=3 for NB+D+B and NB+S+B). We also found a significant 
difference of Penk expression between the NB+B and NB+3F (Tukey’s multiple 
comparison test: p=0.0414; n= 4 for NB+B) and between the NB+B and NB+S+B 
(Tukey’s multiple comparison test: p=0.0169) cultures. Addition of BDNF in NB+B 
culture, however, did not affect Penk expression in comparison to the NB culture 
(Tukey’s multiple comparison test: p=0.1912 for NB vs NB+B). Interestingly, the 
level of Penk expression at day 21 of differentiation was lower than that of day 15, 
although only NB+B culture showed statistically difference (unpaired t test: 
p=0.8127 for NB, p=0.1914 for NB+3F, p=0.6841 for NB+D+B, p=0.3082 for 
NB+S+B and p=0.0326 for NB+B). This indicates that the maintenance of Penk 
expression at later time points in our culture system requires other supporting 
factor(s) in addition to BDNF. 
Analysis of other striatopallidal markers such as Adora2a and Drd2 (Figure 
3.26), unlike Penk, showed no difference in their expression at both day 15 (one-way 
ANOVA: F(4,13)=1.575, p=0.2394 for Adora2a; F(4,13)=0.1526, p=0.9585 for Drd2; 
n=4 for NB, NB+3F and NB+B and n=3 for NB+D+B and NB+S+B) and day 21 of 
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differentiation (one-way ANOVA: F(4,13)=1.511, p=0.2562 for Adora2a; 
F(4,13)=0.9896, p=0.4472 for Drd2; n=4 for NB, NB+3F and NB+B and n=3 for 
NB+D+B and NB+S+B). Likewise, expression of the MSN markers Ppp1r1b, 
Foxp1, Foxp2 and Ctip2 (Figure 3.27) was identical amongst all culture conditions at 
day 21 of differentiation (one-way ANOVA: F(4,13)=1.386, p=0.2924 for Ppp1r1b; 
F(4,13)=1.963, p=0.1598 for Foxp1; F(4,13)=0.4396, p=0.7780 for Foxp2; F(4,13)=2.382, 
p=0.1051 for Ctip2; n=4 for NB, NB+3F and NB+B and n=3 for NB+D+B and 
NB+S+B). We also checked for the expression of striatonigral markers Tac1, Drd1a. 
Although Drd1a showed slightly higher expression in NB+3F, no significant 
difference was detected (one-way ANOVA: F(4,13)=1.199, p=0.3574 for Tac1; 
F(4,13)=1.820, p=0.1852 for Drd1a; n=4 for NB, NB+3F and NB+B and n=3 for 
NB+D+B and NB+S+B). To ensure that all culture conditions used had no bias in 
term of neuronal subtypes specification, we confirmed that expression of Gad1 was 
unchanged. A slight, but not significant increase was observed only in NB+3F 
compared to NB cultures (one-way ANOVA: F(4,13)=1.480, p=0.2647; n=4 for NB, 
NB+3F and NB+B and n=3 for NB+D+B and NB+S+B). This confirmed that similar 
numbers of GABAergic neurons were generated amongst all culture conditions used. 
A non-significant increase in Gad1 expression in NB+3F culture might result from 
higher Tubb3 expression, despite not significantly difference, in this culture 
condition compared to NB culture (one-way ANOVA: F(4,13)=2.041, p=0.1476, n=4 
for NB, NB+3F and NB+B and n=3 for NB+D+B and NB+S+B). 
Lastly, to ensure that cells in cultures could respond to BDNF with no bias, 
we checked whether TrkB receptor (encoded by Ntrk2 gene) expression was similar 
in all culture conditions (Figure 3.27). As expected we found that all cultures 
expressed a comparable amount of Ntrk2 (one-way ANOVA: F(4,13)=1.634, 
p=0.2248, n=4 for NB, NB+3F and NB+B and n=3 for NB+D+B and NB+S+B). 
Neural specification is regulated by several signalling pathway including the 
Wnt and Shh pathways. We, therefore, checked whether the addition of exogenous 
DKK1 and/or Shh to the cultures affected the transcriptional level of their 
endogenous counterparts. Quantitative RT-PCR analysis of Dkk1 demonstrated its 
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constant expression of in all culture conditions at both days 15 and 21 of 
differentiation (Figure 3.28; one-way ANOVA: F(4,13)=1.096, p=0.3990 for day 15; 
F(4,13)=0.2248, p=0.9197 for day 21; n=4 for NB, NB+3F and NB+B and n=3 for 
NB+D+B and NB+S+B). In contrast, exogenous addition of both DKK1 and Shh led 
to significant changes of the endogenous Shh transcript level at both days 15 and 21 
of differentiation (one-way ANOVA: F(4,13)=5.961, p=0.0060 for day 15; 
F(4,13)=5.498, p=0.0081 for day 21; Tukey’s multiple comparison test: p=0.0126 for 
day 15 NB vs NB+3F; and p=0.0277 for day 21 NB vs NB+3F; n=4 for NB, NB+3F 
and NB+B and n=3 for NB+D+B and NB+S+B). The addition of either DKK1 or 
Shh individually in the culture media was not sufficient to produce a similar increase 
in Shh expression.  (Tukey’s multiple comparison test: NB vs NB+D+B: p=0.9541 
for day15 and p=0.8849 for day 21; NB+3F vs NB+D+B: p=0.0061 for day 15 and 
p=0.0085 for day 21; NB vs NB+S+B: p=0.9798 for day 15 and p>0.9999 for day 
21; NB+3F vs NB+S+B: p= 0.0567 for day 15 and p= 0.0412 for day 2).  
To further investigate the direct effect of exogenous DKK1 and Shh in 
NB+3F culture, we performed a similar analysis at earlier time points of 
differentiation (ESC stage, day 3, day 5 and day 7), corresponding to the period 
where both recombinant proteins were added to the cultures (Figure 3.29 A and B). 
In contrast to that observed at the later time points, endogenous Dkk1 and Shh levels 
in NB cultures were higher than in NB+D+S (NB+3F) cultures with a significant up-
regulation observed at day 7 of differentiation (two-way ANOVA, interaction 
between culture condition and time point: F(3,8)=34.98, p<0.0001 for Dkk1; and 
F(3,8)=19.14, p=0.0005 for Shh; effect of time point: F(3,8)=48.48, p<0.0001 for Dkk1; 
F(3,8)=31.90, p<0.0001 for Shh; effect of culture condition: F(1,8)=55.37, p<0.0001 for 
Dkk1; F(1,8)=33.84, p=0.0004 for Shh; Tukey’s multiple comparison test: p<0.0001 
for Dkk1 day 7 NB vs NB+D+S and p=0.0002 for Shh day 7 NB vs NB+D+S; n=2 
per group). Thus, the presence of DKK1 and Shh in NB+D+S (NB+3F) cultures 
leads to the suppression of endogenous Dkk1 and Shh production at day 7 of 
differentiation. However, by day 15 of differentiation the expression of Shh has 
recovered and was higher in NB+3F cultures (Figure 3.28). This may be a result of 
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the abrupt withdrawal of exogenous Shh at day 9 of the differentiation process, 
leading to an over-compensatory production of Shh in the NB+3F culture. 
Specification of LGE progenitors requires both Shh signalling and Wnt 
inhibition, from this data we hypothesised that the endogenous level of Shh and Dkk1 
is enough to drive ESCs towards a LGE fate. Addition of exogenous DKK1 and Shh 
at the concentration and duration we have used, however, may influence ESCs to 
acquire other neuronal fates. It is known that higher concentrations of Shh can induce 
ESCs to acquire a MGE fate rather than a LGE fate (Danjo et al., 2011, Ma et al., 
2012). The neurons in the NB+3F cultures may, therefore, be MGE derivatives rather 
than LGE-derived striatal neurons. To address this we measured the expression of the 
MGE marker Nkx2.1 in the two culture conditions at day 7 of differentiation (Figure 
3.29 C). Indeed, we found a significant enrichment of Nkx2.1 expression but not of a 
forebrain marker Foxg1 in the NB+D+S (NB+3F) culture (Figure 3.29 C and D; 
p=0.0358 for Nkx2.1 and p=0.0612 for Foxg1, unpaired Student’s t-test, n=2 per 
group), indicating that cells in the N+D+S (NB+3F) culture are more MGE primed. 
This may explain the down-regulation of Penk expression in NB+3F culture (Figure 
3.22). However, other striatal markers are similarly expressed in both NB and 
NB+3F cultures, therefore, there may be other unknown mechanisms that contribute 
to this reduction.  
In summary, our data shows that the reporter ESC line we have generated is 
capable of acquiring a GABAergic MSN phenotype in all culture conditions tested. 
However, only the NB culture condition was able to acquire the enkephalinergic 
phenotype typical of striatopallidal MSNs. Enkephalin was highly expressed in the 
absence of exogenous DKK1 and Shh. Therefore, we propose that Penk down-
regulation is a consequence of excess exogenous DKK1 and Shh in the culture 
medium. We, however, also believe that other signalling pathways might be involved 
in this process. Finally, we propose that both NB and NB+B cultures are ideal 
conditions for deriving enkephalinergic MSNs from mESCs. 
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Figure 3.25: Penk is down-regulated in the absence of Bdnf-TrkB signalling. (A) In situ 
hybridisation of the Penk transcript in the caudate-putamen (CPu) of eight months old BAC-
Penk-Cretg/+, Trkblx/lx animals showed a significant reduction of enkephalin in comparison to 
their control littermates (BAC-Penk-Cre+/+; Trkblx/lx).   (B) qRT-PCR analysis demonstrated a 
significant decrease in Penk expression level in BAC-Penk-Cretg/+; Trkblx/lx striata compared 
to Trkblx/lx controls. Figure A is from Besusso et al., 2013. Scale bar is 50 µm. Unpaired 
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Figure 3.26: Expression of striatopallidal-specific genes in differentiating neural cells. 
PNK18 cells were cultured in combinations of NB medium and exogenous factors (no factor 
added, NB; three factors added, NB+3F; no Shh, NB+D+B; no DKK1, NB+S+B; and no 
DKK1 or Shh, NB+B). Quantitative RT-PCR analysis was performed at day 15 and day 21 of 
differentiation. At both time points, Penk was highly expressed in NB and NB+B cultures but 
not in NB+3F, NB+D+B nor NB+S+B. Expression of Adora2a and Drd2 showed no 
significant difference amongst all culture conditions. One-way ANOVA with Tukey’s post-hoc 
analysis; * p<0.05; ** p<0.01; *** p<0.001; p are adjusted p-value from Tukey’s test; n=4 for 
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Figure 3.27: Gene expression analysis of MSN-specific and other important markers in 
differentiating neural cells. PNK18 cells were cultured in combinations of NB medium and 
exogenous factors (no factor added, NB; three factors added, NB+3F; no Shh, NB+D+B; no 
DKK1, NB+S+B; and no DKK1 or Shh, NB+B). Quantitative RT-PCR analysis was performed 
at day 21 of differentiation for the expression of MSN markers (Ppp1r1b, Foxp1, Foxp2 and 
Ctip2), striatonigral markers (Tac1 and Drd1a), GABAergic marker (Gad1), Post-mitotic 
neuronal marker (Tubb3) and TrkB (Ntrk2). One-way ANOVA; No statistical difference was 
observed in all genes analysed; n=4 for NB, NB+3F and NB+B and n=3 for NB+D+B and 
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Figure 3.28: Up-regulation of Shh in NB+3F culture at day 15 and 21 of differentiation. 
qRT-PCR analysis showed that presence of recombinant human DKK1 and mouse Shh in 
NB+3F culture significantly increased Shh transcript compared to NB (both at day 15 and 
day 21) or NB+B (day 21 only) cultures. This effect was abolished when either DKK1 or Shh 
was added individually into cultures (NB+D+B or NB+S+B, respectively). In contrast, Dkk1 
transcript level at day 15 and 21 of differentiation was not influenced by exogenous 
treatment of DKK1 and Shh. One-way ANOVA with Tukey’s post-hoc analysis; * p<0.05; ** 
p<0.01; p are adjusted p-value from Tukey’s test; n=4 for NB, NB+3F and NB+B and n=3 for 
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Figure 3.29: Suppression of endogenous levels of Dkk1 and Shh by addition of 
exogenous DKK1 and Shh leads to up-regulation of Nkx2.1. (A and B) qRT-PCR 
analysis of ESCs and differentiating cells at day 3, day 5 and day 7 of differentiation 
demonstrated that the presence of recombinant DKK1 and Shh in NB+D+S (NB+3F) culture 
inhibits endogenous production of (A) Dkk1 and (B) Shh transcripts. This inhibitory effect 
was gradually increased as differentiation progressed and the difference in Dkk1 and Shh 
expression level between NB and NB+D+S (NB+3F) cultures reached a significant level at 
day 7. As a result, expression of the MGE marker Nkx2.1 at the same time point (day 7) in 
NB+D+S (NB+3F) culture was statistically higher than that of the NB culture. This indicated 
that the NB+D+S (NB+3F) culture exhibited more MGE-primed neurons than the NB culture. 
Expression of forebrain progenitor marker Foxg1 in NB+D+S (NB+3F) culture at day 7, in 
contrast, was similar to that of NB culture, indicating that forebrain specification was not 
altered with exogenous treatment of DKK1 and Shh. Two-way ANOVA with Tukey’s post-hoc 
analysis; * p<0.05; *** p<0.001; **** p<0.0001; p are adjusted p-value from Tukey’s test; n=2 
for each group; Values are mean ± s.e.m. ESCs, embryonic stem cells; MGE, medial 
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3.4.3 Electrophysiological properties of embryonic stem 
cell-derived EYFP-positive neurons 
All of the electrophysiological analyses were conducted by Dr. Andrei-Sorin 
Illie, a postdoctoral research scientist in Dr. Colin Akerman’s group at the 
Department of Pharmacology, University of Oxford. 
We have shown in the previous sections that we were successful in deriving 
EYFP-positive neurons that were enkephalinergic and exhibited the molecular 
phenotype of the MSNs. To test whether these neurons possess electrophysiological 
properties of functional neurons, we performed whole-cell patch-clamp recording in 
current- and voltage-clamp configurations. EYFP-expressing neurons were targeted 
for patch-clamp recording between day 22 and 24 of differentiation (Figure 3.30 A). 
Passive membrane properties of EYFP-expressing neurons of both NB and NB+3F 
cultures were identical (Figure 3.30 B, C and D). The resting membrane potential of 
neurons from NB and NB+3F cultures was -58.1±2.5 mV and -58.2±3.3 mV, 
respectively (Figure 3.30 B; values are mean ± s.e.m., p=0.79, unpaired Student’s t-
test, n=12 per group). The cell capacitance was 36.3±5.4 pF for EYFP-positive 
neurons from the NB culture and 35.3±9.5 pF for EYFP-expressing neurons from the 
NB+3F culture (Figure 3.28 C; values are mean ± s.e.m., p=0.76, unpaired Student’s 
t-test, n=13 for NB and n=12 for NB+3F,). Lastly, the membrane resistance of 
EYFP-expressing cells from NB culture was 1.13±0.17 GΩ whereas that of NB+3F-
derived EYFP-positive cells was 1.50±0.32 GΩ (Figure 3.28 D; values are mean ± 
s.e.m., p=0.20, unpaired Student’s t-test, n=12 per group,). These values are 
consistent with electrophysiological data from hPSC-derived MSNs (Delli Carri et 
al., 2013b) and also confirm that mESC-derived YFP-positive neurons from both 
cultures have similar electrophysiological properties.   
It has been demonstrated that PSC-derived MSNs could produce repetitive 
action potential when stimulated with a current injection (Shin et al., 2011, Ma et al., 
2012, Delli Carri et al., 2013b) This is considered an important property of functional 
neurons. To test whether the EYFP-positive neurons from both NB and NB+3F 
cultures could fire action potential and exhibit repetitive spiking activity, we injected 
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a series of depolarising currents in current clamp mode, in steps of 5 pA from a 
membrane potential of -80 mV (Figure 3.31 A). We found that all recorded EYFP-
positive cells in NB and NB+3F culture fired repetitive action potentials. The 
minimal current needed for inducing action potentials (also known as rheobase) was 
identical between the two groups of EYFP-expressing cells (Figure 3.31 B; 36.6±9.8 
pA for neurons from NB culture, and 56.0±9.4 pA for neurons from NB+3F culture, 
values are mean ± s.e.m., p=0.41, unpaired Student’s t-test, n=6 for neurons from NB 
culture and n=5 for neurons from NB+3F culture). Interestingly, the maximal firing 
rate in response to suprathreshold stimulation was significantly higher in neurons 
derived from NB+3F culture compared to NB-derived neurons (Figure 3.31 C; 
17.1±1.7 spikes/sec for neurons from NB+3F and 12.5±1.3 spikes/sec for neuron 
from NB, values are mean ± s.e.m., p<0.05, unpaired student’s t-test, n=6 per 
group,). A possible explanation of this could be that the neurons in the NB+3F 
culture are more mature, supported by the observation of longer processes (Figure 
3.13 C and D).  Next, we checked whether voltage-activated currents, which underlie 
spiking activity was present in EYFP-expressing neurons.  Voltage-clamp recordings 
with a series of 12 voltage steps, gradually increasing by +10 mV from a holding 
voltage of -90 mV, were performed. All EYFP-positive neurons from both NB and 
NB+3F cultures exhibited voltage-activated fast inward and delayed outward 
currents, which represent sodium and potassium currents, respectively (Figure 3.31 
D; n=7 for NB culture and n=6 for NB+3F culture). The current densities of the 
inward sodium currents and outward potassium currents of NB- and NB+3F-derived 
neurons were not different (Figure 3.31 E and F). These data confirm that EYFP-
positive neurons derived from NB and NB+3F cultures are functionally active.  
MSNs have been shown to express one type of potassium channel, which 
causes a voltage-gated, fast inactivating potassium currents resembling the A-type 
potassium current (IA) (Surmeier et al., 1988, Nisenbaum et al., 1996, Ericsson et al., 
2011). The presence of this current in MSNs contributes to their unique firing 
property, which is a delay in the initiation of first spike of action potentials (Ericsson 
et al., 2011). Interestingly, we did observe that the first action potential generated 
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could be delayed in neurons from both cultures (black traces in Figure 3.31 A). This 
is in accordance with the presence of an IA-like current in EYFP-positive neurons. To 
confirm the existence of an IA-like current in EYFP-expressing cells, we performed 
voltage-clamp recordings in the presence of 1 µM tetrodotoxin to block the voltage-
gated sodium channels (Delli Carri et al., 2013a). Cells were held at -110 mV and a 
series of depolarising test potentials were applied. The IA current can be completely 
inactivated when the test potential is preceded by a 50 ms prepulse to -40 mV (Delli 
Carri et al., 2013a). The fast inactivating IA current was isolated by subtracting traces 
containing a -40 mV prepulse from traces elicited without a prepulse. We found that 
IA currents could be recorded from EYFP-positive neurons in both NB and NB+3F 
cultures (Figure 3.32 A). The majority of EYFP-positive cells in the NB (71.4%, 5 
out of 7) and NB+3F (66.6%, 4 out of 6) cultures analysed possess IA currents 
(Figure 3.32 B). The maximal IA current density was similar between neurons 
derived from two culture conditions (Figure 3.32 C; 16.1±4.5 pA/pF for NB-derived 
neurons and 15.2±3.4 pA/pF for NB+3F-derived neurons, values are mean ± s.e.m., 
p=0.88, unpaired Student’s t-test). Thus, both culture conditions give rise to EYFP-
positive neurons that exhibit the electrophysiological characteristics of MSNs. 
To conclude, electrophysiological data indicates that the EYFP-positive 
neurons derived from both NB and NB+3F cultures are functionally active. They 
exhibit voltage-activated fast inward sodium and delayed persistent potassium 
currents and are able to fire repetitive action potentials, which are basic properties of 
functional neurons. The majority of EYFP-positive neurons generated also possess 
the fast inactivating IA current, the hallmark electrical property of MSNs.   
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Figure 3.30: Electrophysiological properties of EYFP-positive neurons derived in NB 
and NB+3F cultures. The PNK18 line was cultured in NB and NB+3F conditions for at least 
22 days. Patch clamp analysis of EYFP-positive cells was performed between day 22 and 24 
of differentiation. (A) Representative images in bright field and green fluorescent channel 
showed the patched EYFP-positive neurons in both culture conditions. An average (B) 
resting membrane potential (RMP; n=12 for each group), (C) membrane capacitance (Cm; 
n=13 for NB and n=12 for NB+3F) and (D) membrane resistance (Rm; n=12 for each group) 
of EYFP-positive neurons from NB and NB+3F cultures showed no significant difference of 
these parameters between EYFP-expressing neurons derived from NB and NB+3F cultures. 
Scale bars are 10 µm. Unpaired Student’s t-test; n.s., no significance; Values are mean ± 
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Figure 3.31: EYFP-positive neurons from NB and NB+3F cultures are capable of firing 
repetitive action potentials and possess functional sodium and potassium channels. 
The PNK18 line was cultured in NB and NB+3F conditions for at least 22 days. Patch clamp 
analysis of EYFP-positive cells was performed between day 22 and 24 of differentiation. (A) 
Tracings from current clamp recordings show repetitive action potentials after stimulated with 
increasing suprathreshold currents in EYFP-positive neurons from NB and NB+3F cultures. 
Black traces show the minimal current injections to generate action potentials. The delay in 
generating the first spike is noted. (B) Average of the minimal current necessary for initiating 
depolarisation (n=6 for NB and n=5 for NB+3F) and (C) maximum spike rate after 
suprathreshold current injection (n=6 for each group) in EYFP-positive cells. Neurons from 
the NB+3F culture had a significantly higher spike rate than neurons from the NB culture. (D) 
Tracings from voltage clamp recordings show groups of inward and outward voltage-
activated currents, representing functional sodium and potassium channels, respectively, in 
EYFP-positive neurons derived in NB and NB+3F cultures. No difference in (E) potassium 
and (F) sodium current density of EYFP-positive neurons from NB and NB+3F cultures (n=7 
for NB and n=6 for NB+3F). Data from NB-derived neurons and NB+3F-derived neurons are 
represented in blue and red, respectively. Unpaired Student’s t-test; * p<0.05; n.s., no 
significance; Values are mean ± s.e.m. EYFP, enhanced yellow fluorescent protein. 
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Figure 3.32: EYFP-positive neurons from NB and NB+3F cultures exhibited IA currents. 
(A) Tracings from voltage clamp recordings showed families of fast-inactivating A-type 
potassium current (IA) of EYFP-positive neurons from NB and NB+3F cultures. (B) The 
majority of EYFP-expressing cells (5 out of 7 in NB and 4 out of 6 in NB+3F) exhibited IA 
currents. (C) The average maximal IA current density (n=5 for NB and n=4 for NB+3F) was 
identical between EYFP-positive cells from both cultures. Unpaired Student’s t-test; n.s., no 
significance; Values are mean ± s.e.m. EYFP, enhanced yellow fluorescent protein 
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Chapter 4: Discussion 
 
4.1 Characterisation of an enkephalinergic reporter 
embryonic stem cell line 
We have reported here the generation of an enkephalinergic reporter mESC 
line (PNK18), which can be used as a tool for studying enkephalinergic 
differentiation from mESCs. The PNK18 reporter line was generated by crossing a 
male BAC-Penk-Cre mouse (Besusso et al., 2013) to a female Rosa26-EYFP mouse 
(Srinivas et al., 2001) (Figure 3.1 F). Initial characterisation by Oct4 immunostaining 
implied the pluripotent potential of this line. Additionally, EYFP expression was not 
detected in PNK18 ESCs indicating that Cre-recombination had not occurred during 
the pluripotency stage and supported the specificity of the reporter. The PNK18 line 
was further characterised by chimaera generation via blastocyst injection. We found 
that three out of five animals analysed showed EYFP expression in the expected 
brain regions and cell types including the striatum, hippocampal dentate gyrus and 
cerebellum. Double immunofluorescence staining demonstrated that approximately 
half of the enkephalinergic neurons also expressed EYFP (Figure 3.2 D). However, 
all EYFP-positive neurons were enkephalin-positive ensuring the specificity of the 
line. Thus, the PNK18 ESC line is pluripotent and is a precise reporter for 
enkephalinergic neurons.  
Despite of the specificity of the PNK18 line, one of its limitations is when the 
reporter is activated by Cre-mediated deletion of the stop cassette, the cells will 
continue to express EYFP throughout its life, even if it subsequently loses its 
enkephalinergic phenotype. For most applications such as in vivo labelling of 
enkephalinergic neurons in normal condition, this reporter would be ideal. However, 
for some application including in vivo labelling of enkephalinergic neurons in 
Huntington’s disease models and in vitro differentiation of enkephalinergic neurons 
from ESCs, the possibility that enkephalin expression does not last for the lifespan of 
the neurons should be taken into consideration. Therefore, the PNK18 line may be 
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superior for some applications that aim to investigate the cause of Penk down-
regulation in enkephalinergic neurons, an observation also seen in early stage 
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4.2 Enkephalinergic differentiation from mouse 
embryonic stem cells 
 
4.2.1 N2B27 monolayer culture as a platform for neural 
differentiation 
There are two widely used approaches to derive neuronal cell lineages from 
embryonic stem cells: the embryoid body (EB) formation (Bain et al., 1995) and 
monolayer differentiation (Ying et al., 2003). For MSN derivation, both approaches 
have been demonstrated to generate the DARPP32-positive MSNs with variable 
efficiency (Aubry et al., 2008, Zhang et al., 2010, Danjo et al., 2011, Shin et al., 
2011, Ma et al., 2012, Delli Carri et al., 2013b). However, the monolayer culture is 
superior to the EB formation method from our perspective for the following reasons. 
Firstly, differentiated cells found in EB formation are more heterogeneous and 
consist of higher proportion of mesodermal and endodermal lineages compared to the 
monolayer protocol. Secondly, due to the nature of adherent cultures, cells 
undergoing differentiation via monolayer cultures are more easily monitored 
throughout the process. For these reasons, we have selected the N2B7 monolayer 
culture as a platform for neural differentiation.    
It is known that, in monolayer cultures, the plating density needs to be 
adjusted empirically for each cell line. We found that an optimal plating density for 
the PNK18 line in the N2B27 culture is 15,000 cells/cm2. Lower densities (7,500 
cells/cm2) exhibit massive cell death whereas higher plating densities (30,000 
cells/cm2), although reduce the amount of cell death, result in an increased 
percentage of undifferentiated cells in the culture. 
Initial characterisation of cells cultured in the N2B27 monolayer protocol 
showed the presence of Ctip2-positive cells indicating that the culture was already 
committed to striatal fate to some degree since Ctip2 is expressed in post-mitotic 
MSNs (Arlotta et al., 2008) (Figure 3.3 C). Ctip2 is also found in cortical motor 
neurons (CMNs). However, it is unlikely that the Ctip2-positive cells in our cultures 
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were CMNs since it has been shown previously that the specification of dorsal 
forebrain identity from mESCs using monolayer culture requires inhibition of 
endogenous Shh (Gaspard et al., 2008), which did not happen in our culture system.  
Retinoic acid (RA) signalling plays an important role in mESC differentiation 
from neural induction to neuronal subtype specification. Activation of retinoic acid 
signalling induces ESC differentiation towards both neural and non-neural lineages 
(Stavridis et al., 2010). After neural fate is acquired, RA contributes to rostro-caudal 
patterning of neural tube by inducing caudal identity (Gaspard and Vanderhaeghen, 
2010). We, therefore, checked whether the presence of the RA precursor retinyl 
acetate in B27 supplement affected neural induction and patterning. We found that 
Oct4 was expressed at higher levels in both cultures deficient in vitamin A than in 
N2B27 medium. The opposite was true for Tubb3 expression (Figure 3.5). This 
indicates that the RA precursor may be needed for the loss of pluripotency of ESCs 
during differentiation. The expression of striatal markers such as Ctip2 and Ppp1r1b, 
showed a higher trend of expression in the N2B27-vitA d2 onwards condition, which 
could be explained by the fact that this culture condition could have more forebrain 
neurons since RA was absent during neural patterning. However, expression of these 
striatal genes in all culture conditions analysed was only marginally different. We, 
therefore, selected N2B27 as a basal medium in order to minimise the number of 
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4.2.2 Enhancement of cell survival during neural 
differentiation by modifying the culture medium 
Cell death during monolayer neural differentiation is an issue encountered in 
this protocol. The severity of this problem may vary amongst different cell lines. The 
PNK18 reporter line, for example, has a lower survival rate compared to the E14 
line, not uncommon in transgenic cell lines. For this reason we have optimised the 
culture conditions to increase the survival rate during differentiation in several ways. 
We first added Lif to the N2B27 medium on the first day of differentiation (Ying and 
Smith, 2003). In parallel to this, we added the anti-apoptotic molecule Y-27632 
throughout the differentiation process. Under this condition, however, we still 
observed a vast amount of cell death at later stages of differentiation. In contrast, 
when we used ESC medium without Lif supplemented with the ROCK inhibitor (Y-
27632) at day 0, then transferred to N2B27 medium supplemented with Y-27632 
throughout differentiation, cell survival improved (Figure 3.7). This indicates that the 
presence of foetal bovine serum (FBS) in the ESC medium but not Lif in the culture 
at the time of plating is essential for cell survival during differentiation, at least for 
the PNK18 line.  
Next, we checked whether the presence of the ROCK inhibitor for enhancing 
cell survival was needed throughout the differentiation (NB culture) or only on the 
first day of differentiation (NB+R culture). Indeed, the NB culture contained more 
live cells compared to NB+R condition at day 15 of differentiation, confirming the 
anti-apoptotic property of Y-27632 (Figure 3.8). Moreover, expression of the neural 
progenitor marker Sox1, the forebrain markers Foxg1 and Pax6 as well as the LGE 
marker Gsx2 was enriched in NB compared to NB+R cultures (Figure 3.9). This is 
consistent with the literature suggesting that the inhibition of ROCK could induce 
neural differentiation (Chang et al., 2010, Frisca et al., 2013),  
We have also tested whether addition of the neural progenitor mitogen Fgf2 
would increase cell proliferation during differentiation. Although we found that this 
was not the case, an explanation might be the timing we chose to add Fgf2, which 
was day 0-1 of differentiation, was too early. Finding from Ying and colleagues 
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demonstrated that Fgf4 but not Fgf2, could enhance neural specification via an 
increase in the number of Sox1-positive progenitor cells (Ying et al., 2003). Fgf2, 
however, is known to be a potent mitogen for Sox1-positive neural progenitors, so an 
appropriate time point for adding exogenous Fgf2 would be a later time point (e.g. 
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4.2.3 Addition of exogenous DKK1, Shh and BDNF to 
improve striatal differentiation 
Lastly, it has been demonstrated in several publications that addition of 
extrinsic factors could improve the efficiency of PSC-derived MSN generation. The 
most commonly use factors are the WNT inhibitor DKK1, SHH and BDNF. DKK1 
is normally used during the early days of differentiation to induce neural 
specification as well as to instruct the rostral patterning once neural induction is 
occurred (Watanabe et al., 2005, Aubry et al., 2008, Zhang et al., 2010, Danjo et al., 
2011, Delli Carri et al., 2013b). SHH instead, is used to specify forebrain neural cell 
to ventral fate since the MSNs originates from one of the ventral forebrain structure, 
the LGE (Aubry et al., 2008, Zhang et al., 2010, Danjo et al., 2011, Ma et al., 2012, 
Delli Carri et al., 2013b). BDNF is then added at a later stage to support neuronal 
maturation (Aubry et al., 2008, Zhang et al., 2010, Danjo et al., 2011, Ma et al., 
2012, Delli Carri et al., 2013b). Since the enkephalinergic phenotype of DARPP32-
positive MSNs generated using these three factors has not yet been demonstrated, we 
checked the whether enkephalinergic neurons could be produced and if so, more 
efficiently, from cultures using this cocktail. Our preliminary data showed that 
addition of these three factors to our culture (NB+3F) led to an increase in the 
percentage of EYFP-positive cells when compared to the control NB culture 
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4.3 The use of surface markers to identify neural cells 
in culture 
Cells in monolayer cultures are heterogeneous and, therefore, purification of 
neural lineage cells is necessary prior to gene expression profiling to avoid 
misinterpretation. One of the most commonly used techniques to select cells of 
interest is the fluorescence-activated cell sorting (FACS) technique, which is based 
on the light scattering and fluorescent properties, as well as the combination of 
different surface antigens, expressed by each subpopulation. We have shown here 
that CD24 is highly expressed in differentiating neural cells. A CD24-high 
population shows higher expression of neural progenitor and post-mitotic neuronal 
genes whilst the expression of a pluripotency marker was diminished (Figure 3.15). 
In contrast, the CD24-low fraction, a minority in differentiating cultures, comprised 
undifferentiated cells as determined by a high level of Oct4 expression. The findings 
here are consistent with previous study by Pruszak and colleagues (Pruszak et al., 
2009), which demonstrated increased CD24 expression level during ESC 
differentiation toward a neuronal phenotype.  
 In addition to CD24, we tested whether another surface marker, CD133, was 
helpful for separating neural progenitors from neuronal cells. CD133 is highly 
expressed in mouse CNS progenitor cells (Corti et al., 2007). So this marker could 
probably be used to label neural progenitors in our in vitro culture system. We 
speculated that the CD24-high/CD133-positive population would be neural 
progenitors whereas CD24-high/CD133-negative would label neuronal cells. 
However, qRT-PCR analysis showed that only the post-mitotic neuronal marker 
Tubb3 was enriched in the CD24-high/CD133-negative fraction. No enrichment of 
other post-mitotic neuronal genes (e.g. Rbfox3 and Ncam1) was found in such 
population (Figure 3.18). Likewise, the expression of the neural progenitor markers 
Sox1, Nes and Pax6 was equally expressed in both populations analysed. This 
unexpected finding could be explained by the fact that CD133 has been widely used 
to identify CNS progenitor cells in vivo (Uchida et al., 2000, Lee et al., 2005, 
Panchision et al., 2007, Corti et al., 2007). To our knowledge, no publications have 
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demonstrated the use of this marker to label mESC-derived neural progenitor cells. It 
is possible that CD133 expression pattern in ESC-derived neural cells is not identical 
to their in vivo counterpart. To test this hypothesis, one approach would be to sort 
both CD133-negative and CD133-positive fractions and check whether they could 
proliferate when putting them back into culture. Alternatively, qRT-PCR analysis for 
neural progenitor genes of sorted CD133-negative and CD133-positive fractions 
would also be helpful.  
Nevertheless, the use of CD24 is likely sufficient to distinguish neural 
progenitors from neurons. Although the use of CD24 with the established gating 
strategy, which eliminates undifferentiated cells from neural cells, was sufficient for 
the analyses performed. Further optimisation of gating strategies to obtain a more 
homogeneous population would be required prior to transplantation of neural 
progenitors into murine striata. Setting gates on three distinct subpopulations, CD24-
low, -intermediate and -high followed by qRT-PCR analysis from these three 
subpopulations may assist homogeneity. The expectation would be that CD24-low 
fraction contains mainly Oct4-positive undifferentiated cells whilst CD24-
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4.4 In vitro characterisation of embryonic stem cell-
derived enkephalinergic neurons 
 
4.4.1 Penk expression in NB and NB+3F cultures 
The discovery of only a proportion of EYFP-positive cells that co-expressed 
enkephalin in the PNK18 line was unexpected. One hypothesis was that the 
enkephalin peptide is continuously released and not stored in the cell and, thus, is 
difficult to detect. Alternatively, and, perhaps, the most likely, is that the EYFP-
positive cells no longer expressed enkephalin at the time of analysis. The PNK18 line 
was constructed to express EYFP upon activation of Pre-pro-enkephalin promoter 
that would express Cre recombinase, which in turn would delete the conditional stop 
cassette. Therefore, EYFP would label any cells that acquired an enkephalinergic fate 
(including transiently) at any point in their life.  
To test the first possibility (a secretory effect), we performed qRT-PCR 
analysis of the Penk transcript in both NB and NB+3F cultures. Data from bulk 
cultures demonstrated that Penk expression was diminished in the NB+3F culture 
(Figure 3.22). This finding ruled out the first hypothesis and was in favour of the 
second one. It could be argued that the analysis of bulk culture was not precisely 
reflecting what was happening in EYFP-positive cells. However, we believe that 
most of the Penk mRNA detected in the culture should be generated by EYFP-
positive cells, with little possibility that the EYFP-negative cells would contribute to 
any Penk transcript found in the culture. Additionally, a similar finding was found 
from analysis of a more defined subpopulation, the CD24-high/EYFP-positive cells 
fraction sorted from both culture conditions (Figure 3.24). Furthermore, Penk 
expression was found to peak at day 5 of differentiation (Figure 3.23 B). By day 15 
and day 21 of differentiation, Penk expression levels in the NB+3F culture dropped 
dramatically. Expression of Penk in NB culture was also decreased at later time 
points of differentiation (day 15 and 21) but to a milder extent compared to NB+3F 
culture. However, EYFP is highly expressed in NB+3F culture condition as a result 
Derivation of enkephalinergic medium spiny neurons                                                  
from mouse embryonic stem cells 
Chapter 4: Discussion  178 
of the activation of the Penk promoter at earlier time point during differentiation as 
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4.4.2 Role of BDNF 
In vivo data from the previous work in the Minichiello lab by Dr. Dario 
Besusso showed that absence of Bdnf-TrkB signalling in striatopallidal MSNs 
contributed to loss of enkephalin expression (Besusso et al., 2013). This indicated 
that Bdnf is not responsible for the reduction of enkephalin expression observed in 
NB+3F culture. Instead, Bdnf itself, through TrkB signalling, maintains the 
enkephalinergic phenotype in striatopallidal MSNs in vivo. Our in vitro finding also 
supports this since an addition of BDNF in NB+B culture did not alter enkephalin 
expression. We initially expected that expression of enkephalin would be higher in 
the presence of exogenous BDNF although our data did not show so (Figure 3.26). 
Perhaps, the endogenous level of Bdnf in the culture may be enough to maintain 
enkephalin expression and, therefore, addition of exogenous BDNF is not required. 
 It should be noted that the expression level of Penk in both NB and NB+B 
cultures at day 21 of differentiation was slightly lower than that of day 15 despite no 
statistical significance (Figure 3.26). One explanation may be the lack of factors that 
are essential for both neuronal survival and maintenance of an enkephalinergic 
phenotype in the cultures. For instance, it is known that expression of Penk is 
regulated by cyclic adenosine monophosphate (cAMP) and protein kinase C (PKC) 
(Comb et al., 1986, Hyman and Borsook, 1996). Addition of cAMP may, therefore, 
maintain the enkephalin level in cultures. Furthermore, the glial cell line-derived 
neurotrophic factor (Gdnf) has been showed to be necessary for a survival of 
midbrain dopaminergic neurons, motor neurons and peripheral neurons (Lin et al., 
1993, Airaksinen and Saarma, 2002). Enkephalinergic MSNs may also require such 
glial cell support for survival and GDNF was present in the cocktail used to derive 
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4.4.3 Role of exogenous DKK1 and Shh  
Addition of either human DKK1 (in NB+D+B culture) or murine Shh (in 
NB+S+B culture), contrary to BDNF, led to a huge reduction in Penk transcript 
levels comparable to that observed in the NB+3F cultures (Figure 3.26). These data 
demonstrate that addition of exogenous DKK1 and Shh, at least with the same 
concentration and duration we used, should be avoided if an enkephalinergic 
phenotype is desired. We are aware that the loss of enkephalinergic phenotype might 
be due to the differences in duration or concentration of both factors in our system 
compared to others. However, the DKK1 and Shh concentrations used in our study 
was similar to that used by the majority of PSC-derived MSN reports (Table 4.1) 
(Aubry et al., 2008, Zhang et al., 2010, Danjo et al., 2011, Ma et al., 2012, Delli 
Carri et al., 2013b). Likewise, the duration of treatment was the same reported in the 
study that used mESC for deriving the MSN (Danjo et al., 2011). Thus, the 
likelihood that the concentration as well as the duration of treatment for DKK1 and 
Shh we have used are not suitable for MSN derivation is minimal. The discovery of 
increased Nkx2.1 in the presence of exogenous DKK1 and Shh, indicating that these 
cultured cells had acquired other neuronal fates. This explains why the 
enkephalinergic phenotype has not been found in PSC-derived MSNs generated from 
those protocols. 
It has been demonstrated that mESC-derived neural progenitors produced by 
monolayer differentiation devoid of any addition of exogenous ligands related to Shh 
and Wnt signalling pathway are ventral forebrain primed. This is due to an 
endogenous production of SHH in the culture (Gaspard et al., 2008). Likewise, a 
study from Shin and colleagues showed that Darpp32-positive MSNs could be 
derived from mESCs with simple monolayer culture (no exogenous Dkk1 or Shh 
added) (Shin et al., 2011). Consistent with this, we found that the NB culture 
exhibited a significant level of Shh transcript at day 7 of differentiation. Thus, 
endogenous Shh in NB culture may be enough for instructing cells to become LGE-
primed progenitors. Addition of recombinant Shh in NB+D+S (NB+3F) culture, may 
result in excessive concentrations for LGE fate induction, but falls into an optimal 
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level for MGE commitment. Indeed, the higher expression of Nkx2.1 at day 7 of the 
NB+D+S (NB+3F) culture confirms this hypothesis.  
Transcription of Dkk1 and Shh is regulated by a negative feedback loop. It is 
known that activation of the canonical Wnt signalling pathway induces Dkk1 
transcription to negatively regulate β-catenin-mediated transcription of target genes 
(Chamorro et al., 2005, González-Sancho et al., 2005). Inhibition of canonical Wnt 
signalling by exogenous DKK1, therefore, results in a decrease of Dkk1 transcript, as 
observed in the NB+D+S (NB+3F) culture. Likewise, Shh positively regulates the 
expression of the Bmp family, which in turn suppresses Shh transcription (Bastida et 
al., 2009). Excess Shh by exogenous administration in the NB+D+S (NB+3F) 
culture, therefore, could inhibit endogenous production of Shh.  
The reason why Shh was up-regulated in NB+3F culture at day 15 and 21 of 
differentiation is not clear (Figure 3.28). Perhaps, this was a transient over-
compensation due to the removal of exogenous Shh at day 9 of differentiation since 
Shh up-regulation was less prominent at day 21 of differentiation. However, if this is 
the case, up-regulation of Shh should be evident in NB+S+B culture as well. The up-
regulation of Shh in the presence of both exogenous DKK1 and Shh at day 15 and 21 
of differentiation would imply an interaction between the two signalling pathways. 
Consistent with this, it has been shown that activation of Wnt signalling is required 
for Shh expression (Yang and Niswander, 1995). 
It is very interesting that other striatopallidal markers such as Adora2a and 
Drd2 are not influenced by exogenous DKK1 and Shh. Likewise, the MSN markers 
Ppp1r1b, Ctip2, Foxp1 and Foxp2 are similarly expressed in all culture conditions. 
This finding further confirms that, for MSN derivation from mESC, the addition of 
exogenous DKK1 and Shh is dispensable and causes down-regulation of Penk. Thus, 
our finding underscores the benefit of using the NB medium to derive 
enkephalinergic MSNs from mESCs, especially for modelling HD. 
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Table 4.1: Concentration and duration of treatment for recombinant DKK1 and SHH 
in published protocols. 
 DKK1 
Concentraion   Duration                                                                                                                                              
(ng/mL)          (day) 
SHH 
Concentraion Duration                                                                                                                       
(ng/mL)          (day) 
Aubry et al., 2008* 100 25         
(day 21-46) 
200 25           
(day 21-46) 
Zhang et al., 2010* 100 8-10      
(day 22-30) 
250 8-10        
(day 22-30) 
Danjo et al., 2011** 200 6           
(day 0-6) 
200 6             
(day 3-9) 
Shin et al., 2012** - - - - 
Ma et al., 2012* - - 200 14           
(day 12-26) 
Delli Carri et al., 2013* 100 21         
(day 5-26) 
200 21           
(day 5-26) 
* Differentiation protocol for hPSCs. 







Derivation of enkephalinergic medium spiny neurons                                                  
from mouse embryonic stem cells 
Chapter 4: Discussion  183 
4.4.4 Electrophysiological analyses of EYFP-positive 
neurons 
In order to confirm that the EYFP-positive cells grown in the NB and NB+3F 
cultures are physiologically functional, we analysed their electrophysiological 
properties using whole cell patch clamp technique. Basic properties such as resting 
membrane potential, membrane capacitance and membrane resistance were similar 
between EYFP-positive cells in NB and NB+3F cultures. Neurons from both cultures 
also exhibited functional sodium and potassium channels. Moreover, when 
stimulated with currents above a depolarising threshold, EYFP-positive neuronal 
cells from both cultures spiked multiple action potentials. Based on the maximum 
spike rate of EYFP-positive neurons, we found that NB+3F condition had more 
mature EYFP-expressing neurons compared to NB culture as they had a higher spike 
frequency. Furthermore, we also demonstrated that the majority of EYFP-positive 
neurons analysed from both culture conditions (approximately 70 per cent) possess 
an A-type potassium current (IA), which is considered a hallmark for MSNs 
(Ericsson et al., 2011, Delli Carri et al., 2013b). The IA current density was identical 
between EYFP cells derived from NB and NB+3F cultures. These data, therefore, 
indicated that both the electrophysiologically more mature EYFP-positive neurons 
grown in NB+3F and those grown in NB media are functional and exhibit electrical 
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Chapter 5: Conclusion and future directions 
 
5.1 Conclusion 
We have shown that the enkephalinergic MSNs can be generated from mESCs 
using a modified N2B27 monolayer culture. Striatopallidal enkephalinergic MSNs 
have been described as the most vulnerable neuronal population in the inherited 
polyglutamine-induced neurodegenerative disorder Huntington’s disease (Reiner et 
al., 1988, Albin et al., 1990, Albin et al., 1992, Richfield et al., 1995, Deng et al., 
2004). Currently there is no curative treatment and the development of an in vitro 
platform for deriving the enkephalinergic MSNs would be useful for both disease 
modelling and the development of cell-based therapies.  
To allow dissection of enkephalinergic differentiation from mESCs, we 
generated an enkephalinergic reporter mESC line, the BAC-Penk-Cretg+-, Rosa26-
EYFPyfp/+ (PNK18) line. Activation of the Penk promoter in any cells is visualised by 
EYFP expression resulting from the Cre-recombinase deletion of a stop cassette 
upstream of EYFP. Characterisation of the PNK18 line revealed that all of the 
EYFP-positive neurons within the striatum of chimaeras generated by PNK18 
injection into blastocyst were enkephalinergic, confirming the specificity of the line. 
When the PNK18 line was cultured in the N2B27 neural differentiation medium, 
neural progenitors and post-mitotic neurons were found abundantly in the culture. 
Furthermore, use of the modified N2B27 culture (NB culture), in which the ROCK 
inhibitor Y-27632 was added into the culture throughout differentiation, greatly 
enhanced cell survival during neural differentiation. 
By using a cell surface marker, CD24, we have set up a FACS strategy to 
purify neural cells from any undifferentiated cells remaining in the culture. This 
would exclude the possibility of having EYFP-positive undifferentiated cells 
contamination in the analyses.  
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We have shown that the percentage of EYFP-positive neurons in NB cultures 
can be increased approximately ten times by the addition of recombinant human 
DKK1 (100 ng/mL from day 1 to day 6) and recombinant mouse Shh (200 ng/mL 
from day 3 to day 9) into the culture medium (NB+3F). However, the higher number 
of EYFP-positive cells did not correlate with the expression level of Penk as 
determined by minimal Penk expression in sorted CD24-high/EYFP-positive cells. 
We subsequently demonstrated a transient peak of Penk expression in NB+3F 
cultures at day 5 of differentiation, which may account for the higher number of 
EYFP-expressing cells in this culture condition. Further investigation indicated that 
the addition of exogenous DKK1 and/or Shh causes down-regulation of Penk in 
NB+3F cultures. Interestingly, expression of other striatopallidal markers, Adora2a 
and Drd2, and the striatal markers, Ppp1r1b, Ctip2, Foxp1 and Foxp2, were not 
affected by the presence of exogenous DKK1 and Shh. 
Finally, we have shown that the EYFP-positive neurons from both NB and 
NB+3F cultures possessed electrical properties resembling functional MSNs. The A-
type potassium current (IA) was present in the majority of EYFP-expressing neurons 
from both culture conditions. Despite the similarity of the molecular and electrical 
phenotypes of the MSNs from both cultures, the enkephalinergic phenotype of 
striatopallidal MSNs was mainly found in the EYFP-positive neurons derived from 
the NB culture. Therefore, we propose that the presence of exogenous DKK1 and 
Shh in culture is unfavourable to derive enkephalinergic MSNs from mESCs. The 
absence of exogenous DKK1 and Shh in the culture, in contrast, results in the 
generation of enkephalinergic MSNs without affecting the molecular or 
electrophysiological signature of such neurons. These findings could be used to 
derive the enkephalinergic MSNs from mESCs for other applications including in 
vitro disease modelling. 
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5.2 Future directions 
Further studies have been planned to confirm the identity of EYFP-positive 
neurons derived from NB and NB+3F cultures. Although we have shown by qRT-
PCR that, other than Penk, the expression of other key markers for striatopallidal 
MSNs, as well as general markers for MSNs, is similar in both cultures, a 
comparison of the transcriptome of EYFP-positive neurons derived from both 
cultures would be useful for dissecting the cellular phenotypes of the EYFP neurons. 
At present we have performed RNA sequencing from FACsorted CD24-high/EYFP-
positive neurons derived from both NB and NB+3F cultures and are awaiting 
differential expression and pathway analysis. In parallel, we are optimising FACS of 
enkephalinergic neurons from the striatum of transgenic animals (BAC-Penk-Cretg/+, 
Ai9tm/+), in which enkephalinergic neurons are labelled with the tdTomato reporter 
(Madisen et al., 2010). Once this is achieved, enkephalinergic MSNs will be sorted 
from the striatum and RNA sequencing will be performed. Transcriptomic analysis 
will be performed to elucidate the similarities and discrepancies between the in vitro 
and the in vivo neurons. 
Additionally, it is important to investigate whether the derivation of human 
enkephalinergic MSNs resembles the findings we have shown in mouse. It is highly 
likely that, developmentally, different species may behave differently. Indeed, a good 
example comes from two studies, which used either mESC or hESC to derive 
forebrain neurons. When monolayer culture was used without addition of Shh, the 
majority of mESC-derived forebrain neurons express ventral marker including Gsx2 
(Gaspard et al., 2008). In contrast, expression of ventral forebrain markers is minimal 
in hESC-derived telencephalic neurons cultures in medium devoid of exogenous 
SHH (Ma et al., 2012). Therefore, it might be possible that the default neural 
differentiation of mESC is towards ventral telencephalic fate whilst hESC-derived 
neurons are dorsally telencephalic primed. 
Increasing the efficiency of the proportion of enkephalinergic neuron in the 
culture is essential for further applications. This could be achieved by further 
optimisation of the culture conditions. Alternatively, a more powerful approach is to 
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over-express transcription factors involved in enkephalinergic striatal differentiation 
in the differentiating cultures. This would, in theory, lead to an enrichment of the 
number of enkephalinergic MSN in the cultures.  
Finally, to determine whether the EYFP-positive enkephalinergic cells could 
be engrafted and differentiated in vivo, transplantation of such cells should be 
performed. Since neural progenitor cells are more capable of surviving and 
integrating into host tissue, the EYFP-positive cells would be sorted during the 
differentiation stage found to contain the highest number of LGE-committed 
progenitor cells. To do this, we could use the CD24 with a new gating strategy to 
separate progenitors from post-mitotic neurons, or seek a new surface marker that is 
able to label neural progenitors. The sorted EYFP-positive progenitor would then be 
transplanted into the brain of Huntington’s disease model animals such as the R6/2 
mice (Mangiarini et al., 1996) or the YAC128 mice (Slow et al., 2003). Functional 
assessment for any improvement of motor deficit would then be performed. This 
would address whether the EYFP-positive neurons are capable of restoring the 
phenotypes related to striatal degeneration. 
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